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Abstract 
The forage tree legume leucaena [Leucaena leucocephala (Lam.) de Wit ssp. glabrata 
(Rose) Zarate] is a high-quality ruminant feed vitally important as a source of protein for 
livestock production in tropical regions. However, the presence of the acutely toxic non-
protein amino acid mimosine in leaves and seeds, and its breakdown to chronically toxic 
hydroxypyridones (DHP), was believed to limit its productivity and adversely affect animal 
health. The Australian development of a fermenter-cultured oral inoculum containing the 
DHP-degrading ruminal bacterium Synergistes jonesii in the 1980s was thought to 
overcome this issue; however, anecdotal evidence of leucaena toxicity symptoms 
occurring in inoculated animals remained. In response, a program of research was initiated 
to investigate the efficacy of S. jonesii as well as other methods of protection against 
toxicity in ruminants. Broadly, this involved two areas of research, namely the 
effectiveness of: (a) microbiological degradation via S. jonesii; and (b) non-microbial 
metabolic detoxification.  
Key objectives were to: (a) determine the efficacy of inoculation with S. jonesii both within 
Indonesia and Australia; (b) profile the toxicity status of ruminants in eastern Indonesia; (c) 
investigate the impact of mineral supplementation on 2,3-DHP toxicity; and (d) determine 
the extent of in vivo conjugation of DHP and its role in protecting ruminants against 
toxicity. 
Initially, an Indonesian study involving the transfer of rumen fluid from “protected” 
ruminants to naïve Bali bulls was conducted. Sequential monitoring of DHP levels in urine 
indicated that there was no effect of inoculation. Secondly, a controlled animal house 
experiment was conducted in Australia to measure the impact of high leucaena diets on 
production in naïve steers and the effect of inoculation with the commercial S. jonesii 
inoculum. Key findings were: (1) inoculation had no effect on total DHP excretion; (2) 
indigenous S. jonesii strains were present in naïve animals prior to inoculation; (3) DHP 
did not suppress thyroid hormone production; and (4) high levels of the isomer 2,3-DHP 
were present without accompanying signs of toxicity. 
The leucaena toxicity status of ruminants in eastern Indonesia was then assessed in a 
survey across the four islands of Lombok, Sumbawa, Sumba and West Timor. A number 
of different strains of S. jonesii, including the ATCC type strain (78.1), were detected, 
however S. jonesii was always at low population levels and always accompanied by high 
levels of undegraded 2,3-DHP in urine. Despite this apparent failure of S. jonesii to 
degrade DHP, there was no observed impact on animal productivity or health. Accordingly, 
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to investigate non-microbial detoxification mechanisms, a feeding trial involving goats in 
Indonesia was conducted to investigate the effect of Iron(II) sulphate mineral 
supplementation as a possible pathway for reducing the toxicity of 2,3-DHP by chemically 
binding to the toxin. Key findings were: (1) despite high levels of 2,3-DHP ingested by 
goats, no clinical signs of toxicity presented; (2) mineral supplementation did not result in 
an improvement in animal production; (3) evidence of conjugation of 2,3-DHP was 
observed; and (4) goats consuming diets of 100% leucaena were highly productive. 
Finally, the role and mechanism of conjugation was investigated. This involved a 
longitudinal assessment of the toxicity status and productivity of Indonesian Bali bulls on 
100% leucaena diets. High liveweight gains were recorded even though the bulls were 
persistently excreting high levels of 2,3-DHP. Using HPLC and HDMS it was found that up 
to 97% of DHP was excreted as 2,3-DHP in conjugated form. The conjugate was identified 
as glucuronic acid, forming a 2,3-DHP-O-glucuronide. It was concluded that conjugation 
played the key role in preventing DHP toxicity, as conjugation of DHP not only increases 
the speed of clearance of toxins from the body, but also actively detoxifies the compound. 
As the primary mode of toxicity of DHP is as a strong ligand (chelating with essential 
metals, resulting in deficiencies), the attachment of glucuronic acid inhibits this effect. 
Further, as metal binding occurs via the vicinal (O,O) moiety, the isomerisation of 3,4-DHP 
(from mimosine) to 2,3-DHP results in a weaker ligand and is therefore inherently less 
toxic. While the isomerisation pathway is not fully known, the detection of mono-
hydroxypyridines (HP), previously unidentified, using HPLC and HDMS, could indicate 
possible intermediates. 
The findings of this research greatly advance the knowledge of how ruminants adapt to 
DHP in diet, with the innate mechanism of conjugation identified as the primary mode of 
detoxification. 
It is concluded that microbial detoxification is not the main pathway for toxicity control of 
ruminants consuming leucaena, and that inoculation with S. jonesii may no longer 
necessary. However, appropriate management of ruminants being introduced to leucaena 
diets is necessary to allow the animals to adapt and build metabolic tolerance.  
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Chapter 1 General Introduction 
1.1 Background to leucaena toxicity 
Leucaena [Leucaena leucocephala (Lam.) de Wit ssp. glabrata (Rose) Zárate] is a 
multipurpose forage tree legume, widely used as a feed for ruminants in the tropical and 
sub-tropical world (Shelton and Brewbaker 1994). The many desirable traits of leucaena 
(including high crude protein content (Jones 1979); high palatability (Andrew et al. 2000); 
longevity; and tolerance to frequent severe defoliation and drought) have contributed to its 
success in ruminant production systems. Estimates indicate over 5 million ha have been 
planted worldwide (Brewbaker and Sorensson 1990), including more than 200,000 ha of 
leucaena-grass pastures in Australia (Dalzell et al. 2012). 
Despite the many positive nutritional benefits of leucaena, it contains a toxic non-protein 
free amino acid, mimosine (β-[N-(3-hydroxy-4-oxopyridyl)]-α-aminopropionic acid) 
(Hegarty et al. 1976), which in high concentrations can severely affect animal health and 
performance. Ruminants are capable of converting mimosine to the less acutely toxic 
compound, hydroxypyridone (DHP), of which there are two common isomers [3-hydroxy-
4(1H)-pyridone (3,4-DHP) and 3-hydroxy-2(1H)-pyridone (2,3-DHP)]. DHP is chronically 
toxic, reducing feed intake and animal performance (Jones and Hegarty 1984). Chronic 
DHP toxicosis is commonly referred to as ‘leucaena toxicity’. Pioneering research into 
leucaena toxicity was conducted between 1976 and 1994 by R. J. Jones and colleagues 
(Hegarty et al. 1964a; Jones et al. 1976; Allison et al. 1992; Jones 1994). They published 
widely on the symptoms, chemistry, microbiology, and management of toxicity.  
Mimosine, the toxin in leucaena, has anti-mitotic activity, affecting rapidly dividing cells 
(Tsai and Ling 1971; Jones and Hegarty 1984), causing symptoms including alopecia 
(Hegarty et al. 1964b), excessive salivation (Megarrity and Jones 1983), abortions 
(Holmes 1980), poor fertility (Holmes et al. 1981), and death (Jones et al. 1978). A 
compounding effect of mimosine is its strong affinity to bind metal ions, which can lead to 
severe essential element deficiencies (Tsai and Ling 1971). Toxicosis due to mimosine is 
relatively short term, and only appears when ruminants first consume leucaena or after 
substantial periods of time when leucaena is absent from the diet. This is due to the 
degradation of mimosine to DHP which occurs via plant hydrolase activity post-ingestion 
(Lowry et al. 1983) and many endogenous rumen microbes which are capable of rapidly 
and readily degrading the vast majority of mimosine consumed to DHP within 2 weeks 
from initial introduction (Hegarty et al. 1964b; Ghosh et al. 2007; O'Reagain et al. 2014). 
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The main toxin of concern in leucaena is therefore DHP, which is reported to cause 
goitrogenic effects in animals, reducing feed intake and liveweight gains (Hegarty et al. 
1979; Jones 1979; Megarrity and Jones 1983), and it is also a potent ligand, causing 
essential element deficiencies (Tsai and Ling 1971; Ghosh and Samiran 2007). The initial 
metabolite of mimosine, 3,4-DHP, is commonly isomerised to 2,3-DHP, which is 
considered similarly toxic. In 1984, a gram-negative obligatory anaerobic bacterium was 
discovered in Hawaii, and later in Indonesia, subsequently named Synergistes jonesii, that 
was shown to be capable of degrading DHP to harmless by-products (Jones and Megarrity 
1986). Degradation of DHP by S. jonesii was reported to involve the isomerization of 3,4-
DHP to 2,3-DHP, followed by cleavage of the pyridine ring to unnamed pyruvates that are 
non-toxic and may have positive nutritional qualities (Allison et al. 1992). Rumen fluid from 
a Hawaiian goat containing S. jonesii was subsequently imported to Australia and used as 
the basis of a commercially available inoculum from 1984 (Quirk et al. 1988). Originally 
comprising rumen fluid, and later (1995 onwards) a fermenter-produced enrichment culture 
(Klieve et al. 2002), this inoculum was initially reported to protect animals grazing leucaena 
by degrading the majority of ingested DHP to harmless by-products. 
However, recent findings worldwide have indicated the frequent occurrence of high levels 
of DHP in animals, which were otherwise considered protected by S. jonesii. Concerns 
regarding the efficacy of the inoculum were initially raised in 2004, following a survey of 
Queensland cattle which revealed high DHP levels in urine of animals grazing leucaena 
(Dalzell et al. 2012; Graham et al. 2013). Similar findings were subsequently recorded in 
ruminants in Thailand (Phaikaew et al. 2012), Mexico (Contreras-Hernández et al. 2013; 
Ruz-Ruiz et al. 2013), and Indonesia (Halliday et al. 2013; Halliday et al. 2014b) (Chapter 
4), where animals were often fed high levels of leucaena in diet, up to 100%. Although 
shown to be excreting high levels of undegraded DHP, these animals did not present with 
any clinical signs of toxicity, nor was liveweight gain or reproductive performance affected. 
This anomalous yet widespread situation warranted further investigation of the efficacy of 
bacterial degradation with S. jonesii, and the possible role of alternate mechanisms for 
protection against toxicity, such as conjugation and chelation, which have not been the 
subject of in-depth research. 
As leucaena is an important high-quality forage, the issue of uncontrolled DHP toxicity in 
ruminants represents a potentially serious impediment to animal productivity worldwide. 
Accordingly, this research program was initiated to investigate the efficacy of S. jonesii to 
degrade DHP, especially in high leucaena diets, and the role of alternate detoxification 
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mechanisms. The research focussed on the incidence of DHP toxicity and methods of 
detoxification by ruminants consuming leucaena in eastern Indonesia and Australia 
including: microbial degradation of DHP via the rumen bacterium Synergistes jonesii 
(Chapters 4, 5 & 6), and the role of an alternate metabolic pathway involving detoxification 
of DHP via conjugation in the liver (Chapters 7 & 8). 
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Chapter 2 Review of literature: 
Leucaena toxicity—a new perspective on the most widely used forage tree legume 
The full paper can be downloaded from: https://doi.org/10.17138/tgft(1)1-11 
2.1 Introduction  
Leucaena is a multipurpose forage tree legume widely used in the tropical world (Shelton 
and Brewbaker 1994) with past estimates of up to 5 million ha planted worldwide 
(Brewbaker and Sorensson 1990). There are no current estimates but this area will have 
increased substantially (Dalzell et al. 2012). While first domesticated for human use 7000 
years ago (Hughes 1998), its primary value is now as a feed for ruminants. Leucaena is 
high in crude protein (Jones 1979), highly palatable (Andrew et al. 2000), long-lived, and 
tolerant of frequent severe defoliation and drought. This latter feature is especially 
important, as it is able to provide edible forage long into the dry season (Shelton and 
Brewbaker 1994). Leucaena is a vitally important source of protein for ruminants 
throughout south-east Asia, China, India, Hawaii, the Pacific islands, Mexico, Central 
America, South America and Australia (Shelton and Brewbaker 1994). In tropical Australia, 
L. leucocephala ssp. glabrata cultivars were first released in the 1960s, and there are 
currently more than 200,000 ha of leucaena-grass pastures (Dalzell et al. 2012), with more 
plantings each year. 
Factors such as the rapid increase in international demand for animal products, high cost 
of protein concentrates, and shortage of nitrogen for tropical grass pastures have 
increased the need for alternative high protein feed sources in the tropics. This has led to 
increased plantings of leucaena globally. The eastern Islands of Indonesia are just one of 
many examples, where leucaena is fulfilling an important role in ruminant production 
(Panjaitan 2012) and where its wider use is being promoted in Government programs. 
However, while it has many positive nutritional benefits, leucaena possesses the toxic non-
protein free amino acid mimosine in relatively high concentrations in leaves and young 
pods (up to 9% of dry matter (DM) in young leaves and 4–7% of DM in seeds) (Hegarty et 
al. 1964a). Pioneering work on leucaena toxicity was conducted between 1976 and 1994 
by R. J. Jones and colleagues, who published widely on the symptoms, chemistry, 
microbiology and management of toxicity (Hegarty et al. 1964a; Jones et al. 1976; Allison 
et al. 1992; Jones 1994). They found that mimosine was rapidly converted to 3-hydroxy-
4(1H)-pyridone (3,4-DHP) post-ingestion, which was reported to be a potent goitrogen 
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resulting in reduced feed intake, decreased liveweight gain (LWG), and poor animal 
performance on otherwise high-quality pasture (Jones and Hegarty 1984; Pattanaik et al. 
2007). Jones and Hegarty (1984) reported that these symptoms occurred at intakes of 
leucaena >30% of diet. 
Research conducted in the 1980s led to the isolation and identification of a previously 
unknown, and at the time unusual species of bacterium from the rumen of a Hawaiian 
goat; it was shown to be a gram-negative obligatory anaerobic bacterium and was 
subsequently named Synergistes jonesii. Strains from this species of bacterium were 
introduced into Australian cattle herds in 1983 and it was reported to provide protection 
against the toxic effects of leucaena by degrading DHP to harmless by-products (Jones 
and Megarrity 1986). This success was followed by the development of a commercial 
inoculum in Australia, comprised initially of rumen fluid (in vivo) and subsequently of 
fermenter-produced (in vitro) mixed inoculum containing S. jonesii (Klieve et al. 2002). 
Animals were reported to readily transfer the ‘bug’ within a herd (Quirk et al. 1988; 
Pratchett et al. 1991) (the exact method of transfer is unknown, but likely encapsulated in 
saliva or faeces), and it was recommended that only 10% of the herd need be inoculated. 
Protection of herds from toxicity in this way has led to annual LWGs of up to 300 kg in 
inoculated beef cattle grazing leucaena-grass pastures in northern Australia (Wildin 1994). 
For these reasons, the problem of leucaena toxicity was considered resolved in Australia; 
however, a survey of the protection status of herds in Queensland on high leucaena diets 
in 2003 showed that almost 50% appeared to be unprotected, including previously 
inoculated herds (Dalzell et al. 2012). There was also poor understanding and awareness 
of leucaena toxicity by farmers, and ignorance of methods of detection of toxicity and its 
management to limit adverse effects. This was of great concern as undiagnosed 
subclinical toxicity was reported to lead to reduced animal production (Dalzell et al. 2012). 
The aim of this review is to clarify the many issues regarding leucaena toxicity and to 
update readers regarding recent findings and future directions.  
  Chapter 2 Review of literature 
 
 
7 
2.2 Occurrence of toxicity in tropical countries 
During 1984–94, a survey of leucaena toxicity status, based on assay of urinary DHP 
excretions, was conducted in many countries where leucaena was being fed to ruminants, 
to determine the presence or absence of DHP-degrading bacteria (Jones 1994). R. J. 
Jones concluded that countries protected from toxicity by the presence of S. jonesii 
included: Indonesia, Vanuatu, Thailand, Malaysia, India, Seychelles, Mauritius and 
Mexico, while at least 13 other countries were not protected. He hypothesized that lack of 
protection in the latter countries may have caused an aversion to intensive feeding of 
leucaena and become a barrier to adoption, while countries protected from toxicity had a 
long history of use of leucaena as forage for ruminant production (Jones 1981). Thailand’s 
inclusion as a protected country (Jones 1994) was based on the absence of urinary DHP 
in a single goat farm in 1983. However, a comprehensive survey of goat farms within 4 
Thai provinces in 2009 (Phaikaew et al. 2012) found that all 63 goats sampled had 
exceedingly high levels of urinary DHP, often >1000 mg/L. Similarly, urine samples 
collected from goats consuming 100% leucaena in Mexico, also previously listed as a 
protected country, within the Yucatan region where leucaena is thought to have originated, 
had exceedingly high levels of DHP, in one case >10000 mg/L (Graham Kerven, 
unpublished data). Thus, it is not appropriate to refer to ‘protected or unprotected’ 
countries, as capability to degrade leucaena toxins varies among ruminants at the village 
and even farm level.  
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2.3 Confusion regarding the symptoms and molecular structure of the toxins 
When leucaena was first introduced to Australia, the clinical symptoms of toxicity were 
thought to be quite serious, presenting as emaciated animals, and some animal mortalities 
in extreme cases (Jones et al. 1978). However, severe clinical symptoms are no longer 
common and most farmers feeding leucaena rarely report visible symptoms of toxicity. 
While some Australian graziers suspect subclinical toxicity by monitoring reductions in 
LWGs, livestock raisers in most other countries have no way of knowing if their animals 
are experiencing toxicity, as data are not available. Since their animals fed leucaena may 
still be performing better than those without legume, there is understandable denial that 
toxicity is an issue. Another highly anomalous situation is that many ruminants in the 
tropical world are consuming large amounts of leucaena for prolonged periods and 
excreting high concentrations of urinary DHP without any apparent clinical symptoms of 
toxicity (Phaikaew et al. 2012; Graham et al. 2013; Halliday et al. 2014c), including no 
indication of goitre (Palmer et al. 2010). The reasons for this are not understood, but may 
be due to alternative detoxification pathways such as chemical conjugation of the toxins, 
discussed later in this review. 
2.3.1 Molecular structure of the toxins 
The molecular structure of the toxins associated with leucaena are clarified. They are 
mimosine and its primary metabolites: 3-hydroxy-4(1H)-pyridone and 3-hydroxy-2(1H)-
pyridone, commonly referred to as 3,4-DHP and 2,3-DHP, respectively (Figure 2.1). While 
mimosine and DHP are structurally similar, these compounds have different modes of 
toxicity and are largely responsible for different clinical and subclinical symptoms. It is 
therefore essential that toxicity symptoms are understood and the causes correctly 
identified for proper management of leucaena-based feeding systems. 
 
Figure 2.1: The ruminal degradation pathway of: (a) mimosine; (b) 3,4-DHP; and (c) 2,3-DHP, adapted from 
Hammond et al. (1989). 
(a) (b) (c) 
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2.3.2 Mimosine toxicity  
Mimosine (β-[N-(3-hydroxy-4-oxopyridyl)]-α-aminopropionic acid) (Hegarty et al. 1976) is 
acutely antimitotic, and inhibits the synthesis of DNA (Perry et al. 2005; Pandey and 
Dwivedi 2007), particularly in rapidly dividing cells (Tsai and Ling 1971; Jones and Hegarty 
1984), and can cause damage to internal organs (Prasad and Paliwal 1989). The 
symptoms ascribed to mimosine include alopecia (Hegarty et al. 1964b; Ram et al. 1994), 
oesophageal lesions (Jones et al. 1978), foetal abortions (Holmes 1980), low bull fertility 
(Holmes et al. 1981) and death (Jones et al. 1978; Prasad and Paliwal 1989; Dalzell et al. 
2012). It should be noted that mimosine itself is not responsible for the symptoms of goitre 
(Hegarty et al. 1979). 
Structurally, mimosine (Figure 2.1a) is a tyrosine analogue (Hegarty et al. 1964b; 
Hashiguchi and Takahashi 1977), capable of inhibiting enzyme functions such as tyrosine 
decarboxylase and tyrosinase (Crounse et al. 1962). The inhibition of these enzymes, 
especially of [3+]thymidine in the follicle bulbs of hair cells, along with the incorporation of 
mimosine into biologically vital proteins (Tsai and Ling 1971), can result in depilation of 
actively growing hairs. 
For this reason, alopecia is one of the most commonly reported symptoms when animals 
are first introduced to leucaena, and can occur within 7 days of consuming 100% leucaena 
diets (Hegarty et al. 1964b). Hair loss is commonly observed from areas including the 
penis sheath and tail where growth is more continuous as mimosine affects the follicle bulb 
only in the active phase of growth (Hegarty et al. 1964b). This is best demonstrated in 
sheep as wool growth is largely continuous and therefore sensitive to alopecia from 
mimosine toxicity (Hegarty et al. 1964b). Alopecia is evident when levels of mimosine in 
diets are >0.015% body weight (BW) (Szyszka and Termeulen 1985). As a diet of 100% 
fresh leucaena leaves may result in consumption of as high as 0.031% BW mimosine 
(Tangendjaja et al. 1985), it would seem that leucaena feeding at levels greater than 50% 
would lead to alopecia in unprotected animals. 
While mimosine toxicity can be potentially severe, it is relatively short-term and appears 
only when animals are first introduced to high leucaena diets (>50% leucaena) (Ghosh et 
al. 2007; O'Reagain et al. 2014). Ruminants typically acquire the ability to fully degrade 
mimosine within 2 weeks from initial introduction (Ghosh et al. 2007) and excretion of 
mimosine ceases within 24 hours of removal of leucaena from the diet (O'Reagain et al. 
2014). For this reason, symptoms of mimosine toxicity rarely persist within an animal, 
especially if introduced to leucaena slowly (Jones 1979).  
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The degradation of mimosine to 3,4-DHP occurs via many endogenous rumen bacteria 
(Hegarty et al. 1964b) and by plant hydrolase activity of endogenous enzymes within 
leucaena leaves (Smith and Fowden 1966; Lowry et al. 1983). Up to 30% of the mimosine 
is converted to 3,4-DHP in the initial process of mastication (Ram et al. 1994) within 1 hour 
of ingestion (Jones and Megarrity 1983). Although mimosine is readily degraded to 3,4-
DHP, this does not result in detoxification. 
Mimosine also forms strong complexes with metal ions (Hashiguchi and Takahashi 1977). 
While the chelation of mimosine antagonizes its antimitotic ability (Hashiguchi and 
Takahashi 1977), the process of chelation with high affinity metal ions from animal cells, 
such as Fe(II), Cu(II) and Zn(II), inhibits many enzymatic pathways; these metals are also 
required for normal hair growth (Hegarty et al. 1964b; Hashiguchi and Takahashi 1977; 
Paul 2000). Ultimately, the chelatory effects of mimosine exacerbate the overall depilatory 
effects, resulting in overlap of some symptoms with DHP toxicity (Puchała et al. 1995). 
2.3.3 DHP toxicity 
The primary metabolite of mimosine is the compound 3-hydroxy-4(1H)-pyridine (3,4-DHP) 
(Hegarty et al. 1976), which, in the presence of certain ruminal microbes, can be further 
converted to its isomer 3-hydroxy-2(1H)-pyridone (2,3-DHP) (D'Mello 1992). Both isomers 
of DHP are reported to act as potent goitrogens, due to their antiperoxidase activity. By 
inhibiting essential peroxidase- and lactoperoxidase-catalyzed reactions (Christie et al. 
1979; Lee et al. 1980), the iodination of tyrosine in the binding step of the thyroid is 
inhibited. This step is crucial for the synthesis of thyroid hormones, such as thyroxin (T4) 
and triiodothyronine (T3), resulting in depressed serum T4 levels, which causes 
overstimulation and enlargement (up to 4 times) of the thyroid glands (goitre) (Hegarty et 
al. 1979; Jones 1979; Megarrity and Jones 1983). Studies have also shown that persistent 
administrations of DHP increase the uptake of iodine in the hyperplastic thyroid (Hegarty et 
al. 1979). One effect of lowered serum T4 and T3 levels is reduced appetite, and ultimately 
a decreased LWG. Serum T4 levels below 13 nmol/L may even result in death (Jones et al. 
1978). 
Reduced iodine availability due to DHP can also affect the salivary glands. Iodine is 
incorporated into salivary glands via a different method and DHP inhibits the trapping step 
rather than the binding step, as in the thyroid (Koutras et al. 1967; Harden et al. 1968). 
This can lead to excessive salivation after prolonged exposure to leucaena (Jones et al. 
1976; Jones et al. 1978; Holmes et al. 1981; Megarrity and Jones 1983; Ram et al. 1994). 
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Compounding the goitrogenic effects of DHP, is the fact that both isomers also strongly 
chelate with metal ions (Tsai and Ling 1971), forming complexes with Zn, Cu, and Fe in 
particular, leading to excretion and depletion of these elements (Ghosh and Samiran 
2007). A deficiency in Zn was shown to be responsible for skin lesions (Mills 1978; Paul 
2000), increased salivation (Mills 1978; Puchała et al. 1996) and abnormal hair growth 
(Hashiguchi and Takahashi 1977). Zn deficiency can also be responsible for inhibiting 
DNA replication (Perry et al. 2005) and can adversely affect spermatogenesis (Yamaguchi 
et al. 2009). These all suggest that the chelation of essential minerals is a major toxic 
effect of DHP. The presence of existing deficiencies of essential minerals in the diet may 
hasten the manifestation of clinical toxicity symptoms. 
The severity of DHP toxicity is a function of both amount of leucaena in diet and time on 
leucaena. Clinical symptoms may take up to 8 weeks to become evident (Quirk et al. 
1988). This can manifest itself in scenarios where new animals on a leucaena-grass 
paddock can gain up to 1 kg/head.day, while existing animals grazing that same paddock 
for longer periods can be gaining as little as 0–0.2 kg/head.day (Jones and Bray 1983). 
These lowered LWGs were found to be directly related to lowered levels of serum T4, with 
a threshold of 25 nmol/L before clinical symptoms such as drooling and hair loss were 
observed (Jones and Winter 1982). It is this chronic nature of DHP, the dual modes of 
toxicity, and the long periods when toxicity can go unnoticed that contribute to the 
complexity of recognition of potential toxicity. 
However, as mentioned, inexplicably, goats in Thailand and Indonesia on long-term high 
leucaena diets were shown to be excreting high concentrations of 2,3-DHP in urine without 
indication of goitre (Phaikaew et al. 2012; Halliday et al. 2014c). These exceptions will be 
discussed later in this review. 
2.3.4 The dominance of 2,3-DHP 
The isomer 2,3-DHP was originally thought to be transitory, and indicative of incipient 
ruminal colonization of S. jonesii (Ford et al. 1984; Jones et al. 2009). Much recent data 
from Australia, Thailand and Indonesia contradict the notion of 2,3-DHP being transitory 
(Dalzell et al. 2012; Phaikaew et al. 2012; Graham et al. 2013; Halliday et al. 2014c) and 
indicate that it is usually the dominant isomer in ruminants fed leucaena long-term. 
Phaikaew et al. (2012) reported exceedingly high levels (>1000 mg/L) of 2,3-DHP in the 
urine of ruminants fed over extended periods (>3 months). It is generally considered that 
the isomers 3,4-DHP and 2,3-DHP are equally harmful (Lee et al. 1980; Ghosh et al. 
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2008). The latter has been shown to reduce intake (suppress appetite) (McSweeney et al. 
1984), reduce milk production in dairy cows (Ghosh et al. 2007), and be fatal given 
intraruminally in pure form (Puchała et al. 1995). 
In a controlled leucaena feeding trial in India (Ghosh et al. 2007), 2,3-DHP was the 
dominant isomer excreted 21-days after commencement of feeding in cattle naïve to S. 
jonesii, as was the case for animals offered 25–100% leucaena in a controlled trial in 
Queensland (Halliday et al. 2014a). 
The accumulation of high levels and proportions of 2,3-DHP in ruminants both previously 
exposed to S. jonesii and those naïve to it may suggest that: (a) rumen microbes other 
than S. jonesii are capable of degrading 3,4-DHP to 2,3-DHP; (b) the in vitro S. jonesii 
inoculum released in Australia may have lost/mutated the strains effective at complete 
DHP degradation; (c) there are other environmental factors (including regulation of genes 
involved in DHP metabolism) affecting optimal ability of S. jonesii to completely degrade all 
DHP; and lastly, (d) there may be alternative non-bacterial pathways for detoxification of 
DHP.  
  Chapter 2 Review of literature 
 
 
13 
2.4 Taxonomy and distribution of S. jonesii 
Recent advances in molecular techniques for the detection and sequencing of S. jonesii 
have allowed greater insights into the geographic spread and genetic variability of the 
bacterium. From the culture originally imported into Australia from a Hawaiian goat in 
1982, 4 strains were later isolated, including the designated type strain 78.1 (ATCC 
49833) and 3 others (100-6, 113-4, 147-1) (Allison et al. 1992). The strains were shown to 
have differential specificity for degrading mimosine, and/or 3,4-DHP and 2,3-DHP (Jones 
1994). 
PCR amplification using S. jonesii specific primers of the 16S rDNA (small sub-unit of the 
ribosome-ssRNA) was used as a molecular phylogenetic classifier, and has even identified 
S. jonesii 16S rDNA sequences in the gut of disparate animals such as the horse, Tamar 
wallaby, baboon and the emu (Chris McSweeney, unpublished data). The theoretical limit 
of detection of S. jonesii by PCR is 103 cells/mL; however, a realistic PCR amplification of 
genomic DNA from digesta is 104–105 cells/mL due to the co-precipitation of contaminating 
inhibitors. This problem was overcome by a second round of PCR (nested PCR) on the 
initial PCR products, which increased the sensitivity of detection to near theoretical limits. 
Sequencing of the amplified (nested) products not only confirmed the identity of S. jonesii 
but also detected mutations in that segment of the 16S gene. These changes appeared as 
discrete mutations or ‘single nucleotide polymorphisms’ (SNPs) that may be correlated 
with their ability to degrade DHP, relative to the type strain. SNPs can be random or occur 
consistently at the same locus, termed ‘hot-spots’. 
A survey of animals consuming diets of 0–100% leucaena was conducted to understand 
the distribution and changes at the molecular level of S. jonesii (Chris McSweeney, 
unpublished data). Rumen fluid or faeces was collected from cattle in Queensland and 
from cattle, sheep, goats, buffalo and yak from Indonesia, Thailand, Vietnam, China and 
Brazil. In a number of these sites, animals were naïve to leucaena. In general, faecal 
samples failed to generate PCR products for S. jonesii 16S rDNA from either Australian or 
international samples. However, the survey revealed that S. jonesii is far more widespread 
than originally realized. The molecular detection of this bacterium internationally in 
ruminants, irrespective of their leucaena feeding status strongly suggest it is an indigenous 
rumen microbe. 
This information on its ubiquity has come with the proviso that the sequence analysis from 
Australia and other countries showed SNPs across ~800 of the 1500 bases of the 16S 
gene of the bacterium. These SNPs were distributed primarily at ‘hot-spots’ in bases 
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corresponding to E. coli nucleotide positions 268 (C→T), 306 (A→G), 328 (G→A) and 870 
(A→C) between bases 200–900 (~700 base pairs (bp)) of the S. jonesii ATCC 16S rDNA. 
All 4 SNPs were identified at varying frequencies in all farms surveyed in Queensland. Of 
these loci, ‘306’ and ‘870’ were almost always mutated when SNPs were detected. 
Surprisingly, these two SNPs were present consistently in the inoculum provided to the 
farmers. In about 50% of these sequences, all 4 SNPs were present. 
In animals overseas, the very same SNPs were also distributed, ranging from frequencies 
of 15% (for ‘870’ in Brazilian cattle) to 100% (all 4 SNPs in Vietnamese cattle and goats). 
Among all the international samples analysed, those from Jinnan cattle, Tibetan yak and 
Indonesian buffalo were found to have S. jonesii that was 100% identical to the 78.1 type 
strain. Interestingly, the buffalo in Indonesia were on 100% leucaena for 0.5–1 years and 
had high clearance of both 3,4-DHP and 2,3-DHP. The Jinnan cattle and Tibetan yak were 
naïve to leucaena. Other SNPs were detected, whose frequencies were not consistent 
across animals, geographical regions or loci. 
It remains to be determined if these molecular changes also modify the ability of these 
strains to degrade DHP. A detailed molecular and physiologic analysis of these ‘strains’ is 
highly desirable in order to elucidate the link between genetic changes and DHP-
degrading potential. 
Attempts at molecular enumeration of S. jonesii from rumen digesta are similarly fraught 
with ambiguity, relating to the sensitivity and specificity of the quantitative real-time PCR 
(qPCR) technique. Compared with the 2-step nested PCR which produces ~800 bp long 
products, the qPCR typically uses a 100–200 bp PCR product for real-time amplification 
and analysis. Although this method has a statistically higher chance of amplifying a shorter 
target (100–200 bp) than the nested PCR (700–800 bp), it still has to overcome PCR 
inhibition and thus a lack or reduction of sensitivity, unlike the nested PCR. Any specific 
amplification, nevertheless, can accurately enumerate the target molecule (16S rDNA of S. 
jonesii) from a rumen sample. Several primer sets targeting the S. jonesii 16S DNA, 
designed and tested during the past 4–5 years, have indicated S. jonesii exists in the 
rumen at very low numbers, even in animals foraging on leucaena and where degradation 
of DHP was apparently occurring (Graham et al. 2013). 
This extensive molecular analysis of animals consuming leucaena demonstrates that S. 
jonesii is widespread with variants of the ATCC type strain, but in low numbers, regardless 
of quantity of leucaena in diet. Nevertheless, these variants may potentially be responsible 
for the partial DHP degradation results.  
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2.5 Management of toxicity 
2.5.1 Methods for detecting DHP toxicity 
A full understanding of DHP toxicity and of effective methods to detect subclinical toxicity 
is vital for productive management of animals on leucaena. There are several possible 
approaches to detection of toxicity, but the most effective method is assay of urine for DHP 
(Lowry et al. 1985; Phaikaew et al. 2012). Unmetabolised mimosine, 3,4-DHP and 2,3-
DHP are readily absorbed into the blood stream and voided in the urine via glomerular 
filtration at the kidneys (Hammond 1995). While small amounts (up to 15%) may be voided 
in the faeces (Hegarty et al. 1979; Jones and Hegarty 1984; Hammond 1995), most is 
readily absorbed from the gut and excreted via the kidneys (Lowry et al. 1985). 
While HPLC analysis of urine (Dalzell et al. 2012) is currently the most accurate method of 
measuring DHP toxicity, sampling many animals for analysis by HPLC is too expensive for 
graziers, and prohibitive for farmers in developing countries. In response to the need for a 
rapid, accurate and inexpensive urine assay, a colorimetric test kit, modified from earlier 
work (Lowry et al. 1985), has been developed and refined as the most cost-effective and 
immediate assessment of toxicity (Graham et al. 2013). This is now available to Australian 
graziers uncertain about the toxicity status of their herds. This improved urine test gives 
reliable, although not quantitatively precise, indications of the concentration and nature of 
the toxin. 
DHP can be excreted in both the free form and as a conjugate. HPLC analysis with a 
reduced flow rate has been able to separate free DHP from the conjugated DHP-
glucuronide. However, preservation of urine prior to analysis requires strong acidification, 
which hydrolyses all conjugated DHP (Tangendjaja and Wills 1980), unless analysis is 
conducted immediately. 
While assay of serum T4 and T3 can be used as an indicator of DHP toxicity (Jones et al. 
1978; Megarrity and Jones 1983; Jones and Hegarty 1984; Ghosh et al. 2007), changes in 
thyroxin levels occur after longer-term exposure with considerable variation among 
animals (Michael Halliday, unpublished data). Likewise, the development of goitre in 
response to depressed thyroid hormones is also a cumulative longer-term effect. As noted, 
ruminants do not always develop enlarged thyroids on high leucaena diets. Accordingly, 
these methods are not a reliable indicator of current toxicity status. 
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2.5.2 Inoculation 
Following the initial discovery of S. jonesii, inoculation with rumen fluid collected from 
protected animals was the preferred method for transferring protection between herds, and 
even between countries (Jones et al. 1985b). This seminal work on inoculation 
demonstrated that the capability to completely degrade DHP was transferred within 5 days 
following direct inoculation with rumen fluid (Jones and Lowry 1984; Jones and Megarrity 
1986). In 1982, 10 cultures of rumen fluid from a single goat in Hawaii were imported to 
Australia and, in 1983, dosed into rumen-fistulated steers at the CSIRO Lansdown 
Research Station near Townsville (Jones and Megarrity 1986). Rumen fluid from these 
steers was then used as the source of inoculum and given via direct rumen injection, to 
~10% of the remaining herd at Lansdown. It was then thought to have spread passively to 
the entire herd. In 1984, strained rumen fluid from these cattle was administered to steers 
at the Queensland Government Brian Pastures Research Station near Gayndah (Quirk et 
al. 1988). It was from these 2 locations that rumen fluid was collected and distributed to 
Australian graziers and also to livestock raisers in both Ethiopia and China, with reported 
successful transfer of protection (Jones 1994). 
In 1995, production of the inoculum was begun in an in vitro fermenter, using rumen fluid 
containing the mixed bacterial inoculum sourced from cattle at Brian Pastures (Klieve et al. 
2002). While originally successful in transferring protection, the efficacy of the current in 
vitro inoculum appears in doubt, as it is neither rapid nor completely successful in its 
degradation of DHP (Graham et al. 2013). At the time, it was thus postulated that the 
continually cultured oral inoculum may have lost some strains, and/or have undergone 
genetic modification and/or contained other strains with an altered DHP-degrading 
potential (Graham et al. 2013; Halliday et al. 2014a). 
2.5.3 Other microbial control options 
Other microbial solutions apart from S. jonesii have been investigated as alternative 
biological control methods. Domínguez-Bello and Stewart (1991) reported the isolation of 
a DHP-degrading Clostridium bacterium. In China, 4 strains were isolated, which together 
were able to degrade up to 60% of DHP in vitro within 3 days. These gram-positive 
facultative and obligate anaerobes were identified as Lactobacillus spp., Streptococcus 
bovis and Clostridium sporogenes (Tan et al. 1994); and were quite different from S. 
jonesii. Strains of obligate aerobic Streptococci capable of degrading DHP were reported 
by Chhabra et al. (1998). Researchers in Germany isolated a mimosine- (and DHP-) 
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degrading bacterium from the rumen fluid of steers naïve to leucaena (Aung et al. 2011). 
After continuous culture with mimosine for 16 days, their work reported the isolation of an 
aero-tolerant gram-negative coccobacillus belonging to the genus Klebsiella. While 
capable of growing under anaerobic conditions, it grew best in aerobic conditions. As 
such, it may not readily persist in high numbers in the anaerobic conditions of the rumen. 
The researchers also described a method for stabilising the inoculum in alginate beads, 
increasing its shelf-life at room temperature by up to 8 weeks. Methods such as this, and 
freeze-drying, may be incorporated into the in vitro production of S. jonesii inoculum in the 
future, thus preventing loss of bacterial numbers in transit. However, further research is 
required. 
2.5.4 Supplementation and conjugation 
As mentioned, one of the major toxic effects of DHP is to strongly chelate essential 
minerals such as Fe and Zn (Stunzi et al. 1980). Methods for increasing conjugation 
and/or chelation of DHP by modifying the diet have been postulated as a way to reduce 
the toxic effects of leucaena. 
While Christie et al. (1979) reported DHP conjugated with glucuronic acid to have reduced 
antiperoxidase activity in vitro, Hegarty et al. (1979) showed that the conjugate was of the 
same order of chronic goitrogenicity in vivo. However, chelation and conjugation increase 
the polarity of DHP, resulting in a more water-soluble molecule, which can be voided more 
efficiently. In addition, the attachment of a glucuronic acid molecule or metal ion at an 
active binding hydroxyl site, reduces the toxic chelating ability (Lowry et al. 1985). 
While DHP can be excreted in the free form, it is normal for up to 33% to be found 
conjugated as a glucuronide in urine (Hegarty et al. 1964b). Supplementation with 
molasses has previously been shown to increase both the conjugation of DHP, and the 
amount being excreted in unprotected animals (Elliott et al. 1985). Animals receiving a 
high molasses supplement did not exhibit a decline in T4 levels. However, the level of 
molasses required to achieve this effect was ~ 40% dry matter intake, making it an 
impractically large component of the diet. 
Supplementation with minerals to chelate mimosine and DHP has been suggested as a 
method of detoxification (Hashiguchi and Takahashi 1977). Supplemental metal ions were 
shown to have prevented hair loss and skin lesions (Jones et al. 1978), doubled excretion 
of intraruminally infused 2,3-DHP, lowered the levels of 2,3-DHP in the rumen and plasma, 
and prevented clinical toxicity symptoms from developing (Puchała et al. 1995), suggesting 
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that kidney clearance of DHP is more efficient when chelated or conjugated (Puchała et al. 
1995). While DHP is more efficiently voided in the chelated form, if essential metal ions are 
not replaced, deficiencies in these elements will result in toxicity symptoms (Puchała et al. 
1996). 
2.5.5 Feeding management 
Management strategies that control exposure to leucaena have been effective in limiting 
the extent of toxicity. Prior to the discovery of S. jonesii, Jones and Hegarty (1984) 
suggested that leucaena should not exceed 30% of the diet. The current common 
management practice of Australian graziers is still to feed leucaena at ~30% of diet, which 
is also considered an optimal as a protein supplement. As mimosine toxicity rarely occurs 
in animals regularly consuming leucaena and since DHP toxicity is a factor of both time on 
leucaena and amount of leucaena in the diet (Hammond 1995), moderate levels of 
leucaena in the diet for short periods (≤2–3 months) can limit the toxic effects. Quirk et al. 
(1988) showed that it can take up to 8 weeks for clinical symptoms to become evident. 
Alternating time on leucaena with time on other feed sources might be a way to reduce the 
toxic effects associated with DHP. However, reducing consumption of leucaena may also 
limit the LWG potential of a fattening system. Given that leucaena is often the only high 
protein feed available during the extended dry season in many tropical smallholder feeding 
systems, an effective biological control mechanism appears to be the most practical 
solution to leucaena toxicity. Other less effective management strategies include drying 
leucaena. While this converts most of the mimosine to DHP (Hegarty et al. 1964a; Wee 
and Wang 1987), it does not overcome the toxic effects of DHP itself. 
The best practice management guidelines for feeding of leucaena in Australia (Dalzell et 
al. 2006) are current as of 2006 and exclude the new findings of this thesis. The 
recommended intake of leucaena is between 35–40% leucaena in diet, which practically 
involves managing the time animals spend in a leucaena paddock by rotational grazing, 
and also the planting density of the leucaena rows, to provide an overall balance of 
approximately 30–40% leucaena in the paddock. Graziers are currently advised to 
inoculate 10% of their herd with the commercial inoculum, allowing for reported full 
coverage of the herd within 5–6 weeks and to maintain carrier animals on leucaena to 
enable the transfer of S. jonesii after destocking. It is important to note that these best 
practices are targeted towards steers for meat production, where any potential negative 
effects on reproduction are not considered critical. There is less knowledge on the 
management of breeders, especially if naïve to leucaena, and graziers are advised to 
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avoid introducing pregnant cows to leucaena within the first trimester, due the possible 
effects of mimosine as they adapt to leucaena in diet. 
It is the aim of this thesis to provide updated recommendations for the best management 
of animals consuming leucaena in Australia.  
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2.6 Conclusions 
Despite the many nutritive benefits of leucaena, the antinutritional properties of mimosine 
and its DHP-metabolites have the potential to affect animal health and production and limit 
wider adoption of leucaena in ruminant-based feeding enterprises. The discovery of a 
bacterium capable of degrading DHP, S. jonesii, led to greater adoption in Australia where 
it has been distributed as an inoculum, however concerns regarding toxicity persist, both in 
Australia and internationally where an inoculum is not available. 
Although leucaena toxicity has been researched for over 30 years, many knowledge gaps 
still remain. These include the method of transmission of inoculated S. jonesii within a 
herd; the now apparent indigenous nature of S. jonesii; the reason for high levels of 
urinary 2,3-DHP, without apparent negative affect; and the importance of non-microbial 
detoxification mechanisms. Additional clarification is also required regarding the main 
method of toxicity of DHP, given that goitre is now rarely observed, and to the relative 
toxicity of both DHP isomers. 
Conflicting evidence with the original research include the finding that, while high 
concentrations of DHP were reported to be harmful, many ruminants worldwide consuming 
high levels of leucaena are productive and healthy despite incomplete degradation of 
DHP, with 2,3-DHP the common isomer. This, coupled with the findings that S. jonesii: (a) 
may not be fully effective on high leucaena diets; (b) appears not to persist in the rumen at 
high numbers; and (c) has much genetic variation between geographical regions, suggests 
alternate protection mechanisms are therefore important in overall animal protection 
against DHP toxicity. These may include molecular transformation of the DHP compound 
to reduce its toxicity without degradation, such as hepatic conjugation or metal-ion 
chelation. 
As transfer mechanisms involved in bacterial control of toxicity are beyond the resources 
of many countries, and the persistence and efficacy of the Australian inoculum is of 
concern, the international significance of an alternate control mechanism cannot be 
understated. As such, improved understanding and management of leucaena feeding 
systems to minimise any negative effect due to DHP is vital to promote the increased 
uptake of this extremely productive legume. 
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Chapter 3 Scope of thesis 
3.1 Thesis objectives 
The overall objective of this thesis was to investigate methods for overcoming leucaena 
toxicity in ruminant feeding systems in eastern Indonesia and Australia, with the purpose 
of improving feeding efficiency and animal productivity; and ultimately farmer livelihoods. 
The thesis comprises two broad topics of research: microbial degradation and metabolic 
detoxification. The former topic followed the long-held understanding that toxicity was 
overcome by the action of S. jonesii; the latter topic investigated an alternative pathway 
that toxicity was overcome by hepatic conjugation. 
The specific objectives for microbial degradation included: 
• Investigation of the feasibility and efficacy of inoculation of Indonesian 
ruminants using fresh rumen fluid from ‘protected’ animals (Chapter 4). 
• Investigation of the efficacy of the fermenter-cultured S. jonesii inoculum in 
Australia, for control of leucaena toxicity (Chapter 5). 
• Survey of DHP toxicity status and S. jonesii prevalence in ruminants in 
leucaena-based feeding systems in eastern Indonesia (Chapter 6). 
The specific objectives for metabolic detoxification include: 
• Investigation of the impact of 2,3-DHP toxicity on the productivity of weaner 
goats, and the feasibility of detoxification by chelation with mineral 
supplementation (Chapter 7). 
• Optimisation of the method of hydrolysis of conjugated DHP for HPLC analysis 
and identification and quantification of the conjugate using HDMS and HPLC 
(Chapter 8). 
• Determination of the extent of conjugation of DHP as a detoxification 
mechanism in new and existing steers fed 100% leucaena diets in eastern 
Indonesia (Chapter 8).  
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3.2 Thesis hypotheses 
The overall hypothesis of this thesis evolved during the period of study, based on the 
significance and contradictory nature of emerging results when compared to the previous 
understanding of toxicity as outlined in the earlier literature. Accordingly, a new hypothesis 
was postulated that redefines the understanding of leucaena toxicity worldwide. The 
general hypothesis at commencement was: In Indonesia, distribution of S. jonesii would be 
sporadic, isolated to areas where leucaena was being fed and that animals in these areas 
would be protected by functional S. jonesii; and in Australia the commercially produced 
cultured inoculum was effective in controlling leucaena toxicity. 
The final two chapters were conducted with a redefined general hypothesis: S. jonesii is 
not capable of affording complete protection to ruminants on high leucaena diets, and 
animals are protected against DHP toxicity by the process of hepatic conjugation of DHP. 
The original specific hypotheses were: 
• Transfer of fresh rumen fluid from ‘protected’ donor animal to recipient animals 
in eastern Indonesia would quickly confer DHP degrading capacity (Chapter 4). 
• The commercial fermenter-cultured inoculum containing S. jonesii would be 
effective in degrading all DHP in Australian steers on high leucaena diets 
(Chapter 5). 
• In remote regions and islands in eastern Indonesia, where animal movement is 
restricted, the spread of the bacteria may be impeded, and animals may not be 
protected by S. jonesii (Chapter 6).  
The specific hypotheses for the final two chapters were: 
• The primary mode of DHP toxicity is the strong affinity of the hydroxyl groups to 
bind with metal ions, and that supplementation with minerals would reduce the 
toxic effects of DHP (Chapter 7) 
• The low populations of S. jonesii are insufficient to fully degrade all DHP in 
animals consuming high levels of leucaena and they adapt to high leucaena 
diets by the process of conjugating DHP in the liver (Chapter 8). 
• The conjugate compound is the glucose-based carboxylic acid: glucuronic acid 
(Chapter 8). 
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Chapter 4 Effectiveness of inoculation with rumen fluid containing Synergistes 
jonesii to control DHP toxicity in ruminants in eastern Indonesia 
4.1 Introduction 
Leucaena leucocephala (leucaena) is a productive forage tree legume which contains the 
toxic non-protein amino acid mimosine. While this secondary plant compound can 
seriously affect animal health, in ruminants, rumen microbes rapidly convert mimosine to 
hydroxypyridone (DHP) which is chronically, rather than acutely toxic. This occurs post-
ingestion via a combination of rumen microbes and endogenous plant enzymes (Hegarty 
et al. 1964b; Lowry et al. 1983). The widely-published method of protection against DHP 
toxicity is via microbial degradation by a specialized rumen bacterium, Synergistes jonesii, 
strains of which, including the type strain (78-1), can degrade 3,4-DHP to 2,3-DHP and 
further to non-toxic by-products (Allison et al. 1992). Evidence now suggests S. jonesii is 
to be considered a microbe indigenous to the rumen, with discrete mutations or variants 
detected in DNA gene sequences associated with different geographical locations. 
Variants of S. jonesii have been identified in ruminants in Indonesia (Padmanabha et al. 
2014). These variants may account for varying capacity of S. jonesii to degrade DHP 
(Padmanabha et al. 2014). 
Seminal work on leucaena toxicity research has demonstrated that functional S. jonesii 
can be rapidly and readily transferred from ‘protected’ animals to susceptible animals 
using rumen fluid inoculum (Jones and Lowry 1984). In eastern Indonesia, there are vast 
distances separating ‘protected’ animals from those susceptible to toxicity, including 
between islands. For microbial protection against leucaena toxicity to occur, a practical 
method is required to successfully transfer rumen fluid from ‘protected’ to ‘unprotected’ 
ruminants, which may be in remote locations and often of a different species (e.g. goats, 
buffalo, Bos indicus and Bos javanicus cattle). 
Accordingly, this trial was conducted to investigate the feasibility and efficacy of inoculation 
using rumen fluid from ‘protected’ buffalo on Sumba island that were consuming high 
leucaena diets but were excreting low levels of urinary DHP, when transferred to cattle and 
goats in nearby West Timor island. These latter animals were excreting high levels of 
urinary DHP and were thus not fully degrading DHP. As an inoculum does not currently 
exist in Indonesia, apart from the effectiveness of inoculation, it was important to evaluate 
the feasibility of collecting, storing and transporting rumen fluid anaerobically, with 
subsequent inoculation of smallholder animals as a possible long-term solution for 
controlling DHP toxicity in ruminants fed leucaena in eastern Indonesia.  
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4.2 Materials and Methods 
The experiment was conducted on the islands of Sumba and West Timor in eastern 
Indonesia, over an 18-day period beginning in December 2012. 
Donor animals were two female buffalo (Bubalus bubalis) from Melolo, Sumba. These 
buffalo were selected from a herd where S. jonesii had been detected (Chapter 6) 
(Halliday et al. 2014c; Padmanabha et al. 2014) and were excreting low urinary DHP (<20 
mg/L DHP) while consuming >70% leucaena diets. Recipient animals were selected from 
areas known to be prone to DHP toxicity (Chapter 6), including: three kacang goats (Capra 
hircus) from Sumlili, Timor; and four Bali bulls (Bos javanicus) from Bone, Timor. All were 
consuming high leucaena diets (50–100% leucaena), and were excreting urinary DHP at 
levels >1800 mg/L DHP. Three cattle (Bos javanicus, two bulls and one cow) from Tarus, 
Timor, previously consuming low leucaena diets (<30% leucaena), were also inoculated. 
All animals were maintained on diets of 100% fresh cut leucaena throughout the 
monitoring period. Recipient animals were randomly allocated to receive either the Sumba 
rumen fluid inoculum or a control treatment consisting of a water drench (Table 4.1). 
Table 4.1: Number of animals allocated to each treatment. 
Treatment Melolo, Sumba 
buffalo (n) 
Sumlili, Timor 
goats (n) 
Bone, Timor 
cattle (n) 
Tarus, Timor 
Cattle (n) 
Sumba donors 2    
Sumba inoculum  2 1 1 
Control  1 3 2 
Urinary DHP concentration was estimated following colour development using the iron(III) 
chloride method (Plate 4.1) (Graham et al. 2014). Buffalo urine was spot sampled daily for 
3 days prior to collection of rumen fluid, while donor animals were monitored 2–4 times 
during the 8 days pre-inoculation, with urine collected 5 and 10 days post-inoculation. 
Methodology for hydrolysis of conjugated DHP to the free form was adjusted by omitting 
boiling for 1 hour (Graham et al. 2014), and instead allowing samples to hydrolyse over 
several days at ambient temperature (up to 37ºC). During this period the colour intensified, 
indicating hydrolysis of conjugated DHP consistent with Graham et al. (2014). Approximate 
concentrations of free DHP were estimated based on colour hue and intensity (Plate 4.1); 
the overwhelming majority of samples were dominated by the isomer 2,3-DHP. 
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Rumen fluid for inoculation was collected via an orogastric tube (Graham et al. 2013), 
strained through muslin cloth, pooled, mixed and stored in a glass thermos and glass 
Schott® bottles. Inoculation occurred on the same day as collection, including travel 
between islands, and was administered via an orogastric tube. All containers were initially 
flushed with rumen fluid, and young fresh ground leucaena leaves were added as a 
mimosine substrate. The bottles were kept at ~37ºC and an anaerobic environment was 
maintained via the active fermentation of leucaena. Doses were: goats from Sumlili—100 
mL/head; bulls from Bone—240 mL/head; and cattle from Tarus—150 mL/head. The trial 
was sanctioned under animal ethics approval # SAFS/144/11/ACIAR (Appendix 1). 
Repeated observations with time were analysed using Minitab® statistical software 16 
(©2010, Minitab Inc., State College, PA, USA) with a General Linear Model ANOVA using 
a split-plot design (with treatment as the main-plot and time as the sub-plot; individual 
animals as a random factor, nested with treatment and location). 
Colour development Approximate 2,3-DHP concentration (mg/L) 
 0 
 400 
 1000 
 2000 
 3000 
Plate 4.1: Examples of colour hues from the colorimetric test with estimated 2,3-DHP concentration.  
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4.3 Results and Discussion 
There was no effect due to animal species or location on urinary DHP levels (P = 0.84); 
thus, treatment means were assessed as an average of all animals receiving each 
treatment. There was no interaction effect between treatment and location (P = 0.70). 
Mean urinary DHP levels in the two donor buffalo from Sumba, from 5 samples collected, 
were low (<20 mg/L DHP). Although the scale of this study did not afford molecular 
analysis of rumen fluid samples, the buffalo belonged to the same herd which previously 
tested positive for S. jonesii, and as the animals were on up to 100% leucaena diets, it 
was assumed that functional S. jonesii was present in the rumen of these animals. In 
contrast, since mean urinary DHP levels in recipient animals, tested up to four times each 
pre-inoculation, were high (Table 4.2), exhibiting normal variation (Giles et al. 2013; 
Graham et al. 2013), it was concluded that these animals were not ‘protected’ by rumen 
bacteria. The overwhelming majority of DHP was excreted as the isomer 2,3-DHP. Despite 
having originally been thought to indicate the commencement of degradation by S. jonesii, 
the presence of 2,3-DHP is now common, and doesn’t necessarily indicate effective 
degradation is occurring. 
There were no significant differences in mean urinary DHP levels between animals dosed 
with the Sumba inoculum and the control treatment, either pre- or post-inoculation (P = 
0.50) (data not presented). Variation within treatment groups was high, most likely due to 
the differential adaptation of individual animals to high levels of leucaena within their first 
month on the diet. Despite the lack of a treatment effect, ten days post-inoculation, urinary 
DHP levels in all animals, while still high, had declined. This however did not reach 
statistical significance compared with pre-inoculation levels (P = 0.12), likely due to the 
small sample size. DHP levels remained above the considered safe threshold of 100 mg/L 
DHP (Dalzell et al. 2012). This result contrasted with earlier reports where transfer of 
protection following inoculation with rumen fluid was rapid and complete with urinary DHP 
levels declining within 5 days in Indonesia (Jones and Lowry 1984) and within 3 days in 
Thailand (Palmer et al. 2010). However, while Jones and Lowry (1984) reported a 
“dramatic” decline in DHP excretion after inoculation, the 2 dosed goats in the experiment 
were already degrading 45–62% of ingested DHP prior to inoculation. This natural decline 
in DHP excretion and apparent inherent capacity to partially degrade ingested DHP was 
common in both the past and the present study.  
Since it is known that S. jonesii exist in the rumen in low populations, often below the limits 
of detection by nested PCR (<104–105 cells/mL) (Graham et al. 2013), it was possible that 
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the dosed inoculum did not increase S. jonesii populations sufficiently to achieve 
protection. Although in vitro, the study of McSweeney et al. (1993b) required 2 weeks for 
S. jonesii to establish a competitive population capable of 3,4-DHP degradation, quantified 
as abundance of S. jonesii RNA in a mixed-culture chemostat. Therefore, this study may 
have terminated too soon. Doses in this study were limited by the volume of rumen fluid 
collected from the buffalo, and although dosage volumes were less than used in the work 
of Jones and Lowry (1984) (350 mL), they were greater than used by Palmer et al. (2010) 
(30 mL). As S. jonesii was neither confirmed nor quantified in this study, it was possible 
that the selected donor animals did not have effective S. jonesii populations. Possible 
alternative explanations for the low urinary DHP include the diurnal variation of urine 
volume and toxin metabolism and the possibility of a period of low leucaena in diet. 
Table 4.2: Mean (±s.e.) urinary DHP excretions and 95% confidence intervals from all animals as estimated 
by iron(III) chloride test. Due to a lack of significant treatment effect, treatment means are not separated. 
Average of all animals Mean DHP (mg/L) 95% CI n (samples) n (animals) 
Pre-inoculation 1676 ± 276 (948, 2402) 22 10 
5 days post-inoculation 1580 ± 444 (852, 2308) 10 10 
10 days post-inoculation 824 ± 322 (96, 1552) 10 10 
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4.4 Conclusions 
In summary, rumen fluid collected from buffalo in Sumba assumed to contain functional S. 
jonesii and given to unprotected ruminants in Timor did not rapidly and completely transfer 
protection within 10-days post-inoculation. Increasing time on 100% leucaena diets 
appeared to lead to a natural decline in urinary DHP excretion; however, this failed to 
reach significance (P > 0.10). While limited by the length of monitoring, the results of this 
study suggest a different outcome following inoculation procedures from that was originally 
reported over 30 years ago. 
This study has also highlighted the technical and logistical difficulties involved in collecting 
and transferring S. jonesii anaerobically as a method of inoculation against DHP toxicity, 
especially in multi-island countries where supply-chain systems are limited. For this 
reason, it is concluded that the methodology evaluated in this study was not practically 
suitable for eastern Indonesia. The equipment and skills required to complete these 
actions are not currently available in the Indonesian Government livestock and extension 
services, and would require specialist training, the uptake of which would be problematical. 
Further work to develop suitable techniques is warranted, including exploring the 
possibility of transferring animals to allow the natural spread of rumen bacteria in a herd. 
The decline in urinary DHP levels in control animals indicated an inherent ability to adapt 
to DHP. Possible adaptation mechanisms include the presence of a less-functional variant 
of S. jonesii, or metabolic detoxification of DHP by conjugation. Although the method of 
acid hydrolysis of DHP has been improved to optimise colour development in iron(III) 
chloride reagent (Graham et al. 2014), it is possible that the decline in DHP levels could be 
attributed to incomplete hydrolysis. Any remaining conjugated DHP would be unable to 
bind with Fe in the solution, thus preventing the development of colour representative of 
the total DHP in urine. 
Further work should aim to study: (a) the presence and functional capacity of S. jonesii 
throughout the multi-island provinces in eastern Indonesia; and (b) the possible role of 
conjugation in detoxification. At a practical level, finding an alternative control mechanism 
to eliminate the need for inoculation would greatly benefit these systems. 
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Chapter 5 The efficacy of a cultured Synergistes jonesii inoculum to control 
hydroxypyridone toxicity in Bos indicus steers fed leucaena/grass diets 
The full paper can be downloaded from: https://doi.org/10.1071/AN17853 
5.1 Introduction 
The pioneering work on Leucaena leucocephala (leucaena) toxicity, conducted in the 
1980s, reported the unique capability of the gram-negative ruminal bacterium Synergistes 
jonesii to rapidly and almost completely degrade the hydroxypyridone (DHP) toxins in 
ruminants consuming high leucaena diets (Jones and Megarrity 1983; Allison et al. 1992). 
The first step in the degradation process was reported to be the isomerization of 3,4-DHP 
to 2,3-DHP, followed by the cleavage of the pyridine ring to produce unnamed pyruvates 
that are non-toxic and may have positive nutritional qualities (Allison et al. 1992). 
Inoculation with S. jonesii enhanced the value of leucaena as an animal feed. 
These researchers also reported that S. jonesii was not naturally present in ruminants and 
could be found in just a few restricted regions of the world where there had been a long 
history of leucaena feeding; notably in certain regions of Hawaii and Indonesia, and in 
some other tropical countries such as Thailand and Malaysia (Jones 1981; Jones and 
Lowry 1984), but not in Australia. Accordingly, the bacterium was introduced to 
experimental Australian steers via inoculation using a bacterial culture, originally sourced 
from rumen fluid from a Hawaiian goat in 1982 (Jones and Megarrity 1986). Following local 
testing and validation of the efficacy of the bacterium, from 1984 strained rumen fluid from 
cattle at CSIRO Lansdown Research Station near Townsville (Jones and Megarrity 1986), 
and Queensland Government Brian Pastures Research Station near Gayndah (Quirk et al. 
1988) was used to inoculate Australian cattle herds grazing leucaena pastures. It was 
shown that a one-off inoculation of a small proportion of herds (c. 10%) using an oral 
drench was sufficient to provide long-term herd-wide protection provided: (a) the herd was 
maintained on leucaena pastures during the growing season, and; (b) that carrier animals 
were available to inoculate newly arrived naïve animals (Jones and Megarrity 1986). 
Since 1995, the inoculum has been produced in a fermenter and distributed as a frozen 
enrichment culture of rumen microorganisms including S. jonesii (Klieve et al. 2002). 
These achievements led to increased adoption of leucaena pastures in Queensland to 
over 200,000 ha planted (Dalzell et al. 2012) with cattle achieving annual LWGs of up to 
300 kg (Wildin 1994). At this point, the toxicity problem in Australia seemed to be resolved. 
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However, concerns were raised following the results of a 2004 survey, and extensive herd 
urine tests, which found that up to 50% of northern Australian cattle herds were excreting 
high levels of urinary DHP, despite most graziers having taken steps to ensure that their 
herds were protected (Dalzell et al. 2012; Graham et al. 2013). This finding was 
considered a serious impediment to productivity and was often not appreciated by 
graziers, as there were usually no visible clinical signs of toxicity, and there was an 
apparent benefit of leucaena fed for short periods at 30–60% of diet. It was hypothesised 
that the commercial fermenter culture containing S. jonesii inoculum may be less efficient 
than the original rumen fluid inoculum, thus reducing its ability to degrade DHP to levels 
below a suggested critical toxicity threshold (100 mg DHP/L) (Dalzell et al. 2012). 
Accordingly, this study was initiated to investigate the efficacy of the fermenter cultured S. 
jonesii inoculum. A controlled animal house trial was conducted using a range of leucaena 
feeding regimes to monitor the onset of DHP toxicity and the impact of inoculation with the 
fermenter enrichment culture containing S. jonesii.  
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5.2 Materials and methods 
5.2.1 Treatments and animal management 
Sixteen one-year-old Charolais × Santa Gertrudis steers (Bos indicus) (average starting 
weight: 270 ± 26.2 kg (± s.d.)) were used in a 10-week controlled feeding trial, 
commencing in June 2010. The trial was conducted at a private research facility located at 
Mt Cotton, Brisbane, Queensland, Australia (27º 36’ 29” S, 153º 14’ 21” E). The trial 
consisted of a 6-week pre-inoculation feeding period, and a 4-week post-inoculation 
feeding period. Treatments were three combinations of forage-harvested Leucaena 
leucocephala cv. Tarramba (leucaena) and Chloris gayana (Rhodes grass) hay, namely: 
leucaena offered at 25%, 50% & 100% of the diet. A fourth treatment comprised 50% 
leucaena in period 1, switched to 50% Medicago sativa (lucerne) hay in period 2. The 
lucerne hay treatment was offered so that the rate of disappearance of DHP in leucaena 
fed animals following inoculation could be compared with disappearance when leucaena 
was removed from the diet. Total daily dry matter offered was 25 g DM/kg LW.day. 
Treatments were arranged in a randomised complete block design (RCBD) with 4 
replications. At the commencement of period 2, all steers were inoculated with 100 mL of 
fermenter produced rumen enrichment culture containing S. jonesii as an oral drench 
(Klieve et al. 2002). The trial was sanctioned under animal ethics approval # 
LCAFS/035/10 (Appendix 2). 
The forage-harvested and air-dried leucaena cv. Tarramba contained ~60% leaf matter 
and ~40% stem, w/w. Drying occurred for a period of 1 week, and DM% was ~91%. Due to 
supply issues, the Rhodes grass was not consistent between periods of the trial. The first 
batch, used in period 1 (pre-inoculation) was contaminated with lucerne whereas the 
second batch, used in period 2 (post-inoculation) had no lucerne contamination. Prior to 
commencement of period 1, there was a 10-day adaptation period on Rhodes grass 
(period 1 batch). 
All animals used in this study had no previous exposure to leucaena. While the Mt Cotton 
research facility had a history of S. jonesii inoculated cattle grazing leucaena, the trial 
steers were housed separately in pens that were thoroughly cleaned and disinfected with 
antibacterial cleansers prior to their arrival. 
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5.2.2 Daily dry matter intake 
Dry matter intake (DMI) of each feed-type was recorded daily, with mean weekly values 
calculated. Dry matter (DM) content of oven-dried (60°C) samples was determined by 
drying to a constant weight. The content of nitrogen (N) in samples was determined using 
a LECO TruSpec CHN analyser (Matejovic 1995), neutral detergent fibre (NDF) and acid 
detergent fibre (ADF) was measured according to the method described in Van Soest et 
al. (1991), and gross energy (GE) was determined by using an Auto Bomb Calorimeter 
LECO model AC-350 Corporation (USA) (Jetana et al. 2011). 
5.2.3 Urinary DHP measurements 
Weekly urine was obtained from each animal as a bulked 24-hour collection in a 
metabolism crate, with each replicate sampled on a separate day, from Tuesday to Friday. 
Urine volume was recorded and a subsample preserved by acidification at a rate of 1:19 
with concentrated hydrochloric acid (HCl—32%) (Dalzell et al. 2012). The preserved urine 
samples were later analysed for DHP concentration using high performance liquid 
chromatography (HPLC), as described by Dalzell et al. (2012) with a corrected mobile 
phase of 25 mM ammonium dihydrogen phosphate. Total amount of urinary DHP excreted 
per 24 hours was determined based on the urine volume over that period. 
5.2.4 Blood 
Weekly blood serum samples were collected via jugular venipuncture into evacuated tubes 
(Becton Dickinson Vacutainer systems). Tubes were immediately chilled, and after clot 
activation, centrifuged at 1300 × g for 10 minutes before transferring separated serum into 
polypropylene tubes and freezing at −80°C as described by Graham et al. (2013). Serum 
samples were analysed by use of radioimmunoassay using RIAK4 and RIAK5 kits (Ghosh 
et al. 2007). 
5.2.5 Rumen fluid and DNA extraction 
Weekly rumen fluid samples were collected from all animals throughout the trial, including 
during the preliminary feeding period, via an orogastric tube and hand operated vacuum 
pump, as described by Graham et al. (2013) and stored at −80ºC. DNA was extracted 
from all rumen fluid samples using the cetyltrimethylammonium bromide (CTAB) method 
Gagen et al. (2010). Samples (1 mL) were centrifuged (13000 × g for 5 min), and the 
supernatant was removed before DNA extraction. Pellets were homogenized with 200 mg 
of silica-zirconium beads (1:1 mixture of 0.1 and 1.0 mm beads; Biospec, Bartlesville, OK) 
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and 800 µL of CTAB buffer in a FastPrepTM-24 homogeniser (MP Biomedicals Australia) at 
maximum speed (6.5 s/m) for 1 min, twice. Samples were incubated at 70ºC for 20 min 
and centrifuged at 15000 × g for 10 min and the supernatant was extracted with an equal 
volume of 25:24:1 phenol-chloroform-isoamyl alcohol (Sigma Aldrich, Australia). After 
centrifugation, the aqueous phase was used for DNA precipitation using isopropanol and 
ethanol. The DNA pellet was resuspended in elution buffer (10 mM Tris-HCl, pH 8.0) 
quantified using NanoDrop 8000 spectrophotometer (Thermo Fisher Scientific, Australia) 
and stored at −80oC until PCR analysis. 
5.2.6 Detection of Synergistes jonesii by primary and nested PCR 
The gDNA from trial weeks −1, 1, 2, 3, 5, 6, 7, 9 and 10 was diluted 1:10 to measure 
approximately 50–100 ng/μL concentrations. Earlier, during optimisation of polymerase 
chain reaction (PCR) amplification of S. jonesii from rumen fluid derived gDNA, many 
samples did not show a product despite 40 cycles of PCR. In order to increase the 
sensitivity of S. jonesii detection, a second round of PCR using internal primer binding 
sites, termed “nested PCR” was used with the product of the first (“primary”) PCR as the 
template. DNA extracted from the oral drench (fermenter inoculum) containing S. jonesii, 
from 2008 and 2012 year batches, obtained from the Queensland Department of 
Agriculture and Fisheries (QDAF-inoculum), was used as a positive control. 
Primers were designed to amplify the 16S rRNA gene (16S rDNA) of the S. jonesii with 
ARB software (Ludwig et al. 2004) and multiple alignments from other closely related 
bacterial 16S sequences belonging to the Synergistetes phylum (Table 5.1). Of these 
primer sets, Sj_60F–Sj_1039R and Sj_60F–Sj_1004R were used for primary PCR 
amplification. Approximately 50–100 ng of gDNA was used for each 25 μL PCR using 
Platinum Taq (Life Technologies, Carlsbad, CA) with 2 mM MgCl2, 200 μM each of dNTPs 
and 200 nM each of forward and reverse primers. A high annealing temperature of 63ºC 
(72ºC extension) and amplification for only 25 cycles of amplification was done to prevent 
spurious products from becoming targets for amplification in the second, nested PCR. An 
aliquot (2 μL) of the primary PCR was cleaned with enzymes Exonuclease I and Antarctic 
Phosphatase (New England Biolabs, Ipswich, MA) to remove excess primers and dNTPs 
at 37ºC for 20 min, followed by deactivation of these enzymes at 80ºC for 20 min. Nested 
PCR of the cleaned primary product was done utilising Sj_137F–Sj_1004R or Sj_193F–
Sj_1004R primer pairs in a 25 μL PCR, as described above. 
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Table 5.1: S. jonesii 16S rDNA specific primer sets used for primary and nested PCRs extracted from rumen 
fluid samples collected from Bos indicus steers fed leucaena. 
A, Also used as nested primer; B(Graham et al. 2013) 
PCR primers (5’–3’) 
Primary PCR 
  Sj_60F  AGTCGAACGGGGATCATGT 
  Sj_1004RA  CCTCTCGATCTCTCTCAAGTAAC 
  Sj_1039RB CCATGCAGCACCTGTTCTAC 
Nested primers   
  Sj_137F  AGTTACAGGGGGACAACGGA 
  Sj_193FB TAAAAGGAGCGATCCGGTAACA 
 
5.2.7 Sequencing of product from S. jonesii nested PCR positive samples 
S. jonesii positive PCR products (2 μL) were cleaned up by Exonuclease I and Antarctic 
Phosphatase digestion, as described above, prior to sequencing with BigDye Terminator 
v3.1 using the kit Protocol (ABI, Life Technologies, Grand Island, NY). Sequencing (20 μL, 
50 cycles) reactions were run with primer Sj_137F or Sj_193F for the forward and 
Sj_1004R primer (3 pmoles each) for the reverse sequences. The sequenced products 
were cleaned-up using the ABI protocol and run on the ABI 3130xl Prism Genetic 
Analyser. Multiple alignment of all sequences was done using Vector NTI’s Advance 11 
software (Invitrogen, Life Technologies, USA) AlignX module using Clustal W with S. 
jonesii ATCC 49833 (78-1) type strain 16S rDNA as the reference. 
Sequence chromatograms were quality-clipped with the PreGap4 module of the Staden 
Package (http://staden.sourceforge.net/staden_home.html) and sequences manually 
edited to correct base-calling of ‘N’s with MEGA5 (Molecular Evolutionary Genetics 
Analysis software (Tamura et al. 2011) followed by collation of sequences in the FASTA 
format. Paired forward and reverse sequences from each sample were ‘contiged’ on the 
Vector NTI ContigExpress™ module to generate a single sequence from the 5’ to 3’ end of 
the S. jonesii positive PCR product. Multiple alignment of all sequences was done on 
Vector NTI AlignX module using Clustal W and compared with S. jonesii ATCC 49833 (78-
1) type strain 16S DNA as the reference. Any consistent point-mutations (single nucleotide 
polymorphisms — SNPs) were tabulated. 
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5.2.8 Statistical analyses 
Data were analysed using Microsoft Excel computer software (©2011, Microsoft, 
Redmond, WA, USA) and Minitab® statistical software 16 (©2010, Minitab Inc., State 
College, PA, USA). ANOVA GLM models for repeated measures using a spilt-plot design 
were used to analyse mean concentrations of urinary 3,4-DHP, 2,3-DHP and total DHP; 
and changes in DMI and LWG between treatments and periods. One-way ANOVA tests 
were further used to compare differences in total urinary DHP, LWG, and DMI data. 
A one-way ANOVA test was used to test frequency of detection between treatments in S. 
jonesii PCR data. An LSD for serum thyroxine levels was determined using one-way 
ANOVA with pooled error term. The relationship between total urinary DHP and DMI was 
investigated using normal regression analysis. 
Descriptive statistics were used to summarise DHP concentrations, chemical composition 
and gross energy of the feed types, DMI, serum thyroxine, and S. jonesii PCR results for 
each period. 
A probability level of P < 0.05 was considered statistically significant, while a P-value 
between 0.05–0.10 was considered a moderate trend.  
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5.3 Results 
5.3.1 Chemical composition 
The crude protein (CP) content of the leucaena chaff was consistent for each period (80 
g/kg DM for period 1, and 81 g/kg DM for period 2) (Table 5.2). Crude protein (CP) values 
were low due to the high content of stem in the forage-harvested material. The CP content 
of the Rhodes grass was different for each period (76 g/kg DM vs 22 g/kg DM) for periods 
1 and 2, respectively, due to some contamination of the first batch with lucerne chaff. 
Table 5.2: Chemical composition (g/kg DM) and gross energy (MJ/kg DM) of feed types offered to Bos 
indicus steers. 
DMD: dry matter digestibility; GE: gross energy; CP: crude protein; NDF: neutral detergent fibre; ADF: acid detergent 
fibre; period 1: 6-week pre-inoculation period; period 2: 4-week post-inoculation period; A, Rhodes grass chaff 
contaminated with lucerne chaff 
Parameter  Leucaena chaff  Rhodes grass 
chaff 
 Lucerne 
chaff 
Period   1 2 
 
1A 2 
 
2 
DMD (g/kg) 
 
474 ± 5 466 ± 9 
 
553 ± 1 525 
 
660 
GE (MJ/kg DM) 
 
17.5 17.5 
 
16.9 16.6 
 
17 
CP (g/kg DM) 
 
80 81 
 
76 22 
 
197 
NDF (g/kg DM) 
 
650 650 
 
724 807 
 
528 
ADF (total) (g/kg DM)   519 519 
 
513 516 
 
449 
5.3.2 Dry matter intake 
While animals were offered a total daily ration equal to 25 g DM/kg LW.day, all leucaena 
treatments resulted in an average total daily DMI of <20 g DM/kg LW.day (Figure 5.1). 
The steers on the 25% leucaena treatment (n = 4) had an average intake of 19.1 ± 0.2 g 
DM/kg LW.day in period 1, decreasing to 17.8 ± 0.2 g DM/kg LW.day in period 2 (P < 
0.00). Steers consumed an average of 91% of the daily leucaena chaff offered (Figure 
5.1a), and 68% of Rhodes grass offered. Thus, the average actual intake of leucaena was 
31% of diet in period 1 and 34% of diet in period 2. The initial 4 days after introduction to 
treatment diets were excluded from analysis in 2 animals that did not consume any 
leucaena. 
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Steers on the 50% leucaena treatment (n = 4) had an average intake of 18.8 ± 0.2 g 
DM/kg LW.day over both periods 1 and 2. Steers consumed an average of 60% of the 
leucaena, and 90% of the Rhodes grass offered, with no significant difference between 
periods 1 and 2 (Figure 5.1b) (P = 0.29). The average actual intake of leucaena was 39% 
of diet. 
The steers on the 50% leucaena treatment during period 1, and switched to lucerne in 
period 2 (n = 4), had an average intake of 18.8 ± 0.2 g DM/kg LW.day in period 1 (Figure 
5.1c). There was a marked increase in intake of legume and decreased intake of Rhodes 
grass in period 2 (P < 0.01) (20.9 ± 0.3 g DM/kg LW.day) with steers consuming 93% of 
lucerne and 74% of Rhodes grass offered (Figure 5.1c). The average intake of lucerne 
was 57% of diet during period 2. In the final week of the trial, animals on the lucerne 
treatment consumed a total of 23.0 g DM/kg LW.day, the highest of any treatment. 
Steers on the 100% leucaena treatment (n = 4) consumed an average of 15.5 ± 0.2 g 
DM/kg LW.day in period 1 (Figure 5.1d) and 17.5 ± 0.2 g DM/kg LW.day in period 2. The 
increase in intake of leucaena after inoculation was small but significant (P < 0.01). There 
was evidence that intake increased linearly with declining excretion of DHP in urine over 
the 10 weeks of the experiment (Figure 5.2a).  
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Figure 5.1: Mean weekly DMI (+s.e.) of Rhodes grass ( ), leucaena ( ), and lucerne ( ) for Bos indicus 
steers fed diets containing (a) 25% leucaena, (b) 50% leucaena, (c) 50% leucaena for period 1 & 50% 
lucerne for period 2, and (d) 100% leucaena. Arrows (⬇) indicate date of inoculation with cultured S. jonesii. 
DMI: dry matter intake; period 1: 6-week pre-inoculation period; period 2: 4-week post-inoculation period.  
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Figure 5.2: (a) Intake of leucaena (100% leucaena treatment only) in Bos indicus steers in response to 
decreasing urinary DHP excretion for weeks 2–10 (denoted as data labels) (DMI = −1.27 ×10−4 × total 
urinary DHP + 18.2; R2 = 0.97, P < 0.001), and (b) rate of decline in mean total DHP excretion for steers fed 
diets containing 25% leucaena (total urinary DHP = −840 × week + 7062; R2 = 0.89), 50% leucaena (total 
urinary DHP = −1211 × week + 11600; R2 = 0.97) and 100% leucaena (total urinary DHP = −3533 × week + 
29056; R2 = 0.96)(P < 0.001). DHP: hydroxypyridone; DMI: dry matter intake; LW: liveweight. 
5.3.3 Selection index 
A feed selection index (SI) was calculated for the 25 and 50% leucaena, and the 50% 
lucerne (weeks 7–10) treatments (Table 5.3).  
 Selection index was defined by: 
"# = 	&'()*+,-	,&	&../	),-012./&'()*+,-	,&	&../	,&&.'./  
A SI of 1 indicated equal preference for legume and Rhodes grass, while a SI <1 indicated 
negative selection for that species. 
In the 25% leucaena treatment (n = 4), there was a preference for leucaena over Rhodes 
from week 2 onwards, with almost complete consumption of all leucaena offered; the 
selection index for leucaena ranged between 1.09 and 1.41. 
In all steers on the 50% leucaena treatment during period 1 (n = 8), there was a negative 
preference for leucaena with SI varying from 0.68 and 0.82. The SI for Rhodes grass 
remained between 1.17 and 1.32 throughout period 1, and continued unchanged for steers 
remaining on the 50% treatment during period 2 (n = 4). Selection index for Rhodes grass 
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however declined to 0.88 in the steers switched to lucerne during period 2 (n = 4); the 
mean SI for lucerne was 1.12. 
Table 5.3: Mean selection index for period 1 and 2, for each treatment level of leucaena offered to Bos 
indicus steers. 
Period 1: 6-week pre-inoculation period; period 2: 4-week post-inoculation period; A, Rhodes grass chaff contaminated 
with lucerne chaff 
Treatment Period n Leucaena 
chaff 
Rhodes 
grass chaff 
Lucerne 
chaff 
25% leucaena 1 4 1.22 0.93A 
 
 
2 4 1.34 0.89 
 50% leucaena 1 8 0.76 1.24A 
 
 
2 4 0.81 1.19 
 50% lucerne 2 4 
 
0.88 1.12 
5.3.4 Rumen microbial analysis 
Of the 96 rumen fluid samples from period 1, ~22% were positive for S. jonesii 16S rDNA-
based nested PCR; while from the 48 samples from period 2, ~21% were positive for S. 
jonesii (Table 5.4). Interestingly, of the samples collected before treatments began (week 
−1), 3 of 16 animals (~19%) were positive for S. jonesii despite never having previously 
encountered leucaena or been inoculated with S. jonesii. After leucaena treatments 
commenced, there was inconsistency in the number of samples positive for S. jonesii. In 
weeks 1, 2, 3, 5, 6, 7, 9, and 10 the number of positive rumen fluid samples were 19%, 
25%, 13%, 38%, 19%, 31%, 19%, and 13%, respectively. 
Of the 16 animals in the trial, 13 (~81%) were positive for S. jonesii at some stage by 
nested PCR either in period 1 (~69%) or period 2 (50%). Five animals (~31%) were 
positive for S. jonesii only in period 1 whereas only 2 (~13%) became positive for S. jonesii 
after inoculation (period 2); 6 animals (~38%) were positive for S. jonesii in both periods 1 
& 2. 
Multiple alignment analysis of the sequences against the type strain (ATCC 49833 (78.1) 
16S rDNA for S. jonesii positive samples, revealed 4 loci with point mutations 
corresponding to E. coli 16S rDNA base positions 268(C→T), 306(A→G), 328(G→A) and 
870(A→C). These SNPs when present occurred predominantly at loci 306 (100%) and 870 
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(~92%); to a lesser extent at locus 328 (~27%); and rarely at position 268 (~8%). Only 
~16% of the 31 samples positive for S. jonesii were identical to the 16S rDNA sequence of 
type strain 78-1; 2 were from period 1, and 3 from period 2. DNA from the 2 batches of the 
QDAF fermenter culture oral-inoculum (years 2008 & 2012) both showed SNPs, but only 
at loci 306 and 870. 
5.3.5 Urinary DHP excretion 
DHP levels in urine varied with amount of leucaena in diet but were highest in the weeks 
immediately following commencement of leucaena feeding and continued to increase until 
weeks 3 and 4 (Figure 5.3). Thereafter, levels gradually declined. When all animals were 
inoculated at the end of week 6 (end of period 1) DHP levels continued to decline with no 
departure from linearity, indicating no effect of inoculation on rate of change of total DHP 
excretion (Figure 5.2b). Steers fed lucerne ceased all toxin excretion by week 8, 14 days 
after removal of leucaena from their diets (Figure 5.3c). 
All treatment groups showed an increasing proportion of the isomer 2,3-DHP excreted 
during period 1, which then declined from week 7 to low levels during period 2 following 
inoculation (Figure 5.3). However, total DHP remained at levels greater than the 
suggested critical threshold of 350 mg/steer.day (100 mg/L, adapted from Dalzell et al. 
(2012) with an average daily urine volume of ~3.5 L) through to week 10, except when 
leucaena was replaced by lucerne.  
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Table 5.4: The number of times rumen fluid collected from Bos indicus steers tested positive for S. jonesii in 
nested PCR with SNPs detected in at least 1 loci; weeks 0,4 & 8 were not analysed. 
Period 1: 6-week pre-inoculation period; period 2: 4-week post-inoculation period; SNPs: single nucleotide 
polymorphisms; A, no SNPs detected in these samples; –, indicates S. jonesii was not detected 
Treatment Animal ID 
(n = 16) 
Weeks in which animals were 
S. jonesii positive  
(SNPs were also detected) 
Period 1 
(n = 96) 
Period 2 
(n = 48) 
25% leucaena 1 – – 
2 3 – 
3 3,5 7,9,10 
4 1 – 
50% leucaena 5 2A 10 
6 −1,1,2,5,6 – 
7 −1,2 7A 
8 −1,1,5,6 7 
50% leucaena 
(period 1) & 50% 
lucerne (period 2) 
13 – – 
10 5 9A 
11 – 9 
12 5,6A – 
100% leucaena 13 5 – 
14 – – 
15 – 7A 
16 2 7 
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Figure 5.3: Mean weekly DHP excretion patterns of 3,4-DHP ( ) and 2,3-DHP ( ) for Bos indicus steers 
fed diets containing: (a) 25% leucaena, (b) 50% leucaena, (c) 50% leucaena for period 1 & 50% lucerne for 
period 2, and (d) 100% leucaena (+s.e.). Arrows (⬇) indicate date of inoculation with cultured S. jonesii. DHP: 
hydroxypyridone; period 1: 6-week pre-inoculation period; period 2: 4-week post-inoculation period.  
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5.3.6 Serum thyroxine 
Serum thyroxine (T4) levels (Figure 5.4) decreased rapidly during the preliminary period 
prior to commencement of leucaena feeding (during week −1) and were lowest on the first 
day of leucaena feeding when concentrations were 54, 43, and 33 nmol/L for animals 
receiving treatments of 25%, 50%, and 100% leucaena, respectively. Concentrations 
subsequently increased to levels within the normal range (70–120 nmol/L) (Jones et al. 
1978) and remained within this range for the remainder of trial. Animals receiving 25% 
leucaena exhibited higher serum T4 concentrations than those receiving 100% leucaena 
during period 1. No significant difference was evident among treatments during period 2. 
 
Figure 5.4: Mean serum thyroxine (T4) concentration for Bos indicus steers fed diets containing 25% 
leucaena, 50% leucaena, 50% leucaena for period 1 & 50% lucerne for period 2, and 100% leucaena. Bar 
indicates 1 × LSD0.05 where difference in T4 levels was significant (P < 0.05). Arrow (⬇) indicates date of 
inoculation with cultured S. jonesii. Period 1: 6-week pre-inoculation period; period 2: 4-week post-
inoculation period.  
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5.4 Discussion 
There were several important findings from this trial, many of which contradicted the 
original theories described for leucaena toxicity. These original understandings and the 
findings are now compared and contrasted. 
5.4.1 Efficacy of inoculation with cultured S. jonesii 
In past work, inoculation with rumen fluid containing S. jonesii was shown to lead to rapid 
degradation of DHP and therefore provided very efficient protection from toxicity (Jones 
and Megarrity 1983). In this trial, total DHP began to decline prior to inoculation and there 
was no change in the rate of decline after inoculation with cultured S. jonesii (Figure 5.2b) 
suggesting no discernible effect of the inoculum on total DHP excretion. Furthermore, 
urinary DHP results indicated that the inoculum was not capable of reducing total DHP 
levels to below the suggested critical threshold for toxicity (350 mg/steer.day adapted from 
Dalzell et al. (2012)) within 4 weeks of inoculation. 
These results contrast the original work on rumen inoculation, which found that S. jonesii 
completely detoxified all DHP within 5-days after inoculation using in vivo sourced rumen 
fluid (Jones and Lowry 1984; Jones and Megarrity 1986). In other studies using in vivo 
sourced S. jonesii, Quirk et al. (1988) and Pratchett et al. (1991) reported that inoculated 
steers grazing leucaena ceased DHP excretion within 6 and 4 weeks, respectively. 
5.4.2 High levels of 2,3-DHP 
The compound 3,4-DHP was originally reported to be the principal isomer excreted in 
unprotected animals, with 2,3-DHP perceived as transitory. Indeed 2,3-DHP was thought 
to be present only temporarily as the isomerization product of 3,4-DHP prior to degradation 
of the pyridine ring by S. jonesii in newly inoculated animals (Jones et al. 2009). In this 
trial, after 6 weeks consuming leucaena and prior to inoculation, 2,3-DHP levels were 
present in higher proportions than 3,4-DHP (Figure 5.3). The high levels of 2,3-DHP 
excreted in urine were in accordance with the findings of much recent work. In the grazier 
survey in Queensland, Dalzell et al. (2012) showed that almost half of the 44 herds tested 
had levels of urinary DHP above 100 mg/L and over half of these were excreting higher 
proportions of 2,3-DHP than 3,4-DHP. Other workers Ghosh et al. (2007); Palmer et al. 
(2010); Phaikaew et al. (2012); Graham et al. (2013) also reported high levels of 2,3-DHP 
in ruminants after periods of between 2–10 weeks from commencement of consuming 
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leucaena. These findings, and those of the current study, strongly contradict the notion 
that 2,3-DHP is a transitory isomer. 
In the current experiment, 2,3-DHP began to appear in urine samples from week 2 and 
became the predominant isomer by week 6. The accumulation of 2,3-DHP occurred 
simultaneously with a decline in 3,4-DHP, and therefore total DHP. These findings suggest 
the presence of an indigenous strain of S. jonesii, which converted 3,4-DHP to 2,3-DHP at 
a faster rate than 2,3-DHP was able to be degraded. Following inoculation, 2,3-DHP 
excretion was reduced relative to 3,4-DHP indicating that the inoculum may have been 
more effective in degrading 2,3-DHP and that metabolism of each of these isomers is 
controlled by different regulatory conditions which may vary between strains of S. jonesii 
(Hammond et al. 1989; Rincón et al. 2000). 
Whilst not as widely researched as 3,4-DHP, the isomer 2,3-DHP is also considered a 
potent goitrogen (D'Mello 1992; Paul 2000) and has been shown to have acute toxic 
effects when directly infused intraruminally (McSweeney et al. 1984; Puchała et al. 1995). 
For these reasons, in the assessment of leucaena toxicosis, total DHP excretion was 
considered. 
5.4.3 Detection of S. jonesii prior to inoculation 
Synergistes jonesii has been reported to be a unique bacterium present in specific 
countries and at specific locations. However, in this trial, PCR analysis of rumen fluid from 
steers naïve to leucaena, from a coastal property where S. jonesii had not been 
introduced, detected the presence of S. jonesii, albeit at low numbers (<104 cells per mL). 
Thus, while DHP excretion in all treatments was initially quite high, this indigenous 
population of S. jonesii was most likely responsible for the gradual decline in urinary DHP 
levels observed in all leucaena diets prior to inoculation. A decline in urinary DHP in 
uninoculated ruminants was also observed in the work of Ghosh et al. (2007) and Graham 
et al. (2013). 
As S. jonesii is difficult to detect in rumen fluid of livestock, the presence of S. jonesii has 
previously been inferred by either a colorimetric analysis of DHP in urine (Jones and 
Megarrity 1983; Lowry et al. 1985; Jones 1994) and/or by HPLC analysis of urine 
(Tangendjaja and Wills 1980; Dalzell et al. 2012), or by detecting mimosine and DHP 
degradation by a rumen culture enrichment (Allison et al. 1990; Allison et al. 1992). Each 
of these methods has merits and drawbacks, however they do not directly detect S. 
jonesii. 
  Chapter 5 Inoculation in Australia  
 
 
47 
Graham et al. (2013) reported the first use of a nested PCR approach for direct S. jonesii 
detection. They found that detection was sporadic due to very low populations of the 
bacterium in the rumen. The current study again employed a nested PCR approach using 
novel S. jonesii specific primer pairs for both the primary and nested PCRs; in the previous 
study, Graham et al. (2013) used a S. jonesii-specific forward primer with a general 
bacterial reverse primer (1275R). The current approach was able to detect S. jonesii in 
~22% of all samples collected; almost 4 times more frequently than in the study of Graham 
et al. (2013). This increased sensitivity enabled detection of S. jonesii in most steers at 
least once across the 10 weeks of the trial. The advancement of more specific primers is 
required to further overcome the sporadic detection, as evidenced in this trial. 
Other surveys of S. jonesii in ruminant species (cattle, goats, sheep, buffalo, yak and 
native Indonesian and Jinnan cattle) from several countries (Australia, Indonesia, 
Thailand, China, Vietnam and Brazil) used a similar nested PCR-based approach 
(Padmanabha et al. 2014). Sequence confirmation of S. jonesii from these studies now 
suggest ubiquity of S. jonesii in the rumen of different animal species from diverse parts of 
the globe (Padmanabha et al. 2014). This contradicts the notion that S. jonesii is unique 
only to ruminants in certain countries. 
However, in all surveys, the infrequent detection of S. jonesii indicated that abundance 
was low and probably often below the limits of sensitivity/detection by 16S rDNA-based 
PCR assays. The limit of detection by PCR/nested-PCR is theoretically determined to be 
~3 × 103 S. jonesii cells/mL for pure cultures and <104–105 cells/mL for rumen digesta 
(Graham et al. 2013). 
Whilst there is evidence S. jonesii is indigenous to the rumen, positive PCR detection does 
not infer functional capacity to degrade DHP (McSweeney and Shelton 2009). It is also 
possible that the introduced strains of S. jonesii have become pandemic in Australian 
ruminants since its release in the 1980s (Jones et al. 1985b) as S. jonesii can easily 
spread among uninoculated animals within a herd (Klieve et al. 2002) and to nearby 
uninoculated herds if handling facilities are in common (Quirk et al. 1988; Pratchett et al. 
1991). However, the frequent detection internationally likely suggests that S. jonesii is 
indeed normal rumen flora. 
It has been previously thought that the persistence and abundance of S. jonesii is 
dependent upon the presence of leucaena in the diet (Rincón et al. 2000). However, in the 
current study this relationship was not obvious. There was no clear trend of greater 
frequency of S. jonesii positive samples with (a) length of time animals were consuming 
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leucaena, (b) cattle fed 100% compared to 25% and 50% leucaena in diet, or (c) numbers 
of animals positive for S. jonesii pre- and post-oral inoculation. Padmanabha et al. (2014) 
also found that a leucaena diet, or lack thereof, did not influence detection of S. jonesii in 
samples from ruminants in several countries. Similar trends were also observed in the field 
studies of Graham et al. (2013). As S. jonesii is a chemoorganotroph (Allison et al. 1992) it 
relies on the breaking of chemical bonds of amino acids for energy and grows best with 
arginine and histidine as substrates (Allison et al. 1992; Rincón et al. 1998), which gives it 
a competitive physiological niche in the rumen (McSweeney et al. 1993a). By utilising 
these, as well as other amino acids and peptides, S. jonesii is capable of survival in the 
absence of mimosine and DHP in diet (McSweeney et al. 2002). Indeed S. jonesii does 
not require DHP for growth in vitro (McSweeney et al. 1993a). Hammond et al. (1989) also 
reported that three years after removal from the island of St Croix, and without any 
leucaena in diet, cows retained the capability to degrade 2,3-DHP. 
5.4.4 Presence and function of different strains of S. jonesii 
The latest techniques utilizing nested PCR detection methodology have given new insight 
into the genetic diversity of S. jonesii. The frequent detection of SNPs at various loci in 
both the cultured inoculum and the indigenous S. jonesii population in the steers suggests 
there are multiple strains of S. jonesii present in animals and the inoculum, which probably 
differ genetically and functionally from the original isolates and the type strain 78-1 (ATCC 
49833), with which most culture studies have been performed. The type strain and the 
additional three labelled strains (100-6, 113-4 and 147-1) were originally isolated from in 
vitro serial transfers of the original source of rumen fluid from a Hawaiian goat and all 
shared an identical 16S rDNA sequence (Allison et al. 1992). While all strains were able to 
degrade 3,4-DHP and 2,3-DHP, and were phylogenetically identical, some were 
selectively more efficient at degrading a particular isomer of DHP; for example, 78-1 
effectively degrades 3,4-DHP (McSweeney and Shelton 2009). Although the 4 strains 
were isolated from samples from the same Hawaiian goat used to source the inoculum 
introduced to Australian cattle in 1982, the Australian inoculum was composed of 2 
unnamed strains, isolated independently from separate enrichments (Jones 1994), for 
which the DHP isomer-specificity is unknown. 
Domínguez-Bello et al. (1997) reported that degradation of 2,3-DHP, the final step before 
pyridine ring cleavage, began to occur when S. jonesii was present in high numbers. This 
was also regulated by the concentration of pyridinediols present to activate the substrate-
induced isomerase enzymes for degradation to take place (Rincón et al. 2000). As 
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previously discussed, the number of cells of S. jonesii was very low in this trial and this 
may be a contributing factor to its low efficacy. As such, degradation may be delayed until 
sufficient proliferation of the bacterium (Hammond et al. 1989), which was not observed. 
While S. jonesii is the only bacterium in culture collection that can degrade both isomers of 
DHP, it should be noted that Hammond et al. (1989) isolated rumen bacteria from cows 
that were not S. jonesii but were capable of degrading 2,3-DHP but not 3,4-DHP. Tan et 
al. (1994) reportedly isolated 4 strains of bacteria capable of degrading mimosine, 3,4-
DHP and/or 2,3-DHP—Lactobacillus spp., Streptococcus bovis and Clostridium 
sporogenes—which together were able to degrade up to 60% of DHP in vitro within 3 
days. Domínguez-Bello and Stewart (1990) isolated 18 cultures which could degrade 
either 3,4-DHP or 2,3-DHP from a sheep in Venezuela naïve to leucaena, including gram-
positive, and gram-negative bacteria and a gram-positive spore-forming bacterium 
(Domínguez-Bello and Stewart 1991). The work of Aung et al. (2011) isolated an aero-
tolerant gram-negative Coccobacillus species able to degrade DHP, belonging to the 
genus Klebsiella, in ruminants naïve to leucaena. Additional bacteria include another 
Streptococci sp., (Chhabra et al. 1998), a Clostridium (Domínguez-Bello et al. 1997), 
Streptococcus lutetiensis, Clostridium butyricum, Lactobacillus vitulinus, and Butyrivibrio 
fibrisolvens (Derakhshani et al. 2016). While, these observations cannot be verified as 
none of these isolates currently exist in culture collections it nevertheless suggests that it 
is quite possible that a consortium of many morphological types of bacterial species and/or 
strains is involved in the complete degradation of 3,4-DHP (Domínguez-Bello and Stewart 
1990; McSweeney et al. 2002; McSweeney and Shelton 2009). 
Molecular analysis of S. jonesii in this study detected discrete mutations (SNPs) in almost 
84% of positive samples, which occurred consistently at four loci (268, 306, 328 & 870) in 
the 16S rRNA gene. As loci 306 and 870 attracted considerably more SNPs than loci 328 
and 268, it suggested a possible hierarchy of propensity to attract mutations. The same 
SNPs at these two most prominent loci were also recorded for the QDAF oral-inoculum 
from two different batches produced 6-years apart. 
However, all sequences were >97% identical to the S. jonesii ATCC strain 78-1. A similar 
trend for the same loci to acquire SNPs was evidenced in the survey of ruminants from 
Australia and other countries (Padmanabha et al. 2014). The presence of SNPs in the 16S 
rRNA gene can be a harbinger of a break from the type strain and the development of a 
new ‘strain’ for S. jonesii, which could differentially affect its ability to degrade DHP 
isomers. 
  Chapter 5 Inoculation in Australia  
 
 
50 
It is clear now that Australian cattle host strains of S. jonesii that are different from the type 
strain 78-1 and the other strains originally isolated from the Hawaiian goat. These bacteria 
appear to persist in the rumen without the presence of leucaena in the animals’ diet. The 
inconsistency in detection of S. jonesii by the current PCR test indicated that a more 
sensitive amplification-based detection is warranted. 
5.4.5 Dry matter intake & selection index 
The Rhodes grass offered during period 1 was contaminated with lucerne chaff, and 
consequently had a higher crude protein content in period 1 compared to period 2. It was 
therefore possible that the lack of difference in intake and selection index for 25% and 
50% leucaena treatments was partially due to the higher quality of the Rhodes grass in 
period 1. However, this issue was not applicable to the 100% leucaena treatment. 
Previous studies reported that intake of leucaena and LWG increased following inoculation 
(Jones and Lowry 1984; Jones and Megarrity 1986; Quirk et al. 1988). A slight increase 
was partially observed in this trial only for the 100% leucaena diet, further suggesting a 
lack of (complete) protection afforded by the inoculum. 
Fresh leucaena is a high-quality and highly palatable legume feed (Jones 1979; Andrew et 
al. 2000) and in the absence of DHP toxicosis, intake should be high (Dixon and Coates 
2008). However, throughout the experiment, leucaena chaff DMI remained below that 
required for a high production diet (Gupta and Atreja 1999; Dixon and Coates 2008). 
The original research reported that goats fed 100% leucaena for 5 weeks prior to 
inoculation had a stable but low daily intake, which doubled within 3 days after transfer of 
in vivo rumen fluid (Jones and Lowry 1984). A significant increase in intake of leucaena 
(and LWG) post-inoculation was also noted by Pratchett et al. (1991) in a grazing trial 
using irrigated leucaena. 
In this study, there was a strong relationship between DHP excretion and intake in the 
100% leucaena treatment (Figure 5.2a) suggesting that suppression of intake in the initial 
weeks could be attributed to high levels of circulating DHP. Interpreting this relationship 
further, maximum intake would have reached 18.2 g DM/kg LW.day when zero DHP 
excretion was reached i.e. complete degradation. An intake of this level would not 
constitute a high production diet, and intake was probably constrained due to the high 
stem content of the leucaena chaff that reduced the crude protein content (~8% DM) and 
digestibility (<48% DMD) of the chaff. At higher levels of leucaena offered, stem was often 
selected against, while animals consuming lower levels of leucaena readily consumed all 
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stem material. Regardless of stem content, the refusals from steers fed 100% leucaena 
always contained uneaten leaf material in addition to uneaten stem, suggesting that feed 
quality alone was not solely responsible for the reduced intakes. No similar relationships 
between intake and DHP excretion were observed in animals offered 25% or 50% 
leucaena in this trial. Since the actual intakes for these treatments were 31% and 39%, 
they were unlikely to cause significant intake suppression over the short period of time of 
this trial (Jones and Hegarty 1984). 
Leucaena was preferred over Rhodes grass when fed at the lowest level of 25% and was 
completely consumed with a positive selection index (Table 5.3). However, there was clear 
selection against leucaena when offered at 50 or 100%, leading to reduced intake. When 
the 50% leucaena diet was switched to a 50% lucerne diet, intake of legume increased 
(Figure 5.1c), reflecting the much higher selection index of lucerne compared to leucaena 
(Table 5.3). Although fresh leucaena has been reported to be of comparable in quality to 
that of lucerne (Shelton and Brewbaker 1994) the forage-harvested leucaena chaff that 
contained stem was clearly less preferred. Ghosh et al. (2007) used a similar feed and 
also recorded a reduction in leucaena intake in unprotected animals as levels of leucaena 
offered increased. When protected from toxicity, cattle will readily select diets high in 
leucaena (Jones and Jones 1984), and can safely tolerate 100% leucaena diets (Halliday 
et al. 2014b). Pratchett et al. (1991) also reported high leucaena diets (70–95%) were 
consumed by shorthorn heifers after they acquired S. jonesii. Dixon and Coates (2008) 
used faecal near infrared reflectance spectroscopy (F.NIRS) to measure amount of 
legume in the diet of steers free-grazing leucaena/grass pastures and found that intake 
levels were as high as 30 g DM/kg LW.day, and were regularly in the range of 20–25 g 
DM/kg LW.day. 
The intake results from this experiment confirmed the original notion that short-term 
feeding of leucaena below 30% of diet is considered ‘safe’ (Jones and Hegarty 1984), with 
few of the deleterious impacts on production that are often observed at higher levels of 
feeding (e.g. reduced intake and decreased LWG). 
5.4.6 Serum thyroxine 
Earlier work indicated that DHP was a potent goitrogen that could strongly suppress T4 in 
response to toxicity (Hegarty et al. 1979), reportedly due to the inhibition of the iodination 
of tyrosine-based hormones due to its analogous nature with pyridoxal which antagonises 
peroxidase-based enzyme pathways (Christie et al. 1979; Lee et al. 1980). Thyroxine 
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levels were found to return to normal after removal of leucaena from diet or inoculation 
with S. jonesii (Jones et al. 1978; Megarrity and Jones 1983; Ghosh et al. 2007). The 
findings of this trial were in contrast as T4 levels were low even before the consumption of 
leucaena, and generally increased with time on leucaena. T4 concentrations remained 
within the normal range (70–120 nmol/L) for animals on 25% and 50% treatments after 2 
weeks on leucaena. Animals on 100% leucaena experienced lower levels of T4 during 
period 1 but returned to the normal range after 4 weeks.  
It is possible that alternate coping mechanisms, for instance conjugation, were involved in 
preventing the goitrogenic effects of DHP from manifesting. Although the level of 
conjugated DHP was not measured, with urine samples hydrolysed prior to HPLC 
analysis, as much as 70% of DHP in circulation has been reported as conjugated (Hegarty 
et al. 1979). Hepatic conjugation of xenobiotics is a common phase II detoxification 
pathway which can greatly reduce the bioactivity of toxins (Lindsay et al. 1974; Christie et 
al. 1979). The detoxifying effect of conjugation is due to the attachment of an acidic 
molecule at the active binding hydroxyl site of DHP, preventing any antagonistic or 
chelatory effects (Lowry et al. 1985). 
 
5.4.7 Signs of toxicity 
None of the animals, even consuming 100% leucaena, displayed clinical signs of leucaena 
toxicity during the trial, e.g. short-term hair loss, despite high levels of DHP recorded. 
Subclinical toxicity, such as reduced intake and LWG, may have occurred, however these 
results are confounded with feed quality in the experiment. Signs of subclinical toxicity 
however, have been reported in animals fed leucaena for longer periods (Jones et al. 
1976; Quirk et al. 1988; Phaikaew et al. 2012) with Pratchett et al. (1991) reporting a LWG 
of only 0.40 kg/day in heifers grazing 70–95% leucaena over a 20-week period. Other 
work has reported unprotected steers fed 100% leucaena gained as little as 0.18 kg/day, 
with 2 animals dying (Jones et al. 1978). 
In stark contrast to the above feeding trials, there is evidence of uninoculated cattle 
achieving high LWG on high leucaena diets, despite high urinary DHP levels. Bali bulls 
(Bos javanicus) in Indonesia on 100% leucaena diets were reported to be gaining weight 
near to their maximum genetic potential for the breed of 0.85 kg/steer.day (Mastika 2003; 
Halliday et al. 2014b; Panjaitan et al. 2014). Unexpectedly, these animals were shown to 
be excreting high levels of DHP in urine, demonstrating that they may possess an 
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alternative mode of adaptation to leucaena toxicity. It is hypothesized that conjugation of 
the toxin may be the operative pathway (Elliott et al. 1985); if so, this represents a major 
shift in the way leucaena toxicity could be managed. Further work is required to investigate 
the extent and significance of this detoxification pathway in Australian cattle.  
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5.5 Conclusions 
This study demonstrated that the cultured S. jonesii inoculum had reduced capacity to 
protect animals on high leucaena diets from toxicity compared to the earlier research in 
which inoculation with rumen fluid from protected animals completely and rapidly degraded 
DHP. 
Inoculation had no effect on the rate of degradation of total DHP and the levels of urinary 
DHP remained well above that considered to be a safe threshold. Despite this, thyroxine 
levels were not significantly reduced. The results contradicted the long-standing belief that 
2,3-DHP is a transitory isomer. There was a small increase in intake of animals on 100% 
leucaena post-inoculation, but overall feed intake levels remained low. 
It was found that an indigenous population of S. jonesii was present in the rumen of steers 
prior to inoculation. There was evidence of different strains (detected as SNPs) of S. 
jonesii, in both the indigenous population and the cultured inoculum, that were different to 
the type strain 78-1. These strains may have differential capacity to degrade the two DHP 
isomers thus contributing to varying proportions of 3,4-DHP and 2,3-DHP detected in urine 
before and after inoculation. 
While not measured or discussed in this study, further research should investigate the 
possible effects of conjugation and chelation of DHP as an alternative means of limiting 
leucaena toxicity in ruminants worldwide and in Australian beef cattle. 
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Chapter 6 Survey of toxicity status of ruminants consuming Leucaena 
leucocephala in eastern Indonesia 
6.1 Introduction 
The productive forage tree legume Leucaena leucocephala (leucaena) is traditionally used 
as a feed for ruminant livestock in cut-and-carry systems in eastern Indonesia (Piggin and 
Parera 1985) where its high nutritive value and protein content make it ideal for cattle 
fattening, especially through the extended dry season. Although highly nutritious, leucaena 
contains the toxic non-protein free amino acid mimosine in relatively high concentrations 
(4–9% dry matter (DM) in young leaves and green seeds), which can adversely affect 
animal production (Hegarty et al. 1976). 
In ruminants, the degradation of mimosine to 3-hydroxy-4(1H)-pyridone (3,4-DHP) post-
ingestion occurs via many endogenous rumen bacteria (Hegarty et al. 1964b) and plant 
hydrolase enzymes within leaves (Lowry et al. 1983). The isomerisation of 3,4-DHP to 3-
hydroxy-2(1H)-pyridone (2,3-DHP) and further catabolism of the pyridine ring, however, 
has been reported to require the specialised rumen bacterium Synergistes jonesii (Jones 
and Megarrity 1983; Allison et al. 1992), the presence of which was thought to be limited 
to specific tropical countries where leucaena feeding was historically practiced (Jones 
1994). S. jonesii was originally discovered in Hawaiian goats, and later in Indonesian 
goats, that were consuming leucaena without ill affect (Jones 1981; Jones and Megarrity 
1986), and was shown to be capable of detoxification of 3,4-DHP and 2,3-DHP to non-
toxic by-products (Jones and Lowry 1984). 
This led to the assumption that all ruminants in those countries where S. jonesii occurred 
naturally were protected from DHP toxicity (Jones 1994). However, in eastern Indonesia, 
where leucaena had become naturalised, adoption of leucaena-based cattle fattening 
systems was sporadic, with the occurrence of signs of DHP toxicity reported to be a 
potential barrier to adoption. It was hypothesised that in remote regions and islands, where 
animal movement is restricted, the spread of the bacterium may be impeded, and that 
animals may not be protected from DHP toxicity by S. jonesii. 
In chapter 4, a field study to test the effectiveness of transfer of rumen fluid from 
‘apparently protected’ animals to ‘apparently unprotected’ animals did not show any 
positive effect of inoculation. It was found that S. jonesii occurred at low populations in the 
rumen, and that there may be variation in the functional capacity of S. jonesii. 
 Chapter 6 Toxicity status in eastern Indonesia 
 
 
56 
Accordingly, a field study was initiated with the objective of surveying the toxicity status of 
ruminants consuming leucaena. As leucaena-based cattle fattening presents an excellent 
opportunity to improve the livelihoods of smallholder farmers, overcoming possible toxicity 
limitations could enhance adoption and result in substantial benefits to rural communities.  
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6.2 Materials and Methods 
6.2.1 Animal selection 
A study of the occurrence of leucaena toxicity in ruminants in eastern Indonesia was 
conducted in the provinces of West and East Nusa Tenggara (NTB and NTT) in October 
2011. Five villages were selected from each of the islands of Lombok, Sumbawa, Sumba 
and West Timor (Plate 6.1) where leucaena feeding was an established practice; up to 10 
animals were sampled from each village (Table 6.1) including cattle (Bali bulls and cows: 
Bos javanicus; and Ongole bulls: Bos indicus), kacang goats (Capra hircus), and buffalo 
(Bubalus bubalis). The animals, belonging to local villagers, were tethered or housed in 
‘kandangs’ (individual pens within a small shed) and fed fresh cut leucaena daily. The 
percentage of leucaena in diet was recorded and varied according to availability of forage 
at the end of the dry season. Animal breed, sex, age, and the approximate level of 
leucaena in diet were also recorded, as well as the number of days animals had been 
consuming leucaena prior to sampling (Table 6.1). This study was sanctioned under 
animal ethics #SAFS/144/11/ACIAR (Appendix 1). 
 
Plate 6.1: Locations of sample collection (●) in the islands of (from left to right): Lombok; Sumbawa; Sumba; 
and West Timor. 
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Table 6.1: General data on animals sampled, percentage of leucaena in diet and time consuming leucaena, animal age, and village location. 
Island Animal Species District Village GPS Coordinates n Approx. 
leucaena 
in diet (%) 
 Approx. time 
consuming 
leucaena 
(days) 
 Approx. age (months) 
  Mean Range 
Lombok Cattle Bos javanicus North Lombok Bayan 8º 13' 50.99" S 116º 19' 50.40" E 10 30 
 
920 
 
74 36–84 
   
West Lombok Sekotong 8º 44' 17.40" S 116º  4' 34.01" E 9 30 
 
500 
 
36 36–36 
 
Goat Capra hircus Central Lombok Rembitan 8º 50' 29.03" S 116º 17' 37.19" E 7 30 
 
90 
 
24 12–36 
   
East Lombok Pringgabaya 8º 30' 51.60" S 116º 39' 22.40" E 9 100 
 
4 
 
11 11–13 
   
North Lombok Bayan 8º 13' 50.99" S 116º 19' 50.40" E 8 30 
 
600 
 
36 36–36 
   
North Lombok Pemenang 8º 24' 27.56" S 116º 3' 38.03" E 8 30 
 
300 
 
24 24–24 
   
West Lombok Sekotong 8º 44' 17.40" S 116º 4' 34.01" E 9 30 
 
217 
 
19 12–36 
Sumba Buffalo Bubalus bubalis East Sumba Kakaha 10º 14' 58.62" S 120º 22' 48.89" E 5 44 
 
217 
 
28 24–42 
   
East Sumba Melolo 9º 52' 50.83" S 120º 39' 35.31" E 4 100 
 
180 
 
15 12–24 
   
East Sumba Wanga 9º 46' 11.40" S 120º 36'  4.31" E 1 100 
 
180 
 
12 12–12 
 
Cattle Bos indicus East Sumba Kakaha 10º 14' 58.62" S 120º 22' 48.89" E 3 20 
 
365 
 
24 24–24 
   
East Sumba Wanga 9º 46' 11.40" S 120º 36'  4.31" E 2 100 
 
730 
 
24 24–24 
 
Goat Capra hircus Waingapu Kamalaputi 9º 39'  5.86" S 120º 16'  4.67" E 7 50 
 
28 
 
12 12–12 
   
Waingapu Kambaniru 9º 39' 51.59" S 120º 17' 38.58" E 6 90 
 
639 
 
21 12–24 
Sumbawa Cattle Bos javanicus Sumbawa Jati Sari 8º 25' 10.20" S 117º 15' 56.09" E 10 92 
 
39 
 
24 18–48 
   
Sumbawa Labangka I 8º  53' 49.58" S 117º  46' 8.88" E 8 93 
 
202 
 
17 12–30 
   
Sumbawa Penyenger 8º  26'  7.05" S 117º  4' 59.56" E 9 74 
 
473 
 
25 13–36 
   
Sumbawa Rhee 8º 24' 39.88" S 117º 13'  8.13" E 6 50 
 
20 
 
18 18–18 
   
West Sumbawa Poto Tano 8º 32' 30.06" S 116º 52' 0.83" E 7 97 
 
94 
 
15 12–24 
Timor Cattle Bos javanicus Amarasi Ponain 10º 12' 11.69" S 123º 51' 16.22" E 6 43 
 
365 
 
22 12–24 
   
Amarasi Tesbatan II 10º 12' 44.81" S 123º 54' 17.65" E 6 80 
 
365 
 
21 12–24 
   
Fatuleu Lili 10º  3' 49.73" S 123º 53'  2.65" E 10 70 
 
365 
 
30 24–48 
   
Fatuleu Oelbeba 10º 4' 26.76" S 123º 58' 32.11" E 8 85 
 
90 
 
24 24–24 
   
West Kupang Sumlili 10º 18' 1.53" S 123º 32' 53.09" E 4 79 
 
60 
 
24 24–24 
 
Goat Capra hircus West Kupang Sumlili 10º 18' 1.53" S 123º 32' 53.09" E 6 100 
 
180 
 
26 12–36 
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6.2.2 Urine measurements 
Urine was collected via voluntary urination following manual stimulation of the penis 
sheath in males or vulva in females. A soft brush was employed to encourage urination if 
necessary (Plate 6.2). A subsample of each urine collection was preserved by acidification 
with concentrated hydrochloric acid (HCl—32%) at a ratio of 1:19 and stored chilled. The 
preserved samples were exported to Australia and mimosine and DHP concentration 
measured using HPLC by the method described in Dalzell et al. (2012) with a corrected 
mobile phase of 25 mM ammonium dihydrogen phosphate. An additional peak in HPLC 
chromatograms was identified eluting prior to 2,3-DHP with a ≥98 similarity in absorption 
spectra in the wavelength range λ = 190–400 nm, which was suspected to be the 
conjugate form, indicative of incomplete acid-hydrolysis. Samples were also tested 
immediately on location using the colorimetric method of Graham et al. (2013). 
 
Plate 6.2: Urine being collected from a Bali bull in Jati Sari, Sumbawa, using a plastic collecting cup and a 
soft brush to stimulate urination. 
6.2.3 Rumen fluid collection 
Rumen fluid samples were collected from up to 3 animals in each village via an orogastric 
tube and hand operated vacuum pump as described in Graham et al. (2013) (Plate 6.3). 
Rumen fluid was strained through 4 layers of muslin cloth into a collection container; a 
duplicate 3 mL sub-sample was withdrawn from the middle of the collection, and then 
 Chapter 6 Toxicity status in eastern Indonesia 
 
 
60 
added to 7 mL of 100% ethanol and exported to Australia for DNA isolation. Remaining 
rumen fluid was used for the degradation study as described below. 
 
Plate 6.3: Rumen fluid being collected from a buffalo in Melolo, Sumba, using a hand-operated orogastric 
pump. 
6.2.4 Degradation study 
Hungate tubes were prepared anaerobically as described in Hungate (1969) and modified 
in Bryant (1972). For fresh rumen fluid collection, tubes were prepared with 0.5 mL of 400 
mg/L pure L-mimosine solution, as the substrate for degradation. A second batch of tubes 
was prepared with 0.5 mL of 400 mg/L pure L-mimosine solution added to 9 mL culture 
media containing modified medium 3,4A (Allison et al. 1992; McSweeney et al. 1993a). 
The resultant media contained the following: 0.5 mL of 400 mg/L pure L-mimosine 
solution; 30% (vol/vol) clarified rumen fluid; 3.8% (vol/vol) mineral solution 2 (Caldwell and 
Bryant 1966) with additional with 6 g/L K2HPO4; 3.8% (vol/vol) mineral Solution 3 
consisting of 6 g/L KH2PO4, 6 g/L (NH4)2SO4, 12 g/L NaCl, 2.5 g/L MgSO4•7H2O, and 1.6 
g/L CaCl2•2H2O; 1 g/L resazurin; 1mL/L haemin; 1 g/L yeast extract, 1 g/L phytone 
peptone, 1 g/L peptone P; 2 g/L tryptone; 0.4 g/L cysteine hydrochloride; and 
supplemented with B-vitamins (McSweeney et al. 2005). The pH was adjusted to pH 6.8 
with 2.5 M NaOH at ambient temperature prior to autoclaving at 121ºC (15 psi) for 15 
minutes. 
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When available, a 9.5 mL sub-sample of strained rumen fluid was added to the prepared 
Hungate tubes containing 0.5 mL mimosine solution using a 21G needle, maintaining 
anaerobic environment with a 25G needle allowing backflow of gas. Where rumen fluid 
was limited or unattainable, as was the case on the island of Sumbawa and Timor, either 
0.5 mL of rumen fluid or 0.5 mL of strained fresh faeces liquor was used to inoculate tubes 
prepared with 9.0 mL of culture medium and 0.5 mL of 400 mg/L pure L-mimosine 
solution. 
All tubes were incubated, initially in a portable esky maintained at 39ºC (±2ºC) through a 
thermostat-controlled heating element and fan while collections took place. Tubes were 
later transferred into an incubator, maintained at 39ºC on a rocker. Sub-samples were 
taken of 21 and 28 days after inoculation to measure DHP degradation. Hungate tubes 
were inverted and a 2 mL aliquot was withdrawn using a 21G needle and dispensed into 2 
mL Eppendorf tubes. These were spun at 1300 × g for 15 mins. The supernatant was 
withdrawn and frozen at <−20ºC prior to analysis by HPLC. 
6.2.5 DNA isolation and detection of Synergistes jonesii 
Rumen fluid samples, exported to Australia preserved in ethanol, were used for DNA 
isolation. DNA extraction was performed with detection of S. jonesii by primary and nested 
PCR, according to the method described in Chapter 5. Sequencing of positive nested PCR 
products was aligned with the 16S rDNA sequence of the S. jonesii type strain (ATCC 
49833 (78-1)). Samples identical to the type strain (without any single nucleotide 
polymorphisms — SNPs) were noted. 
6.2.6 Statistical analyses 
Data were analysed using Microsoft Excel computer software (©2016, Microsoft, 
Redmond, WA, USA) and Minitab® statistical software 16 (©2010, Minitab Inc., State 
College, PA, USA). 
One-way ANOVA tests were undertaken for urinary 3,4-DHP and 2,3-DHP levels in 
comparison with: the presence of S. jonesii; presence of the ATCC type strain; island; and 
species of ruminant. The presence of S. jonesii and the presence of the ATCC type strain 
were analysed with an ANOVA using a GLM including island, species, and type of sample 
collected. Significant terms were further analysed using a one-way ANOVA with pairwise 
comparisons made using Fishers least significant difference (LSD) method. 
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Regression analysis was undertaken for urinary 3,4-DHP, urinary 2,3-DHP, presence of S. 
jonesii, and presence of the ATCC type strain, with respect to the time animals had been 
consuming leucaena, and the amount of leucaena in diet. A GLM ANOVA model was used 
for repeated measures analysis for results of the degradation study, with respect to 
species, island and sampling time. 
Descriptive statistics were used to summarise mean values with standard errors listed. A 
probability level of P < 0.05 was considered statistically significant, while a P-value 
between 0.05–0.10 was considered a moderate trend.  
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6.3 Results 
6.3.1 Diet composition 
The amount of leucaena in diet varied among villages, with farmers offering between 20–
100% leucaena (Table 6.1), with most animals fed >30% leucaena in diet. Percentage of 
leucaena in diet was dependant on individual farmer management, forage availability, and 
their perceived value of leucaena as a forage. In general, levels of leucaena in diet were 
lower than usual, as the amount of leucaena available was limited due to the dry season. 
6.3.2 Urinary DHP excretion 
The mean, and range, of urinary DHP excretions are presented in Table 6.2 by island and 
by species. Mimosine was not detected in any sample. The dominant isomer of DHP 
excreted was 2,3-DHP comprising a mean of 77% of all DHP excreted, consistent across 
all species, with the exception of Bos indicus cattle from Sumba, where both percentage of 
leucaena in diet and DHP excretions were low. The range in 2,3-DHP excretions was also 
10 times greater than that of 3,4-DHP. One-way ANOVA was conducted to establish 
possible linkages. There were no significant differences in level of 3,4-DHP excretion due 
to the detection of S. jonesii (P = 0.45) or to the presence of the ATCC type strain (P = 
0.43) in rumen fluid. Likewise, there were no significant differences in level of 2,3-DHP 
excretion due to detection of S. jonesii (P = 0.13) or to the presence of the ATCC type 
strain (P = 0.15) in rumen fluid. There were also no significant differences in 3,4-DHP 
excretion due to island (P = 0.33) or to species (P = 0.39). For 2,3-DHP excretion 
however, while there was no significant difference among species (P = 0.18), there was a 
significant effect due to island (P < 0.01) with Sumba having the lowest concentrations 
(Table 6.3). 
One-way ANOVA regression analyses indicated no trend in 3,4-DHP excretion with time 
on leucaena (months) (P = 0.79) or with amount of leucaena in diet (%) (P = 0.13). There 
was also no trend in 2,3-DHP concentrations with time on leucaena (months) (P = 0.97), 
but there was a significant (P = 0.00), though weak relationship (R2 = 0.08), with amount of 
leucaena in diet (%) (2,3-DHP = 918 × leucaena in diet + 36). 
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Table 6.2: Mean (±s.e.) and range of urinary DHP excretions from animals as determined by HPLC, and mean percentage of 2,3-DHP that remained conjugated 
after hydrolysis. 
 
Island Animal Species District Village     3,4-DHP (mg/L)   2,3-DHP (mg/L)   Total DHP (mg/L) 
n   Mean±s.e. Range   Mean±s.e. Range Mean % remaining 
conjugated 
  Mean±s.e. Range 
Lombok Cattle Bos javanicus North Lombok Bayan 8   4±2 0–14   10±6 0–34 4   14±8 0–52 
      West Lombok Sekotong 9   116±30 0–226   622±192 0–1506 25   738±216 0–1680 
  Goat Capra hircus Central Lombok Rembitan 7   262±86 34–806   1812±490 368–4778 13   2074±554 402–5236 
      East Lombok Pringgabaya 9   10±4 0–32   0±0 0–0 47   12±4 0–32 
      North Lombok Bayan 10   258±82 0–794   1680±512 122–4480 20   1938±588 122–5274 
      North Lombok Pemenang 8   16±10 0–66   342±226 0–1416 0   358±236 0–1484 
      West Lombok Sekotong 9   126±100 0–908   1090±716 0–6304 24   1216±806 0–7214 
Sumba Buffalo Bubalus bubalis East Sumba Kakaha 2   68±24 44–90   270±148 122–416 36   336±124 212–460 
      East Sumba Melolo 4   104±14 74–136   268±72 186–482 40   372±84 264–618 
      East Sumba Wanga 1   32± 32–32   92± 92–92 45   124± 124–124 
  Cattle Bos indicus East Sumba Kakaha 2   10±10 0–20   0±0 0–0 0   18±4 14–20 
  Goat Capra hircus Waingapu Kamalaputi 6   4±4 0–20   22±12 0–72 23   24±12 0–72 
      Waingapu Kambaniru 5   28±10 0–62   72±58 0–298 21   100±68 0–360 
Sumbawa Cattle Bos javanicus Sumbawa Jati Sari 9   144±82 0–450   2284±1058 0–5920 41   2430±1126 0–6370 
      Sumbawa Labangka I 8   400±52 204–646   2238±570 652–5220 35   2650±594 888–5742 
      Sumbawa Penyenger 9   190±54 0–418   2798±1254 0–10144 32   2998±1302 16–10558 
      Sumbawa Rhee 6   348±138 0–1092   2536±1184 40–7670 23   2886±1316 40–8772 
      West Sumbawa Poto Tano 7   220±36 108–464   1384±406 294–3360 33   1606±438 402–3796 
Timor Cattle Bos javanicus Amarasi Ponain 6   28±6 18–38   72±30 16–156 13   98±36 34–192 
      Amarasi Tesbatan II 5   300±62 112–544   1774±412 374–3034 35   2076±464 486–3422 
      Fatuleu Lili 4   92±70 0–432   700±450 0–2438 27   792±482 0–2438 
      Fatuleu Oelbeba 6   152±52 54–256   592±270 130–1288 40   746±320 184–1544 
      West Kupang Sumlili 4   94±40 0–202   772±404 0–1952 38   866±432 0–2070 
  Goat Capra hircus West Kupang Sumlili 4   620±146 358–1040   4994±786 3224–6962 44   5614±928 3582–8002 
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Table 6.3: Mean 2,3-DHP excretion levels by island. 
Means with different subscripts are significantly different at P < 0.05 
Island Mean 2,3-DHP excretion (mg/L) 
Lombok 852bc 
Sumba 94c 
Sumbawa 2230a 
Timor 1426ab 
6.3.3 Degradation study 
The mean mimosine and 3,4-DHP levels for each animal species within islands at 0, 21 
and 28 days after inoculation are presented in Table 6.4. The initial concentration of 
mimosine (~17 mg/L) was consistent among tubes. No mimosine was present from 21 
days post-inoculation regardless of method of inoculation. Also notable was the lack of 
presence of 2,3-DHP, regardless of source of inoculum or time sampled. With the 
exception of a single bull from Timor, all samples inoculated with 9.5 mL of fresh rumen 
fluid resulted in complete degradation after 21 days (Table 6.4a) (Figure 6.1). There was 
no significant difference between day 21 and 28, nor between species or islands. 
In contrast, when 9.5 mL of culture media with mimosine was inoculated with 0.5 mL of 
rumen fluid or strained faeces, not all 3,4-DHP was degraded (Table 6.4b) (Figure 6.2). 
The isomer 3,4-DHP was detected at 21 and 28 days post-inoculation in culture media 
tubes; but there was no significant difference in degradation between these sampling 
times. This indicated that in culture media, faeces microbes possessed the same efficacy 
in degrading 3,4-DHP as rumen fluid. However, since mean degradation was only ~35% at 
28 days, more time may be required to achieve complete degradation with only 0.5 mL of 
inoculum. Analysis of variance revealed no significant differences among islands (Figure 
6.2) and no significant difference in degradation capability. However, the percentage of 
3,4-DHP degraded was significantly greater when inoculated with rumen fluid from Sumba 
buffalo, compared to rumen fluid from Sumba goats or from cattle faeces samples from 
Sumbawa and Timor (P < 0.001) (Table 6.4b). 
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Table 6.4: Mean mimosine and 3,4-DHP concentrations (mg/L) of sub-samples from Hungate tubes from the degradation study at 0, 21, and 28 days after 
inoculation with either: (a) 9.5 mL of rumen fluid, or (b) 0.5 mL of rumen fluid or faeces liquor into culture media. 
(a) Inoculation of 9.5 mL of rumen fluid into 0.5 mL 400 mg/L mimosine 
Means within columns with differing subscripts denote significant differences at the 5% significance level 
Sample type Island Animal Species n Mean mimosine (mg/L) 
 
Mean 3,4-DHP (mg/L) 
 
Mean±s.e 
final degradation (%) days after inoculation 
 
days after inoculation 
 0 21 28 
 
0 21 28 
 Rumen fluid Lombok Cattle Bos javanicus 5 17 0 0 
 
0 0a 0a 
 
100±0a 
  
 
Goat Capra hircus 11 17 0 0 
 
0 0a 0a 
 
100±0a 
  Sumba Buffalo Bubalus bubalis 5 17 0 0 
 
0 0a 0a 
 
100±0a 
  
 
Cattle Bos indicus 2 17 0 0 
 
0 0a 0a 
 
100±0a 
  
 
Goat Capra hircus 3 17 0 0 
 
0 0a 0a 
 
100±0a 
  Timor Cattle Bos javanicus 3 17 0 0 
 
0 3a 3a 
 
83±17a 
  
 
Goat Capra hircus 2 17 0 0 
 
0 0a 0a 
 
100±0a 
(b) Inoculation of 0.5 mL rumen fluid or faeces liquor into 9.0 mL culture media and 0.5 mL 400 mg/L mimosine 
Means within columns with differing subscripts denote significant differences at the 5% significance level 
Sample type Island Animal Species n Mean mimosine (mg/L)   Mean 3,4-DHP (mg/L)   Mean±s.e 
Final degradation (%) days after inoculation   days after inoculation   
0 21 28   0 21 28   
Rumen fluid Sumba Buffalo Bubalus bubalis 3 17 0 0   0 8a 8a   57±20a 
    Cattle Bos indicus 1 17 0 0   0 11ab 11ab   39ab 
    Goat Capra hircus 3 17 0 0   0 11b 14b   24±2b 
  Timor Cattle Bos javanicus 7 17 0 0   0 10ab 12ab   33±4ab 
    Goat Capra hircus 1 17 0 0   0 13ab 12ab   31ab 
Faeces Sumbawa Cattle Bos javanicus 15 17 0 0   0 11b 12b   34±1b 
  Timor Cattle Bos javanicus 7 17 0 0   0 11b 12b   29±3b 
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Figure 6.1: Degradation of mimosine [all islands (●)] and 3,4-DHP (solid lines) during the incubation period 
for tubes inoculated with 9.5 mL of fresh rumen fluid for: Lombok (◼ ); Sumba (⬥); Timor (▲). 
 
Figure 6.2: Degradation of mimosine [all islands (●)] and 3,4-DHP (solid lines) during the incubation period 
for tubes containing culture medium, inoculated with 0.5 mL of rumen fluid for: Sumba (⬥); Sumbawa (◼ ); 
Timor (▲).  
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6.3.4 Detection of S. jonesii and ATCC type strain 
The detection rates of S. jonesii and presence of the ATCC type strain, collected from 
rumen fluid and from faeces are presented in Table 6.5a and Table 6.5b. Of the 66 
animals sampled, 45% were positive for S. jonesii; 40% of all positive samples were also 
positive for the ATCC type strain after nested PCR sequencing (18% of total animals 
sampled). A one-way analysis of variance, indicated detection of S. jonesii was 
significantly higher (P < 0.001) in rumen fluid samples (66%) compared to faeces samples 
(5%); only 1 of the 23 faeces samples was positive for S. jonesii. The lack of detection of 
S. jonesii in samples from Sumbawa island was due to the collection of faeces only. There 
was also a significant difference (P = 0.04) in presence of the ATCC type strain in rumen 
fluid (25%), compared to faeces (5%), with only 1 of the 23 faeces samples positive for the 
ATCC type strain. 
An analysis of variance (GLM) showed that there was no significant difference in detection 
rate for S. jonesii due to island (P = 0.88); however, there was a significant difference 
between species (P < 0.001) (Table 6.6); detection rate in buffalo and goats was greater 
than in Bali cattle. There was no significant difference in detection of the ATCC type strain 
due to island (P = 0.55); however, there was a significant (P < 0.001) difference in 
detection rate due to animal species, with greater detection in buffalo, compared to Bali 
cattle and goats (Table 6.7). 
There were no significant trends when the detection rate of S. jonesii was regressed 
against percentage of leucaena in diet or time consuming leucaena; P = 0.23 and P = 
0.06, respectively. Similarly, the detection rate of the ATCC type strain was also not 
related to percentage of leucaena in diet or time consuming leucaena (P = 0.98 and P = 
0.84, respectively). 
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Table 6.5: Number of (a) rumen fluid, and (b) faeces samples, tested positive for Synergistes jonesii and positive for the ATCC type strain. 
(a) Rumen fluid  
Island Animal Species District Village n 
(rumen fluid) 
Animals 
positive for 
S. jonesii  
Animals positive 
for ATCC type 
strain 
S. jonesii 
detection 
rate (%) 
ATCC type stain 
detection rate 
(%) 
Lombok Cattle Bos javanicus North Lombok Bayan 3     0 0 
      West Lombok Sekotong 2     0 0 
  Goats Capra hircus Central Lombok Rembitan 3 3 1 100 33 
      East Lombok Pringgabaya 3 3   100 0 
      North Lombok Pemenang 3 3   100 0 
      West Lombok Sekotong 2 2   100 0 
Sumba Buffalo Bubalus bubalis East Sumba Kakaha 3 1 1 33 33 
      East Sumba Melolo 3 3 3 100 100 
      East Sumba Wanga 1 1 1 100 100 
  Cattle Bos indicus East Sumba Kakaha 1 1 1 100 100 
      East Sumba Wanga 2 1   50 0 
  Goats Capra hircus East Sumba Kamalaputi 3 3   100 0 
      East Sumba Kambaniru 3 2   67 0 
Timor Cattle Bos javanicus Amarasi Ponain 3 2 2 67 67 
      Amarasi Tesbatan II 3 2 2 67 67 
      Fatuleu Lili 3     0 0 
  Goats Capra hircus West Kupang Sumlili 3 2   67 0 
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(b) Faeces  
Island Animal Species District Village n 
(faeces) 
Animals 
positive for 
S. jonesii  
Animals positive 
for ATCC type 
strain 
S. jonesii 
detection 
rate (%) 
ATCC type stain 
detection rate 
(%) 
Sumbawa Cattle Bos javanicus Sumbawa Jati Sari 3     0 0 
      Sumbawa Labangka I 3     0 0 
      Sumbawa Penyenger 3     0 0 
      Sumbawa Rhee 3     0 0 
      West Sumbawa Poto Tano 3     0 0 
Timor Cattle Bos javanicus Fatuleu Lili 2 1 1 50 50 
      Fatuleu Oelbeba 5     0 0 
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Table 6.6: Mean (±s.e.) detection rate of S. jonesii from rumen fluid collected from each species across all 
islands. 
Means with differing subscripts denote significant differences at the 5% significance level 
Species Mean±s.e. S. jonesii detection rate (%) 
Bubalus bubalis 71 ± 13a 
Bos indicus 67 ± 33ab 
Bos javanicus 29 ± 13b 
Capra hircus 88 ± 6a 
 
Table 6.7: Mean (±s.e.) detection rate of the ATCC type strain from rumen fluid collected from each species 
across all islands. 
Means with differing subscripts denote significant differences at the 5% significance level 
Species Mean±s.e. ATCC type strain detection rate (%) 
Bubalus bubalis 71 ± 13a 
Bos indicus 33 ± 33ab 
Bos javanicus 29 ± 13b 
Capra hircus 6 ± 4b 
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6.4 Discussion 
The major finding of this study was that in eastern Indonesia, previously considered 
protected from leucaena toxicity by S. jonesii (Jones 1994), animals regularly consuming 
high leucaena diets were not completely degrading DHP. Although S. jonesii, the most 
widely accepted DHP-degrading rumen microbe, was detected in the majority of rumen 
fluid samples (Padmanabha et al. 2014), it was however, present in low populations often 
at or below the limit of detection using PCR techniques (Graham et al. 2013). The absence 
of mimosine in urine, in association with high levels of DHP indicate that ruminants 
possesses sufficient microbial capacity to degrade mimosine, however insufficient rumen 
microbes to fully degrade the resultant DHP. Despite animals having DHP levels 
considered high enough to cause severe toxicosis, no animals were exhibiting signs of 
clinical or subclinical toxicity. As there was evidence of conjugation (Table 6.2), it is 
possible that this may have contributed to the detoxification of DHP and lack of symptoms. 
These findings are now discussed.  
6.4.1 High levels of DHP in urine 
In ~75% of all locations sampled, animals were classified as excreting levels of DHP 
exceeding the threshold for subclinical toxicity of 100 mg/L (Dalzell et al. 2012) with some 
individual animals excreting very high levels, exceeding 10000 mg/L (Table 6.2). This 
result strongly contrasts the previously considered protection status for ruminants on high 
leucaena diets in eastern Indonesia, where S. jonesii was considered endemic (Jones 
1994) and capable of degrading 100% of DHP (Jones and Lowry 1984). However, the 
findings of this study are in accord with other more recent studies in Indonesia (Halliday et 
al. 2013; Halliday et al. 2014b)(Chapter 4), Thailand (also originally considered protected) 
(Phaikaew et al. 2012) and Mexico (Contreras-Hernández et al. 2013; Ruz-Ruiz et al. 
2013). 
While the incidence of high levels of DHP should indicate potential serious health issues 
(Jones and Winter 1982; Jones and Bray 1983; Quirk et al. 1988), no clinical signs of 
toxicity were observed with animals in excellent condition. Although liveweight gain (LWG) 
was not recorded, farmers reported satisfaction with the growth performance of the 
animals, and there was no effect on breeding performance. Farmers did however note that 
there were usually initial signs of mimosine and DHP toxicity, but these resolved within 3–4 
weeks of adaptation to leucaena consumption. This adaptation period was reported to be 
common and normal, especially in cut-and-carry systems in Sumbawa, where 100% 
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leucaena is often fed over a 4–6 month period (Panjaitan et al. 2013). The variability 
exhibited in urinary DHP excretions within and among locations was also normal, as time 
after consuming leucaena, hydration and fullness of bladder, and individual animal 
metabolic rates have resulted in large differences in urine concentration of DHP due to 
sampling time (Guyton and Hall 2000; Giles et al. 2013). 
Also contradicting the original work on leucaena toxicity, was the finding of high levels of 
2,3-DHP in urine in this study. The presence of 2,3-DHP was originally considered novel 
(Ford et al. 1984) and transitory (Jones et al. 1985a); however, it is clear that it is a regular 
end-product of ruminal metabolism of mimosine. Occurrence of 2,3-DHP has been 
recorded in many countries. A meta-analysis conducted by Halliday et al. (2014b) showed 
this to be the case in Australia (Dalzell et al. 2012; Graham et al. 2013; Halliday et al. 
2014a), India (Ghosh et al. 2007), Thailand (Phaikaew et al. 2012) and Indonesia (Halliday 
et al. 2014c). Thus, it is concluded that 2,3-DHP is the predominant isomer excreted in 
urine, and it is present at very high concentrations; enough to potentially cause chronic 
toxicity. 
6.4.2 S. jonesii is present in low numbers 
The results of this study also support the more recent discoveries that there is ubiquitous 
rather than isolated distribution of S. jonesii (Padmanabha et al. 2014)(Chapter 5). S. 
jonesii was detected, at low population levels, using rDNA PCR in the majority of rumen 
fluid samples collected (~66% of rumen samples), in all islands and species, despite high 
urinary DHP levels detected in most animals. 
Although S. jonesii was not detected in 100% of rumen fluid samples, all Hungate tubes 
inoculated with 9.5 mL of fresh rumen fluid were capable of complete degradation of small 
amounts of mimosine within 21 days; this was positive evidence for the presence of DHP-
degrading microbes. Jones et al. (2009) conducted a similar experiment and found 100% 
degradation of DHP in fresh ground leucaena within ~4 days, using a greater volume of 
rumen fluid (20×) and larger mimosine concentrations (1000×). As the theoretical limit of 
detection for S. jonesii is between 104–105 cells/mL in rumen digesta (Graham et al. 2013), 
it was therefore apparent that S. jonesii was present in all animals, however at populations 
at or below the limit of detection using current methodologies. 
Thus, although the indigenous nature of S. jonesii would imply no inoculation would be 
required to transfer the microbe, the lack of complete degradation in vivo and the 
ubiquitously low populations, evidenced in this study, suggest S. jonesii would not be 
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capable of fully protecting ruminants on high leucaena diets. The results of the inoculation 
study in Chapter 4, where DHP levels remained high in recipient animals 10-days post-
inoculation with fresh rumen fluid, support this assertion. 
Detection of S. jonesii was even lower in faeces samples (~5%) and the degradation of 
mimosine in vitro with culture media inoculated with 0.5 mL of rumen fluid or 0.5 mL of 
faeces liquor was not capable of complete degradation within the 28-day monitoring 
period, achieving only approximately 32–36% degradation. This was likely due to the 
methodological limitations of the culture media, receiving ~0.3% of the volume, and hence 
a lower initial population of microbes, as those inoculated with rumen fluid only. It was thus 
clear from this study that S. jonesii does survive in the faeces at very low levels and may 
require extended periods to colonise and build the capacity to degrade DHP. Transfer of 
S. jonesii encapsulated in the faeces has been suggested as a possible vector of 
migration of ‘the bug’ throughout cattle herds (Pratchett et al. 1991). 
This study confirms the fundamental ability of S. jonesii to degrade DHP; the results of the 
degradation study using 9.5 mL of rumen fluid strongly support other work on the DHP-
degrading ability of S. jonesii (Allison et al. 1990; Klieve et al. 2002). However, there is 
considerable evidence that S. jonesii does not have the capability to completely degrade 
all DHP when ruminants are daily consuming high leucaena diets. The absence of any 
2,3-DHP in vitro, despite it being the predominant isomer excreted in vivo, further suggests 
that the static, artificial nature of in vitro studies cannot be directly extrapolated to the 
continuous flow of high levels of mimosine/DHP entering the rumen. A notable example in 
this study includes rumen fluid collected from individual goats in Sumlili, West Timor, 
positive for S. jonesii, with SNPs detected, that were capable of 100% degradation in vitro; 
however, in vivo urinary DHP excretions were >7600 mg/L. 
What is not clear however, is the reason for the high levels of 2,3-DHP in urine. The 
presence of 2,3-DHP infers the presence of a microorganism capable of the isomerisation 
of 3,4-DHP. However, by inference from PCR assay, the populations of S. jonesii were 
insufficient to completely degrade DHP in animals consuming high leucaena diets. To 
explain this paradox, three new hypotheses are suggested: (1) that other microbes, such 
as those described in Hammond et al. (1989), Domínguez-Bello and Stewart (1991), Tan 
et al. (1994), Chhabra et al. (1998), Aung et al. (2011) and Derakhshani et al. (2016) are 
present contributing to the isomerisation of 3,4-DHP; (2) that the many variants of S. 
jonesii identified have differential functional capacity to degrade individual isomers, and 
these molecular variants cannot metabolise 2,3-DHP (Halliday et al. 2014b); or, (3) that 
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the conversion of 3,4-DHP to 2,3-DHP is not an essential intermediary in the complete 
degradation of DHP. It is inconclusive as to what mechanisms are operating and further 
investigation is warranted. 
6.4.3 The animals on high leucaena diets were healthy 
Despite high levels of DHP in urine, there were no apparent deleterious effects on animals 
consuming high leucaena diets. Production levels were not only unaffected but greatly 
increased when leucaena was fed. There were no indications of toxicity apart from the 
initial alopecia, when animals were first introduced to leucaena, due to mimosine toxicity. 
This clinical sign disappeared in 2–4 weeks. Other studies have reported high weight 
gains achieved on high leucaena diets, even though high levels of DHP were being 
excreted (Panjaitan et al. 2014). Also, the lack of reproductive impairment, normally 
sensitive to toxicity, suggests that animals were not experiencing DHP toxicosis. It was 
clear the presence of S. jonesii was insufficient to elicit full protection, yet animals were 
not adversely affected by DHP. This provides evidence for the hypothesis that an 
alternate method of protection is involved, either in concert with or independent of S. 
jonesii. 
It is postulated that hepatic conjugation is occurring, a natural mechanism for detoxifying 
hydroxyl compounds (Smith 1971) such as DHP. The process of conjugation has a two-
fold effect on detoxification. Firstly, it increases the polarity of the molecule, and therefore 
water-solubility, increasing urinary clearance of the toxin. Secondly, it is hypothesised that 
conjugation reduces the ion-binding affinity of the hydroxyl group/s, reducing the acute 
toxicity of the molecule (Tsai and Ling 1971; Ghosh and Samiran 2007). The common 
conjugation mechanism in mammals is that of glucuronidation, which comprises the 
attachment of a glucose-based carboxylic acid: glucuronic acid. 
The methodology employed in this study was not able to measure initial levels of 
conjugated DHP at time of excretion, as the acidification of samples initiated hydrolysis of 
the conjugated DHP. Nevertheless, despite sample preparation involving an additional 
acidification step (Graham et al. 2014), after acid hydrolysis, ~27% (range 0–47%) of total 
2,3-DHP remained in the conjugated form (Table 6.2). The fact that animals were not 
suffering from clinical or subclinical toxicity, despite in some cases, excreting exceedingly 
high levels of DHP, suggested that much of the DHP may have been in the non/less toxic 
conjugated form at time of excretion, and therefore was not contributing towards the 
animals’ toxicity status. 
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The amelioration of toxins via conjugation is not a novel phenomenon and occurs in all 
mammals for a variety of xenobiotics (Smith 1971; Christie et al. 1979; Elliott et al. 1985). 
First postulated as a coping mechanism for animals consuming leucaena (Hegarty et al. 
1979), there has been little focus on this mechanism since. However, if the hypothesis put 
forward is correct—that conjugation of DHP is a major pathway in DHP detoxification—it 
represents a major paradigm shift from current leucaena management practices and is 
good news for leucaena feeding operations worldwide. 
6.4.4 Limitations 
A limitation of measurements of DHP concentration in urine is the inherent diurnal dilution 
factor involved with urine excretions and the potential to lead to the risk of false toxicity 
assessment. The continuous monitoring study of Giles et al. (2013) recorded a 50 fold 
difference (138–6932 mg/L) in minimum and maximum DHP concentrations of 34 
individual samplings over a 24-hour period (total urine volume 16.9 L) in a steer 
consuming 100% leucaena. Thus, a single sample in isolation could lead to false 
assessment of the actual DHP load animals were experiencing. 
The other limitation of this study, associated with the single collection obtained from 
individual animals was the possibility that animals were in a period of transition where 
animals were adapting to leucaena (Jones et al. 2009). This was unlikely as samples were 
collected at differing times of the day for different animals, and many animals had been on 
high leucaena diets for extended periods. This study sought to overcome these limitations 
by assessing mean DHP levels of a population of 10 animals per species, per location. 
Nevertheless, it should be noted that the unusually low DHP levels recorded in Sumba, 
although coupled with high detection rate of S. jonesii, could possibly be an effect of 
smaller sample sizes on that island. 
This study has highlighted contradictions to the original theory that ruminants in only 
specific countries were protected by S. jonesii (Jones 1981). As the original survey work 
relied on urinary DHP tests from few animals where there was likely incomplete and in 
some cases minimal hydrolysis of the bound DHP (Jones 1994), the validity of urinary 
free-DHP testing in isolation is questioned as it does not profile other mechanisms that the 
animal may be employing to adapt to DHP in diet. Furthermore, the classification of an 
entire country based on isolated testing does not reflect the myriad feeding systems 
utilised within these countries.  
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6.5 Conclusions 
In conclusion, this study postulates a new paradigm in toxicity management for ruminants 
consuming high leucaena diets. It is apparent that inoculation with S. jonesii is not a 
prerequisite for protection against toxicity for two reasons: (1) it is already an indigenous 
microbe in all ruminants; and (2) it is not capable of completely detoxifying DHP in animals 
on high leucaena diets, due to its presence at low populations in the rumen. In spite of the 
poor efficacy of S. jonesii, and the resultant high levels of DHP excreted, animal health 
and production in these herds were not adversely affected. The hypothesis put forward is 
that animals were coping with undegraded DHP via the mechanism of hepatic conjugation 
with glucuronic acid. Although the methodology of this study was not designed to quantify 
levels of conjugation, there was evidence that conjugation was occurring. 
The significance of this hypothesis, if confirmed, cannot be understated as leucaena-
based feeding systems have the capacity to double animal production, while halving the 
labour requirements of forage collection in developing tropical countries. Ruminal 
inoculation with S. jonesii is not a feasible option in developing countries (Chapter 4), and 
to safely avoid the need for inoculation would be an important economic outcome. 
Further studies are recommended to ascertain the significance of conjugation as a 
detoxification mechanism. As the isomer 2,3-DHP is of greatest abundance, improved 
understanding as to its mode of toxicity, and relative toxicity to 3,4-DHP is warranted. 
Future work should determine the levels of conjugation of excreted DHP and the effect of 
conjugation of DHP on the ion-binding affinity. As the binding and depletion of essential 
metals is a primary mode of toxicity, mineral supplementation may also assist to overcome 
toxicity.
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Chapter 7 Liveweight gain, dry matter intake and urinary hydroxypyridone (DHP) 
levels of Capra hircus goats in response to diets of Gliricidia sepium infused with 
DHP and Leucaena leucocephala, with and without iron(II) sulphate mineral 
supplementation. 
7.1 Introduction 
As many smallholder ruminant feeding systems in eastern Indonesia rely on Leucaena 
leucocephala (leucaena) for vital protein nutrition, especially into the extended dry 
seasons, the amelioration of toxicity is of great importance to maximise the positive 
benefits of the forage. Toxicity in leucaena is due to the effects of mimosine and its 
breakdown products: 3-hydroxy-4(1H)-pyridone (Hegarty et al. 1976) and its structural 
isomer 3-hydroxy-2(1H)-pyridone (Ford et al. 1984; Jones and Megarrity 1986; Allison et 
al. 1992; McSweeney et al. 2002), commonly referred to as 3,4-DHP and 2,3-DHP, 
respectively. Early toxicity research focussed on the 3,4- isomer (Christie et al. 1979; Lee 
et al. 1980), and although 2,3-DHP was perceived to be transitory (Jones and Megarrity 
1983; Jones et al. 1985a), it was considered similarly toxic (Lowry et al. 1985). The toxic 
nature of DHP can be attributed to its structure as a strong ligand, readily chelating with 
transition metal ions, which are mobilised and excreted in the urine (Tsai and Ling 1971; 
Stunzi et al. 1980; Hider 1995). As such, toxicity, when manifest, presents as the side 
effects associated with deficiencies of essential elements, including Zn, Cu and Fe (Mills 
1978; Puchała et al. 1996; Paul 2000; Perry et al. 2005); this can contribute to the 
development of goitre (Nishi et al. 1980; Lukaski et al. 1992; Smith et al. 1992). 
To counteract the deficiencies, mineral supplementation with iron(II) (Ross and Springhall 
1963), or in combination with other bivalent metals including copper(II), zinc(II), and 
magnesium(II) (Jones et al. 1978; Puchała et al. 1995) was an early strategy for 
amelioration of leucaena toxicity. This was shown to increase dry matter intake (DMI) and 
liveweight gain (LWG), and to reduce clinical signs of DHP toxicosis (Tsai and Ling 1974; 
Jones et al. 1978; Puchała et al. 1995). 
Despite the reported success, research into mineral supplementation waned after the 
discovery of the DHP-degrading rumen microbe Synergistes jonesii (Jones and Megarrity 
1983; Jones and Lowry 1984). However, it has been demonstrated in earlier chapters 
(Chapters 4 & 5) that the efficacy of S. jonesii is limited in ruminants on high leucaena 
diets and, in light of the possible alternate metabolic detoxification mechanisms, a new 
paradigm has been proposed (Chapter 6). It is now postulated that detoxification of excess 
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DHP also occurs by either intraruminal chelation with available metal ions and/or hepatic 
conjugation post-ingestion. 
A consistent outcome of recent research is the accumulation of high levels of the isomer 
2,3-DHP (Ghosh et al. 2007; Dalzell et al. 2012; Phaikaew et al. 2012; Graham et al. 
2013), without apparent adverse effects on animal health or performance (Chapters 4, 5 
&6). Accordingly, controlled feeding trials were conducted to investigate the toxicity 
response to the now predominant isomer 2,3-DHP in goats and the impact of Fe(II) 
mineral supplementation on reducing its toxicity. 
Two experiments were undertaken with goats as they are commonly fed leucaena in 
smallholder systems in eastern Indonesia and they represent a model small ruminant. In 
experiment 1, goats were infused with 2,3-DHP, while in experiment 2, goats received a 
single element mineral supplementation of Fe(II) sulphate, chosen to promote chelation of 
DHP as a prophylactic measure. Dosage was designed to maintain a net positive balance 
of available cations, rather than to overcome accumulated element deficiencies. The 
justification for the work was that, if mineral supplementation proved effective, it would 
represent a huge advance in the control of toxicity worldwide.  
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7.2 Materials and methods. 
Experiment 1 primarily investigated the impact of 2,3-DHP infusion, with a short-term 
supplementary study added to investigate the effect of mineral supplementation on DHP 
excretion level and conjugation in goats infused with 2,3-DHP. Experiment 2 investigated 
the impact of longer-term mineral supplementation on goat performance. The experiments 
were conducted at a research farm in Sumlili village, West Kupang district, West Timor 
island, East Nusa Tenggara (NTT) province, Indonesia (10º 18' 2.10" S, 123º 32' 53.61" 
E). 
It was hypothesised that: (a) directly infused free 2,3-DHP would have greater toxicity than 
2,3-DHP originating from diets comprising a high percentage of leucaena; and (b) the 
chemical bonding of supplemented Fe(II) with DHP intraruminally would assist in 
preventing chelation of essential elements and subsequent metal deficiencies. In addition, 
the bonded DHP would be more efficiently excreted due to an increase in water-solubility 
(Galanello 2007; Sooriyaarachchi and Gailer 2010), thus minimising time spent in the body 
and reducing the overall toxic effect. 
A control legume diet of gliricidia was provided at similar levels to standardise the legume 
intake of animals supplemented with 2,3-DHP and/or minerals. Gliricidia has a similar 
crude protein content to leucaena (Dahlanuddin 2001) and is widely fed to ruminants in 
eastern Indonesia (Shelton et al. 2005). It is a regular component of diets for goats in West 
Timor, where it is planted extensively as a living fence (Dahlanuddin et al. 2014). 
7.2.1 Treatments and animal management 
Experiment 1 
Experiment 1 was a 7-week study and consisted of 4 treatments with 4 replications (Table 
7.1) using 16 weaner kacang goats (Capra hircus) (average starting weight 12.7 ± 2.6 kg 
(±s.d.)) commencing in May 2012. Treatments are shown in Table 7.1 and described as 
follows: 
• A control treatment of 50% Gliricidia sepium (gliricidia) and 50% local grasses, 
primarily Bothriochloa insculpta. 
• A 2,3-DHP infusion treatment comprising the control diet plus 0.04% body weight 
(BW) 2,3-DHP, administered as an oral drench incrementally, 4 times a day. The 
2,3-DHP was purchased as 2,3-dihydroxypyridine (95% pure) from Sigma-Aldrich®. 
• Two levels of Leucaena leucocephala cv. Cunningham (leucaena) in diet: 50% 
leucaena and 50% local grasses as above; and 100% leucaena. These treatments 
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were designed to provide a comparison of naturally occurring 2,3-DHP with infused 
2,3-DHP. 
In the supplementary study, an additional 4 goats per treatment (average starting weight 
14.0 ± 2.5 kg (±s.d.)) were given a mineral treatment comprising 0.04% BW Iron(II) 
sulphate heptahydrate (FeSO4•7H2O) as an oral drench given incrementally, 4 times a 
day. This study, with a total of 32 goats, was conducted for the first 3 of the 7 weeks of the 
primary experiment. 
There was a 5-day preliminary period that preceded the commencement of the experiment 
during which animals were gradually introduced to their full treatments, increasing 
incrementally every 2 days. All goats were originally from local villages and had previously 
consumed both leucaena and gliricidia. The trial was sanctioned under animal ethics 
approval # AFS/160/12/ACAIR (Appendix 3). 
Table 7.1: Diet allocations for treatments applied in experiment 1. 
*, Supplementary study 
Treatment n Period 
of study 
(wks) 
gliricidia 
in diet  
(%) 
leucaena 
in diet  
(%) 
local 
grasses in 
diet (%) 
BW 
FeSO4•7H2O 
(%) 
BW  
2,3-DHP 
(%) 
Gliridia-50 (ctrl) 
±minerals 
4 
(4+4)* 
7 
(3) 
50 
50 
0 
0 
50 
50 
0 
0.04 
0 
0.04 
Gliricidia-50+DHP 
±minerals  
4 
(4+4)* 
7 
(3) 
50 
50 
0 
0 
50 
50 
0 
0.04 
0 
0.04 
Leucaena-50 
±minerals  
4 
(4+4)* 
7 
(3) 
0 
0 
50 
50 
50 
50 
0 
0.04 
0 
0.04 
Leucaena-100 
±minerals  
4 
(4+4)* 
7 
(3) 
0 
0 
100 
100 
0 
0 
0 
0.04 
0 
0.04 
7.2.1 Urinary DHP measurements 
Urine was collected from under each individual pen in a collection container. Pens had a 
slatted floor, with a mesh screen underneath to collect faeces allowing urine to pass 
through for collection. A 24-hour bulked urine sample was obtained weekly; from this a 9.5 
mL sub-sample was extracted and stored acidified with concentrated hydrochloride acid 
(HCl). Samples were exported to Australia for analysis of DHP concentration using high 
performance liquid chromatography (HPLC) as described by Dalzell et al. (2012) with a 
corrected mobile phase of 25 mM ammonium dihydrogen phosphate. 
The quantification of conjugated DHP was estimated from the area under a related peak of 
2,3-DHP with a reduced retention time. This peak has previously been identified as 
conjugated DHP (Halliday et al. 2014b) and is discussed in Chapter 8. 
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7.2.2 Blood 
Weekly blood serum samples were collected via jugular venipuncture into red-capped 
evacuated tubes (Benton Dickinson Vacutainer systems) with clot-activator using a BD 
Vacutainer Eclipse blood collection needle. Weekly blood plasma samples were also 
collected using royal-blue-capped BD Vacutainer® glass sterile tubes with Sodium heparin 
and 158 USP units as an anticoagulant. Tubes were inverted 5–8 times and immediately 
chilled. All samples were centrifuged at 1300 RCF for 10 minutes; the serum tubes were 
spun after clot activation. The serum and plasma samples were then transferred into 
polypropylene tubes and stored frozen (<−20ºC) prior to analysis. 
Samples from weeks 4 and 6 were analysed by QML Pathology Vetnostics Service. 
Plasma samples were analysed for Fe concentration, according to the ferrozine method of 
Carter (1971) without the deproteinisation protocol, and Zn concentration according to the 
method of (Homsher and Zak 1985) using the 5-Br-PAPS protocol; quantification was 
performed on a Cobas 8000 biochemistry analyser (Roche). Serum samples were 
analysed for alanine aminotransferase (ALT) according to the recommendations of the 
expert panel on enzymes of the international federation of clinical chemistry (IFCC) 
(Bergmeyer 1980), however, without pyridoxal phosphate activation. 
Experiment 2 
Experiment 2 followed directly after experiment 1 and consisted of a 10-week trial period in 
which 20 kacang goats from experiment 1 (average starting weight 15.0 ± 3.4 kg (±s.d.)) 
were assigned to new treatments (Table 7.2). The control treatments were adjusted to 
include 100% gliricidia, to match the continuing 100% leucaena treatments. The mineral 
supplement was given orally 4-times per day at a total rate of 0.04% BW iron(II) sulphate 
heptahydrate (FeSO4•7H2O). There were 5 replications of each treatment. For logistical 
reasons, it was not possible to collect urine samples in experiment 2.  
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Table 7.2: Diet allocations for treatments applied in experiment 2. 
Treatment n Percentage 
of gliricidia 
in diet 
Percentage 
of leucaena 
in diet 
Percentage of 
FeSO4•7H2O in 
diet (%BW) 
Gliricidia-100 5 100 0 0 
Gliricidia-100+M 5 100 0 0.04 
Leucaena-100 5 0 100 0 
Leucaena-100+M 5 0 100 0.04 
 
Both experiments 
Total dry matter (DM) was offered at a minimum of 25 g DM/kg LW.day, increasing as 
required to ensure a 10% refusal of feed offered. Rations were determined weekly after 
animal weighing. The experiments were conducted in an existing goat feeding shed 
(‘kandang’), modified to house individual goats in separate feeding pens in a randomised 
complete block design (RCBD) with 4 and 5 replications in experiment 1 and 2, 
respectively. Each feed type was offered separately, with minerals delivered as an oral 
drench dissolved in 20 mL water. The 2,3-DHP was also delivered orally as a suspension 
in 20 mL water and the 2,3-DHP plus minerals treatment was delivered as a combined 
solution. Gliricidia and leucaena only animals were given a 20 mL water only drench to 
harmonise handling procedures. 
Liveweight measurements were recorded weekly and prior to the daily allocation of feed 
and water, using a Dunlop 50 kg scale. Scales were calibrated with a standard weight prior 
to commencement of weighing and periodically throughout. 
Legume forages were harvested fresh daily and consisted of fresh stripped leaf material 
only. All animals had previously consumed leucaena, gliricidia, and local grasses 
intermittently before entering the experiment. The local grasses were primarily 
Bothriochloa insculpta and were fed fresh chopped using a small petrol-powered chaff-
cutter or were hand-chopped with a machete. The animals were selected from Sumlili 
village as previous samplings (Chapter 6) had identified that goats consuming leucaena in 
that area had high urinary DHP levels. This experiment was sanctioned under animal 
ethics approval # AFS/160/12/ACIAR. 
7.2.3 Daily dry matter intake 
Dry matter intake (DMI) of individual feed types was measured daily with weekly treatment 
mean values calculated from all animals within replicates. The dry matter of each feed 
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offered and refused was estimated by drying a sub-sample to constant weight in a portable 
wood-fired oven. The content of nitrogen (N) in samples was determined using a LECO 
TruSpec CHN analyser (Matejovic 1995) and neutral detergent fibre (NDF) and acid 
detergent fibre (ADF) were measured according to the method described in Van Soest et 
al. (1991). 
7.2.4 Statistical analyses 
Data were analysed using Microsoft Excel computer software (©2016, Microsoft, 
Redmond, WA, USA) and using Minitab® statistical software 17 (©2010, Minitab Inc., State 
College, PA, USA). 
Repeated observations of weekly DMI and DHP levels in experiment 1 were analysed with 
a General Linear Model (GLM) ANOVA using a split-plot design (with treatment as the 
main-plot and time as the sub-plot; replications as a random factor) with pairwise 
comparisons using Fishers least significant difference (LSD) method. A GLM ANOVA was 
undertaken to compare animal LWG in experiment 1, with pairwise comparisons using 
Fishers LSD method. 
Animal plasma Fe and Zn in experiment 1, and DMI and LWG in experiment 2 were 
analysed as a 2-way ANOVA using a GLM including legume treatment and mineral 
supplementation interaction term. One-way ANOVA tests were further used to compare 
significant terms, with pairwise comparisons made using Fishers LSD method. Descriptive 
statistics were used to summarise DHP concentrations, proximate analysis of the feed 
types, DMI, and animal LWG. 
A probability level of P < 0.05 was considered statistically significant, while a P-value 
between 0.05–0.10 was considered a moderate trend.  
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7.3 Results 
Experiment 1 
7.3.1 Intake 
There were no significant differences in the mean total intake of animals offered 50% 
gliricidia in diet, indicating that infusion with 2,3-DHP did not reduce intake in comparison 
with the control treatment. However, intake of animals offered 50% leucaena (leucaena-
50) was greater than that of animals offered gliricidia (P < 0.01). The intake of animals 
offered 100% leucaena was greater than other treatments and almost double that of 
animals offered 50% gliricidia, due to the greater intake of legume compared to the 
legume plus grass diets (Table 7.3). Thus, there was no negative effect of DHP on levels 
of intake, whether administered as oral 2,3-DHP directly or via the breakdown of mimosine 
to 3,4-DHP and 2,3-DHP from leucaena in the diet. 
The effective proportion of legume in diet of the legume plus grass treatments was 62% for 
gliricidia and 74% for leucaena, again indicating a preference for legume over grasses and 
a higher preference for leucaena over gliricidia. The treatment means for all weeks were 
pooled over the 7-week period; no significant week × treatment interaction (P = 0.12) was 
observed.
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Table 7.3: Liveweight gain (LWG), dry matter intake (DMI) and urinary hydroxypyridone (DHP) levels of Capra hircus goats in response to diets of gliricidia and 
leucaena, infused with DHP (Experiment 1) or supplemented with FeSO4 mineral salts (Experiment 2). 
Means within a column with differing subscripts denote significant differences at the 5% significance level. 
Expt Length 
(weeks) 
Treatment LWG 
(g/day) 
Leucaena 
DMI (g/day) 
Gliricidia 
DMI 
(g/day) 
Grass 
DMI 
(g/day) 
Total DMI 
(g/day) 
Total DMI 
(g DM/kg 
LW.day) 
Proportion 
legume 
(%) 
Mean 
3,4-DHP 
(mg/L.day) 
Mean 
2,3-DHP 
(mg/L.day) 
Proportion of 
2,3-DHP 
remaining 
conjugated 
1 7 Gliricidia-50 15ab ± 3 0 196 ± 8 137 ± 8 334 ± 16 28a ± 1 60 ± 1 8a ± 3 64a ± 22 – 
  Gliricidia-50+DHP 2a ± 2 0 215 ± 10 127 ± 7 343 ± 16 26a ± 1 63 ± 1 20a ± 10 426b ± 74 25%a 
  Leucaena-50 23b ± 3 287 ± 15 0 103 ± 9 391 ± 22 31b ± 1 74 ± 1 160b ± 39 636bc ± 97 22%a 
  Leucaena-100 41c ± 8 756 ± 36 0 0 756 ± 36 54c ± 2 100 86c ± 19 772c ± 112 36%a 
2 10 Gliricidia-100 22a ± 9 0 511 ± 20 0 511 ± 20 37a ± 1 100 – – – 
  Gliricidia-100+M 18a ± 6 0 494 ± 14 0 494 ± 14 37a ± 1 100 – – – 
  Leucaena-100 44b ± 8 1006 ± 25 0 0 1006 ± 25 53b ± 1 100 – – – 
   Leucaena-100+M 29ab ± 3 984 ± 22 0 0 984 ± 22 53b ± 1 100 – – – 
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7.3.2 Liveweight gain 
The mean daily liveweight gain (LWG) of animals receiving gliricidia-50 and leucaena-50 
was similar over the 7-week period. Animals receiving the gliricidia-50+DHP diet had the 
lowest weight gain (Table 7.3), while the highest mean LWG was achieved by animals fed 
100% leucaena and was approximately double the mean of animals fed treatments of 
leucaena-50 or gliricidia-50 (P = 0.01). A regression of LWG with DMI displayed a 
significant trend (LWG = −12.6 + 0.945 × DMI; P = 0.01; R2 = 52%), as was expected. 
The LWG of goats at conclusion of the 3-week supplementation study was reduced in all 
treatments supplemented with iron(II) sulphate (Table 7.4). 
Table 7.4: Liveweight gain (LWG) after the 3-week supplementary study of experiment 1 involving Capra 
hircus goats in response to diets of gliricidia and leucaena, infused with DHP and supplemented with FeSO4 
mineral salts. 
Treatment LWG (g/day) 
Gliricidia-50 -0.23 
Gliricidia-50+M -0.50 
Gliricidia-50+DHP 0.20 
Gliricidia-50+DHP+M -0.35 
Leucaena-50 0.60 
Leucaena-50+M -0.40 
Leucaena-100 0.75 
Leucaena-100+M 0.35 
7.3.3 Urinary DHP excretions 
The mean weekly urinary 3,4-DHP and 2,3-DHP levels were highly variable, due in part 
due to their relatively low concentrations, with no significant week × treatment interaction 
(P = 0.15). Thus, the treatment means of all weeks were pooled over the 7-week period. 
As expected, the mean daily urinary 3,4-DHP excretions were substantially lower than 2,3-
DHP excretions, being present at levels between 5–25% of 2,3-DHP. The highest level of 
3,4-DHP was detected in the leucaena-50 treatment, almost twice that of animals receiving 
double the amount of leucaena (leucaena-100 treatment) (Table 7.3). The levels of 2,3-
DHP were not significantly different between leucaena treatments, although they were 
higher in the leucaena-100 compared to the gliricidia-50+DHP treatment (P = 0.03). The 
percentage of 2,3-DHP remaining conjugated after hydrolysis treatment was consistent 
among treatments. 
Low levels of DHP were detected in the collections from animals receiving the control 
(gliricidia-50) treatments, despite not receiving any leucaena or DHP. This was indicative 
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of a small level of contamination during urine collection. However, levels were negligible 
and did not greatly affect treatment means. 
In the 3-week supplementary investigation, the mean levels of total DHP excreted 
(combined 3,4-DHP and 2,3-DHP) when Fe(II) mineral supplementation was administered 
were reduced by ~40% for gliricidia-50+M and leucaena-100+M, and by ~70% for 
gliricidia-50+DHP+M and leucaena-50+M treatments compared to un-supplemented 
treatments (Table 7.5). 
Table 7.5: Urinary hydroxypyridone (DHP) levels of the supplementary study of experiment 1 involving 
Capra hircus goats in response to diets of gliricidia and leucaena, infused with DHP and supplemented with 
FeSO4 mineral salts. 
Experiment Length 
(weeks) 
Treatment Mean 3,4-DHP 
(mg/L.day) 
Mean 2,3-DHP 
(mg/L.day) 
proportion of 2,3-DHP 
conjugated 
1supplementary 3 Gliricidia-50+M 6 10 – 
  Gliricidia-50+DHP+M 0 211 30% 
  Leucaena-50+M 56 288 14% 
  Leucaena-100+M 49 139 17% 
7.3.4 Blood constituents 
Plasma Iron 
The mean plasma Fe level of all samples was 1.94 ± 0.14 mg/L. There were no significant 
differences in mean plasma Fe levels between week 4 or 6 (P = 0.13) or due to the 4 
treatments offered (P = 0.27); week 4 included the final collection from goats receiving 
mineral supplementation (total 8 treatments) which had no effect on plasma Fe levels. 
Plasma Zinc 
There was a positive effect on plasma Zn with increasing percentage of leucaena in diet (P 
< 0.01), and a negative effect due to Fe(II) mineral supplementation (P < 0.01), with levels 
highest in leucaena fed goats not receiving Fe supplementation (P < 0.01) (Table 7.6). The 
levels of plasma Zn in all treatments, including control goats, were below normal levels 
reported by Mills (1978) of 0.9–1.2 mg/L for calves and lambs. There was no significant 
difference in plasma Zn levels between week 4 or 6 (P = 0.55).  
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Table 7.6: Mean plasma Zn levels collected in weeks 4 and 6 from Capra hircus goats in response to diets 
of gliricidia infused with DHP or leucaena, with and without Fe mineral supplementation. 
Means with differing subscripts denote significant differences at the 5% significance level 
Treatment n Mean plasma Zn (mg/L) 
Gliricidia-50 4 0.15a ± 0.05 
Gliricidia-50+M 4 0.18a ± 0.05 
Gliricidia-50+DHP 4 0.15a ± 0.05 
Gliricidia-50+DHP+M 4 0.20a ± 0.10 
Leucaena-50 4 0.38b ± 0.05 
Leucaena-50+M 4 0.20a ± 0.07 
Leucaena-100 4 0.58c ± 0.05 
Leucaena-100+M 4 0.13a ± 0.03 
Serum ALT 
The mean serum alanine aminotransferase (ALT) level of all goats was 15.4 ± 2.0 U/L. 
There were no significant differences between week 4 or 6 (P = 0.70) or between 
treatments (P = 0.26).  
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Experiment 2 
7.3.5 Intake 
The mean daily intake of animals consuming leucaena diets (leucaena-100 and leucaena-
100+M) was significantly higher (P < 0.01) at approximately double that of animals on 
gliricidia diets (gliricidia-100 and gliricidia-100+M) (Table 7.3). The weekly trends in intake 
were consistent among treatments with no week × legume (P = 0.69), or week × minerals 
interaction (P = 0.99). Thus, the treatment means were pooled over the 10 weeks. 
There was no significant effect of mineral supplementation on DMI (P = 0.54), or a 
significant interaction between mineral supplementation and legume offered (P = 0.80). 
7.3.6 Liveweight gain 
Mean daily liveweight gains were calculated for each treatment over the 10-week period 
(Table 7.3). Animals on diets containing 100% leucaena only (leucaena-100) achieved 
LWGs approximately double those of animals on 100% gliricidia diets (gliricidia-100 and 
gliricidia-100+M) (P = 0.02), reflecting the similar trend in intake levels. There was no 
significant effect on LWG due to supplementation with minerals (P = 0.14) nor a significant 
interaction of mineral supplementation with legume offered (P = 0.36). 
Both experiments 
7.3.7 Feed chemical composition 
The crude protein content was highest in the fresh cut leucaena leaf material. The high 
voluntary intake and preference for leucaena can also be attributed to the low NDF and 
ADF values of the forage (Table 7.7). While leucaena leaf contained the lowest levels of 
both Fe and Zn (Table 7.7), the Fe and Zn levels of all feed types exceeded adequate 
levels for plant health (>44 mg Fe/kg DM and >13 mg Zn/kg DM) (H. M. Shelton, personal 
communication). 
Table 7.7: Chemical composition (g/kg DM) of feed types offered to Capra hircus goats. 
DMD: dry matter digestibility; GE: gross energy; CP: crude protein; NDF: neutral detergent fibre; ADF: acid detergent 
fibre 
Parameter Leucaena Gliricidia Local grasses 
CP (g/kg DM) 223 ± 8 153 ± 8 58 ± 5 
NDF (g/kg DM) 447 ± 22 498 ± 11 699 ± 7 
ADF (total) (g/kg DM) 365 ± 21 410 ± 19 456 ± 6 
Fe (mg/kg) 88 ± 7 107 ± 17 422 ± 80 
Zn (mg/kg) 14 ± 1 18 ± 3 34 ± 2 
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7.4 Discussion 
Much has been learned in the last 10 years of research regarding leucaena toxicity, 
contradicting the original hypothesis that bacterial degradation by Synergistes jonesii was 
the principal pathway of DHP degradation. This has led to an updated/alternate 
hypothesis: that Synergistes jonesii is not capable of complete detoxification of DHP in 
ruminants on high leucaena diets and other physiological and/or metabolic pathways are 
operating to detoxify DHP (Halliday et al. 2013; Halliday et al. 2014b). The findings from 
this experiment support this hypothesis and are now discussed in detail with respect to the 
key objectives. 
7.4.1 Toxicity response to infused 2,3-DHP administered orally 
The first objective of this study was to investigate the toxicity of 2,3-DHP as it is 
persistently present in high concentrations in animals maintained on leucaena diets 
worldwide (Halliday et al. 2014b). The infusion rate of 0.04% BW 2,3-DHP in this study 
resulted in urinary levels of 2,3-DHP comparable with the 50% leucaena diet with no 
observable signs of acute toxicity from any treatment. In comparison, in a similar study by 
McSweeney et al. (1984), when 2,3-DHP was administered continuously via a rumen 
fistula at the same rate of 0.04% BW, sheep stopped eating after 7 days. And in an Indian 
study, the single intraruminal dose of 0.017% BW 2,3-DHP administered by Puchała et al. 
(1995) was fatal within 24 hours in Angora goats. 
Although 2,3-DHP toxicity in ruminants is comparatively less studied, it was assumed to be 
similarly toxic as 3,4-DHP (D'Mello 1992; Paul 2000; Ghosh et al. 2008), based on the 
assumption that it possessed similar goitrogenic effects (Jones et al. 1978; Christie et al. 
1979; Hegarty et al. 1979; Jones 1979; Lee et al. 1980; Megarrity and Jones 1983; Jones 
et al. 1985a; Lowry et al. 1985; Dalzell et al. 2012). Studies involving the administration of 
the isomer 3,4-DHP (0.02% BW) were fatally toxic in rats and monkeys, and clinical signs 
included organ atrophy, and damage to bone marrow (Berdoukas et al. 1993; Hoffbrand 
and Wonke 1997; Porter 1997; Kwiatkowski 2008). These studies notably did not observe 
any goitrogenic effects of 3,4-DHP. In other trials, the development of goitre itself has been 
shown to be caused by metal deficiencies, with compromised thyroid function in Fe 
deficient rats (Smith et al. 1992), depressed thyroxin levels after 42 days in Zn deficient 
rats (Lukaski et al. 1992), and Zn deficiency via urinary excretion correlated with 
hypothyroidism in human patients (Nishi et al. 1980). 
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Metal deficiencies of Fe, Cu, Zn also explain many of the other signs of toxicosis, including 
hair loss in rats and mice (Cunningham 1932; Hashiguchi and Takahashi 1977) (Day and 
Skidmore 1947; Smith and Ellis 1947; Hashiguchi and Takahashi 1977; Stunzi et al. 1980) 
and DNA inhibition (Tsai and Ling 1971). Considerable work has also been conducted in 
the pharmacological field, with hydroxypyridones used as orally active metal chelators in 
patients with iron overload (Santos 2008; Santos et al. 2012; Lachowicz et al. 2015). 
Examples include hereditary haemochromatosis (Sooriyaarachchi and Gailer 2010) which 
affects approximately 1 in 300 people of European background (Bridges 2001) and 
thalassaemia intermedia (Zhou et al. 2006; Lachowicz et al. 2015). The reported negative 
side effects of continued exposure to DHP in chelation therapy are well documented and 
make no mention of a reduction of thyroid hormones, rather, are related to the disruption 
of homeostasis of essential metals (Sooriyaarachchi and Gailer 2010), especially Zn 
(Megarrity and Jones 1983; Barman Balfour and Foster 1999; Hoffbrand 2005; Crisponi 
and Remelli 2008). This affected a wide range of vital metalloenzymes (Berdoukas et al. 
1993; Hider 1995; Hoffbrand 2005) including superoxidase dismutases, such as succinate 
dehydrogenase (Tsai 1961) and alkaline phosphatase (El-Harith et al. 1981), both of which 
require Zn, Mg, and Cu. 
The main toxic effect of DHP (in humans, rats, mice, monkeys, and ruminants) is now 
understood to be due to its action as a strong ligand, chelating essential metals in vivo. 
This occurs because although DHP is often described as a dihydroxypyridine, it actually 
exists as the keto-enol tautomer with the equilibrium strongly favouring the 
hydroxypyridone form at physiological pH (Scarrow et al. 1985). 
The referral of hydroxypyridones as DHP in ruminant toxicology can be considered 
something of a misnomer, as many chemists have chosen more descriptively accurate 
abbreviations of what exists at physiological pH as 3-hydroxy-2(1H)-pyridone such as: 2,3-
DOHP (Morais et al. 2006); H2pp (Nurchi et al. 2012); 3,2-Hopo (Scarrow et al. 1985); 3,2-
HOPO (Harrington et al. 2010; Santos et al. 2012); and vhpo (Stunzi et al. 1979). Taking 
these into account, an abbreviation such as HPo would more descriptively represent the 
hydroxypyridone conformation. For consistency however, this thesis will continue to use 
the generally accepted abbreviation of DHP. 
In hydroxypyridone form, the O substituent vicinal to the C-3 enol/hydroxyl (–OH) moiety, 
exists as a keto/carbonyl (=O) moiety (Figure 7.1a & b). This is due to the resulting stability 
of the zwitterionic canonical mesomer in this form, with the delocalisation of electrons from 
the N resulting in a high charge density over the para or ortho carbonyl group (in 3,4-DHP 
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and 2,3-DHP, respectively) (Figure 7.1c & d), which also has a greater bond strength 
(Cottrell 1958), and is further promoted by the aromatic resonance of the ring (Gardner 
and Katritzky 1957; Hider 1995; Santos 2002). The pyridinium ring N does not deprotonate 
in aqueous solution (Curtis et al. 1970; Stunzi et al. 1980). 
 
Figure 7.1: Structures of: (a) the 3-hydroxy-4(1H)-pyridone (3,4-DHP) tautomer in keto-enol form; (b) the 3-
hydroxy-2(1H)-pyridone (2,3-DHP) tautomer in keto-enol form; (c) the zwitterionic mesomer of 3,4-DHP; and 
(d) the zwitterionic mesomer of 2,3-DHP. Adapted from Curtis and Atkinson (1972), Stunzi et al. (1980) and 
Scarrow et al. (1985). 
The resultant hydroxo-carbonyl moiety on the pyridine ring of hydroxypyridone makes it a 
strong bidentate (2 binding points) ligand (Gardner and Katritzky 1957; Goel et al. 1970; 
Stunzi et al. 1980; B. Di Marco et al. 1999; Flora and Pachauri 2010). Hydroxypyridones, 
including 3,4-DHP and 2,3-DHP, bind metals via ionic bonds with the oxyanion 
(deprotonated 3-hydroxyl) (Goel et al. 1970; Vovk et al. 2003) and coordinate bonds with 
an ortho electronegative carbonyl moiety (Scarrow et al. 1985). At physiological pH, this 
forms a 2:1 ligand:metal ratio with bivalent cations in four-coordinate geometries using x-
ray crystallography (Clarke and Martell 1992; Flora and Pachauri 2010).  
The crystal structure of 2,3-DHP has been confirmed with trivalent Al(III) and Fe(III) 
complexes binding in 3:1 ligand:metal ratios (Scarrow et al. 1985; B. Di Marco et al. 1999; 
Nurchi et al. 2012) with X-ray diffraction data confirming the bond through the (O,O) 
complex (Streater et al. 1990; Vovk et al. 2003) (Figure 7.2). The 1,2-dimethylated 3,4-
DHP (3-hydroxy-1,2-dimethyl-4-pyridone), pharmacologically used as iron chelator and 
(b) 
(d) 
(a) 
(c) 
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branded as Deferiprone (DFP) (Galanello 2007) also forms chelate bonds via the (O,O) 
complex (Xiao et al. 1992; Melchior et al. 2001; Sooriyaarachchi and Gailer 2010; Kaviani 
et al. 2016). 
 
Figure 7.2: Crystal structure of the Al(III):2,3-DHP3 complex, catalogued in the Cambridge Structural 
Database (CSD) as CAQDON, source Nurchi et al. (2012). Scarrow et al. (1985) and B. Di Marco et al. 
(1999) reported identical structures with Fe(III) and Al(III), respectively. 
Although both isomers of DHP bind in the same fashion, the strength of these two ligands, 
measured by the stability constants for protonation of the chelating hydroxyl moiety (pKa1) 
(Curtis and Atkinson 1972; Scarrow et al. 1985), is markedly different. The pKa1 of 2,3-
DHP (8.7) is substantially lower than 3,4-DHP with a pKa1 of between 9.5–9.9 (Dobbin et 
al. 1993; Santos 2002). The reason for the decreased ligand strength of 2,3-DHP, is due 
to the arrangement of the electronegative carbonyl moiety at the C-2 position, which 
places it nearer the positive pyridinium ring-N (Santos 2002). The reduced electron density 
of the coordinating hydroxyl/carbonyl (O,O) moiety (Santos et al. 2012) and the 
electrostatic repulsions between the positive charge of the pyridinium N have an inductive 
destabilising effect on the chelate (B. Di Marco et al. 1999) resulting in a decreased 
binding strength with metal cations (Santos 2002). The resulting affinity of 2,3-DHP to bind 
with essential elements such as Cu(II), Zn(II), Mg(II) and Ca(II) at physiological pH (~7.4) 
is reduced by factors of 30, 10, 4, and 2, respectively in comparison to 3,4-DHP (Stunzi et 
al. 1980; Dobbin et al. 1993). This weaker chelating ability of 2,3-DHP (Spinner and White 
1966; Stunzi et al. 1980; Streater et al. 1990; Dobbin et al. 1993) has the result of 
significantly reducing its toxicity in vivo. The reduction in ligand strength has even 
precluded it as a ligand for iron chelation therapy (Santos 2002). 
The results of this study support the observation that 2,3-DHP has a reduced toxicity in 
comparison to 3,4-DHP, as intake of leucaena was not negatively affected in 
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unsupplemented 2,3-DHP-infused goats over the 7-week period and there was no 
significant impact on LWG in comparison to control gliricidia-50 animals. The LWG of 
gliricidia-50+DHP animals was lower in comparison to the leucaena-50 treatment, with an 
equivalent DHP intake, although this effect was confounded with the different legume diet. 
Another possible contributing factor for the lack of toxicosis was that the goats in this study 
were already adapted to eating leucaena, unlike the naïve animals in the experiments of 
McSweeney et al. (1984) and Puchała et al. (1995). This previous adaption to leucaena 
may have afforded them tolerance of 2,3-DHP, a common phenomenon observed in 
productive ruminants maintained for long periods on leucaena diets despite persistent high 
levels of 2,3-DHP excreted (Halliday et al. 2014b). It is noted that even the Hawaiian 
goats, assumed to be protected by the presence of the ruminal bacterium S. jonesii, in the 
seminal study of Jones and Megarrity (1983), were excreting DHP as the 2,3-DHP isomer, 
without negative effects. 
7.4.2 The effects of mineral supplementation on detoxifying DHP 
The objective of the second experiment was to investigate the ability of mineral 
supplementation with iron(II) sulphate (FeSO4) to promote the intraruminal chelation of 
DHP as a prophylactic protective mechanism. Supplementation was intended to exploit the 
high affinity of DHP to bind with Fe cations, forming a stable chelate, reducing the toxicity 
and increasing urinary clearance of the chelated DHP (Puchała et al. 1995; Galanello 
2007; Flora and Pachauri 2010). 
Surprisingly, the findings of this study did not support the hypothesis of increased DHP 
excretion. When a solution of iron(II) sulphate was administered in the short-term study in 
experiment 1, there was a slight reduction of 2,3-DHP excreted with the greatest effect in 
goats receiving 100% leucaena and in animals receiving 2,3-DHP orally (Table 7.5). In 
other work, the combination of Fe(II), Cu(II), and Zn(II) (Jones et al. 1978) and Fe(II), 
Mg(II), and Zn(II) (Puchała et al. 1995) mineral salts doubled urinary clearance compared 
to un-supplemented goats infused with 2,3-DHP. While the use of multiple metal 
supplements will aid in correction of deficiencies of these elements, that was not the 
objective of this study. A single element supplement was employed to isolate the effects of 
intraruminal detoxification of DHP via chelation. The very low levels of Zn in goats fed 
gliricidia, as well as those fed leucaena with Fe supplementation, was unexpected, and did 
not appear associated with DHP toxicity. Also, although the stability constant of Fe(II) 
when binding with DHP is the lowest of the bivalent transition metals (12.1), the values are 
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relatively similar. It is therefore unlikely that an alternate metal supplement for promoting 
chelation (such as Cu(II) or Zn(II)) would have affected the outcome. 
The addition of the Fe(II) treatment in experiment 2 also did not improve animal 
performance as hypothesised. Un-supplemented animals achieved the same intake as 
those receiving the Fe(II) treatment and there was a trend of reduced LWG in 100% 
leucaena-fed goats receiving Fe(II). Mineral supplementation with Fe(II) (Ross and 
Springhall 1963), or in combination with other bivalent elements (Jones et al. 1978; 
Puchała et al. 1995) has previously been shown to increase DMI, LWG, and decrease 
clinical signs of DHP toxicosis (Tsai and Ling 1974; Jones et al. 1978; Puchała et al. 
1995). Possible reasons for the lack of response include: (a) alternate coping mechanisms 
preventing the development of DHP toxicity in any treatment; and, (b) a possible 
contraindication of the Fe(II) supplementation treatment. Although not quantified, there 
was indication that the Fe(II), delivered as an aqueous solution of FeSO4, appeared to be 
partially oxidised to Fe(III) from dissolved oxygen in the water. This was observed as a 
yellow colour in solution with water, indicative of Fe(III) hydroxide precipitate. The solution 
of Fe(II) sulphate and 2,3-DHP also immediately turned a purple colour, indicative of 
oxidisation to the Fe(III) ion (Howlin et al. 1982; Scarrow et al. 1985). Once precipitated 
out of solution, Fe(III) hydroxide would be incapable of binding 2,3-DHP intraruminally, 
when delivered orally.  
Despite the similar DMI and LWG of goats both receiving the Fe(II) supplementation 
treatment and those without, there were no observed negative effects of the Fe(II) 
sulphate solution on these parameters in experiment 2. However, during the 
supplementary mineral study within the first 3 weeks of experiment 1, albeit a short period 
to assess LWG differences, there was an observed trend in loss of LW in all treatments by 
−27 ± 8 g/day when supplemented with Fe(II) sulphate (Table 7.4). 
7.4.3 Impact of DHP on LWG 
There was no indication of subclinical toxicity (depressed LWG) in goats in relation to 
DHP-induced mineral deficiencies. The unremarkable mean plasma Fe levels of goats in 
all treatments (1.94 mg/L) was within the published normal range for small ruminants 
(1.66–2.22 mg/L) (Constable et al. 2017). This was maintained by adequate dietary Fe 
levels in the diets offered (88–224 mg/kg DM); within the nutritional range for goats (35–
500 mg/kg DM) (Hart 2008). 
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Plasma Zn levels were, however, below adequate (0.8 mg/L) (Mills 1978) in all treatments; 
although goats fed diets of leucaena without Fe mineral supplement had the highest 
plasma Zn levels (Table 7.6). The addition of Fe(II) sulphate reduced plasma Zn levels in 
these animals to levels similar to those of goats on gliricidia-based diets; Fe(II) sulphate 
had no effect on the already low plasma Zn levels in gliricidia-fed goats. It is possible that 
Zn deficiency in leucaena-fed goats supplemented with Fe(II) sulphate was due to excess 
Fe, not involved in chelation with DHP, decreasing the absorption of dietary Zn (Hart 
2008); however, it is not clear why plasma Zn levels were low in control animals. Mills 
(1978) reported clinical signs of Zn deficiency occurred at serum levels <0.8 mg/L and loss 
of LW at levels <0.4 mg/L. Although plasma Zn levels were below 0.6 mg/L in all 
treatments, there were no apparent clinical signs of Zn deficiency. Although the Zn levels 
in leucaena were adequate for plant growth, the percentage of Zn in diet (14 mg Zn/kg 
DM) in the leucaena-100 treatments was below required levels for goats (40–500 mg 
Zn/kg DM) (Hart 2008). While the signs of DHP toxicity are associated with essential 
element deficiencies, including Zn (Megarrity and Jones 1983), the low levels of Zn in this 
study did not appear associated with DHP. On the contrary, high leucaena diets promoted 
high serum Zn levels and high liveweight gains. This occurred, despite high levels of 2,3-
DHP remaining undegraded. 
7.4.4 Evidence of conjugation occurring 
It has been suggested (Puchała et al. 1995) that chelation may be necessary for efficient 
excretion of DHP, as the increased polarity of the chelate prevents reabsorption in the 
kidneys. While an increase in DHP excretion in association with Fe mineral 
supplementation was not observed, a similar effect is achieved when DHP is bound as a 
conjugate (Galanello 2007). In fact, the chelatory ability of DHP is reduced when 
conjugated (Singh et al. 1992; Crisponi and Remelli 2008). As there was evidence of 
considerable conjugation occurring, this also may have negated the effectiveness of the 
mineral treatment. This pathway is now discussed. 
Despite samples in this study undergoing acid hydrolysis at collection, not all DHP was 
hydrolysed to the free form, as indicated by HPLC results. In animals fed 100% leucaena 
during the 7-weeks of experiment 1, up to 42% of DHP excreted remained conjugated 
after acid hydrolysis; animals fed lower levels of leucaena/DHP had a lower level of 
conjugation of 28%. While the total amount of DHP conjugated prior to hydrolysis was not 
measured, other studies have reported up to 90% of DHP to be excreted as a conjugate 
(Singh et al. 1992; Flora and Pachauri 2010) preventing toxicosis. 
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The underlying principle of conjugation is similar to that of chelation: binding of the 
hydroxyl site reduces the affinity of the molecule to act as a ligand, and therefore limits 
depletion of metal ions (Singh et al. 1992). Once conjugated, DHP is rapidly eliminated 
from the body within 1–2 hours (Galanello 2007; Flora and Pachauri 2010; 
Sooriyaarachchi and Gailer 2010). The glucuronic acid complex is the most common 
conjugation pathway (glucuronidation) in mammals and is a non-specific mechanism for 
detoxifying a variety of xenobiotic compounds (Gupta and Akbar 1993; Sahlu et al. 1995; 
Galanello 2007; Crisponi and Remelli 2008). The identification of the conjugate is 
described in detail in Chapter 8, whereby specialised collection methodologies were 
utilised to preserve the conjugated DHP from hydrolysis. 
Despite conjugation primarily occurring in the liver (Gupta and Atreja 1998), the persistent 
high levels of 2,3-DHP entering circulation did not appear to affect liver health. Elevated 
serum alanine aminotransferase (ALT) levels are indicative of liver damage and have been 
observed in patients receiving DHP chelation therapy (Barman Balfour and Foster 1999; 
Cohen et al. 2000; Ha et al. 2006; Roberts et al. 2007; Fisher et al. 2013). However, ALT 
levels were not elevated in goats on any treatment and were within normal levels for small 
ruminants (5–20 U/L) (Constable et al. 2017). Similar findings (~12 U/L) were recorded in 
the work of Girdhar et al. (1991) where no significant increase was recorded in leucaena-
fed goats over an 8-month period. 
It is entirely possible that conjugation has always been an important mechanism of 
detoxification. Much like the underappreciated significance of 2,3-DHP by Jones and 
Megarrity (1983), the methodologies for preserving DHP were not suitable for accurately 
quantifying conjugated DHP due to acidification of the samples prior to analysis (Jones 
and Lowry 1984). This acidification step hydrolysed conjugated DHP to the free (toxic) 
form. However, it is now apparent that considerable amounts of residual conjugated DHP 
commonly remain. Even the improved methodologies for hydrolysing DHP (Graham et al. 
2014) have not achieved complete hydrolysis of the conjugate (Halliday et al. 2014b). It is 
therefore likely that the conclusion of Jones and Lowry (1984), that detoxification of DHP 
occurred via microbial degradation, underestimated the importance of the conjugation 
pathway. 
7.4.5 Low levels of DHP in 100% leucaena-fed goats 
The level of total DHP excreted when goats were administered 2,3-DHP orally at a rate of 
0.04% BW were similar to that of goats receiving 50% leucaena in diet, which contained 
an equivalent level of DHP intake. However, a surprising result was that animals 
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consuming a 100% leucaena diet did not have significantly higher levels of DHP in urine. 
This is in contrast with results obtained from similar goats from the same farm in Sumlili 
during sampling in 2011 (Chapter 6) where mean 2,3-DHP levels reached 4980 mg/L 2,3-
DHP. 
Other studies have similarly shown a variable relationship between amount of leucaena 
ingested and levels of DHP in urine. The study of Tangendjaja et al. (1985) found that 
DHP levels in Indonesian goats fed 100% leucaena declined from high levels (7000 mg/L) 
to approximately 300 mg/L after 3 weeks of feeding. These researchers did not 
discriminate as to which isomer of DHP was detected. In the feeding trial in Chapter 5, 
levels of total DHP declined in undrenched leucaena-fed steers over a 6-week period. This 
effect was most pronounced in the 100% leucaena treatment, and coincided with an 
increase in leucaena intake. The low levels of DHP in urine of goats fed 100% leucaena in 
these studies and the current experiment suggest possible evidence for loss of DHP 
through metabolism with indigenous microbes, including S. jonesii. Nevertheless, the 
continued presence of DHP in animals known to have S. jonesii (Dalzell et al. 2012; 
Halliday et al. 2014c) (Chapter 5) suggest bacterial degradation alone is not sufficient to 
afford complete protection against DHP toxicity. 
7.4.6 Leucaena is the most productive diet 
Despite high urinary DHP excretions, the leucaena-fed goats showed no indication of 
reduced intake or LWG. Furthermore, 100% leucaena-fed goats outperformed all other 
treatments offered, demonstrating the high production potential of a high leucaena diet 
when animals are adapted. Intake and mean LWG of animals on 100% leucaena diets 
were up to 2-times greater than for animals fed 50% leucaena or 50% gliricidia combined 
with local grasses. These sole leucaena diets are commonly fed to goats, buffalo and Bali 
bulls in East Nusa Tenggara, including on the island of West Timor where this study was 
conducted. This is often out of necessity due to a lack of availability of other forages in the 
dry season (Dahlanuddin et al. 2014), however it is clear it also offers substantial 
production advantages. 
The high productivity of 100% leucaena diets in this study is in strong contrast with the 
results of other feeding trials which have reported poor animal performance (Puchała et al. 
1995; Ghosh et al. 2008) (Chapter 5). A major difference in this study was that the goats 
were already accustomed to consuming leucaena. Animals naïve to leucaena require an 
adaptation period of between 4–8 weeks during which intake is often reduced and clinical 
signs of toxicosis including alopecia are common (Mullenax 1963; Hegarty et al. 1964b). 
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Adaptation involves the proliferation of endogenous rumen microorganisms (Hegarty et al. 
1964b) capable of degrading mimosine to DHP (Ghosh et al. 2007; O'Reagain et al. 2014), 
and the induction of enzymatic pathways involved in conjugation, primarily in the liver 
(Mohamed and Frye 2011). Once adapted, animals are capable of excellent performance 
on high leucaena diets (Panjaitan et al. 2014). 
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7.5 Conclusion 
This study has highlighted the high value of leucaena as a forage, especially when fed at 
high levels. It has also demonstrated the efficacy of adapted animals to detoxify high 
levels of DHP, providing credible evidence that 100% leucaena diets can be safe and 
productive. 
The first objective was to confirm the toxicity of 2,3-DHP. However, no clinical signs or a 
negative effect on intake were observed in any treatment. The infusion of 2,3-DHP to 
goats offered 50% gliricidia appeared to reduce LWG over the 7-week period in 
comparison to diets of gliricidia without 2,3-DHP, though the difference did not reach 
statistical significance. There were no differences in the leucaena-fed goats. Animals fed 
100% leucaena diets outperformed those of all other treatments. The lack of toxicity was 
likely associated with the higher nutritive value of leucaena coupled with the detoxification 
and excretion of DHP in conjugated form, reducing the metal binding affinity and 
preventing potential deficiencies of essential elements. 
The second objective was to investigate the impact of Fe(II) mineral supplementation on 
chelation of DHP as a mechanism to prevent toxicity. A reduction in toxicity of DHP with 
supplemented Fe(II) was not observed in this study. The notion of conjugation however, 
was identified as an important protective pathway. Recent studies, and the results of 
earlier chapters, have shown that although S. jonesii is part of the normal ruminal flora, it is 
rarely present in sufficient numbers to provide sole protection against toxicity 
(Padmanabha et al. 2014) (Chapter 5). 
It is therefore concluded that the high leucaena diets used in this study were not toxic. The 
comparatively low levels of DHP in the urine of goats in the 100% leucaena treatment, 
along with the isomerisation of 3,4-DHP to 2,3-DHP (a weaker ligand and less toxic 
isomer), suggest an endemic S. jonesii, or possible other bacterial population, was likely 
responsible for some degradation of DHP. However, the high levels of remaining DHP 
(normally considered toxic (Dalzell et al. 2012)) were being detoxified by innate metabolic 
pathways, such as the conjugation in the liver. While the relative significance of each 
pathway is not definitively known, the presence of high quantities of DHP in urine without 
the accompanying toxicity signs, indicates hepatic detoxification as a major pathway. 
As animals inherently possess the capacity to conjugate a variety of toxins, this eliminates 
the need for the labour-intensive practice of inoculation. This has the advantage of 
considerable savings for Australian graziers utilising leucaena pastures, if a similar 
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pathway exists in Australian cattle, and it greatly benefits smallholder farmers in 
developing countries where the supply chain and expertise to distribute and administer an 
inoculum does not exist. 
The low plasma Zn levels in all animals indicated the need for a mineral supplement to 
complement the forage. While there was no indication of DHP-induced essential element 
deficiencies, mineral supplementation will promote a net positive essential element 
balance, especially during the mildly symptomatic adaptation phase, after animals are first 
introduced to leucaena. 
Further research should focus on the conjugation pathways involved in detoxifying DHP, 
especially in animals fed 100% leucaena diets. 
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Chapter 8 Longitudinal survey of Bali bulls (Bos javanicus) in eastern Indonesia 
and the prevalence of conjugation of hydroxypyridone as a detoxification 
mechanism 
8.1 Introduction 
The fattening of bulls for slaughter is of great importance to the profitability of farming 
enterprises of smallholder farmers in eastern Indonesia (Waldron 2016). The feeding of 
forage tree legumes (FTLs), especially Leucaena leucocephala (leucaena), in these cut-
and-carry systems, is a vital contributor to the profitability of this system as it is a low-cost 
protein source and has greatly improved the nutrition of Indonesian smallholder cattle and 
reduced associated labour costs. The Balinese farmers in the hamlet of Jati Sari, within 
Rhee village on Sumbawa island, are a notable example of this phenomenon (Panjaitan et 
al. 2014). They have successfully fattened bulls on sole leucaena diets for over 20 years. 
Despite the many excellent nutritional properties of leucaena, the presence of the toxin 
mimosine in plant tissue and its toxic breakdown compounds (hydroxypyridones (DHPs)) 
was believed to limit potential animal productivity in the absence of intervention. Diets 
containing greater than 30%, and certainly 100% leucaena, were historically considered 
incapable of sustaining liveweight gains (LWG) (Jones and Hegarty 1984), without prior 
inoculation with the rumen bacteria Synergistes jonesii. The toxic effects were originally 
ascribed to the goitrogenic effect of 3,4-DHP depressing T4 and T3 levels (Jones et al. 
1978), however a major pathway of toxicity is the chelation with, and depletion of, 
essential elements (Tsai and Ling 1971; Stunzi et al. 1980). 
The observed lack of toxicity in goats consuming moderate (<50%) levels of leucaena, in 
Bogor, Indonesia (Jones and Lowry 1984) and in Hawaii (Jones and Megarrity 1983) was, 
at the time, attributed to the natural occurrence of the DHP-degrading ruminal bacterium S. 
jonesii (Jones and Lowry 1984). Similar conclusions were made regarding ruminants in 
other countries (Indonesia, Vanuatu, Thailand, Malaysia, India, Seychelles, Mauritius and 
Mexico) with a longstanding history of feeding leucaena (Jones 1994). However, the 
findings of this thesis indicate that S. jonesii is not capable of completely degrading all 
DHP in ruminants on high leucaena diets. Other relevant findings include: the discovery of 
the ubiquity of the bacterium and the high propensity for point mutations in the 16S rDNA 
gene sequence of S. jonesii (Padmanabha et al. 2014); the dominance of 2,3-DHP as a 
metabolic endpoint of mimosine degradation (Halliday et al. 2014b); and the perpetual 
presence of high levels of 2,3-DHP in urine of ruminants consuming high leucaena diets 
without detrimental toxic effects (Halliday et al. 2014c). 
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Accordingly, a new hypothesis was formulated that postulates metabolic conjugation of 
DHP as the critical pathway in toxicity amelioration. 
Despite early evidence supporting this hypothesis (Christie et al. 1979), the role of 
conjugation of DHP in detoxification has not been greatly researched since that time. In 
fact, the methods employed for measuring DHP intentionally hydrolysed conjugated DHP 
to the free form, without quantification (Ford et al. 1984), and overlooked any protective 
benefits of the conjugate. In the work of this thesis, despite following the recommended 
acid-hydrolysis protocols, the more advanced analytical procedures (Chapters 4, 6 and 7) 
have consistently identified HPLC peaks for what was suspected to be additional 
remaining conjugated DHP in HPLC chromatograms. 
In order to investigate the role of conjugation in reducing toxicity, urine was sampled in Jati 
Sari hamlet, from bulls fed 100% leucaena which were not only asymptomatic of DHP-
toxicity, but were also achieving liveweight gains approaching the genetic potential of Bos 
javanicus bulls (Panjaitan et al. 2014) (0.85 kg/day) (Mastika 2003). When bulls from this 
hamlet were first sampled in 2011 (Chapter 6), they were found to be excreting high levels 
of DHP, specifically 2,3-DHP. This was consistent with recent findings in which DHP was 
voided from ruminants primarily in the form of 2,3-DHP. It was apparent that the bulls were 
able to tolerate high levels of 2,3-DHP without degradation of the toxin. 
The first objective of this study was to conduct a longitudinal monitoring survey of urinary 
DHP excretory patterns in bulls fed 100% leucaena diets, to overcome limitations of the 
single “spot” samples obtained in previous assessments, and to characterise the isomeric 
form of DHP excreted. The second objective was to identify and quantify the DHP-
conjugate in bulls adapted to high leucaena diets. A refined collection methodology was 
employed in order to prevent hydrolysis and to preserve the conjugated form of DHP. 
If confirmed, the detoxification of DHP via conjugation has the potential to lessen the 
management requirements of leucaena-fed ruminants worldwide, as reliance upon 
inoculation with S. jonesii to manage leucaena toxicity would no longer be required. This 
would represent a paradigm shift in the way in which leucaena toxicity is viewed and the 
issue of toxicity as a barrier to adoption in many countries would be eliminated.  
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8.2 Materials and methods. 
The survey was undertaken in the leucaena-based bull-fattening hamlet of Jati Sari, Rhee 
village, Sumbawa Island, West Nusa Tenggara (NTB) (8° 25' 10.88" S, 117° 16' 0.46" E) in 
eastern Indonesia (Plate 8.1). Jati Sari was first identified in the sampling survey of 
Chapter 6 where bulls were fed diets of up to 100% fresh cut leucaena 3–4 times per day 
in a cut-and-carry system, while tethered in simple sheds (‘kandangs’). 
Two sampling periods were undertaken in this study: the first was a 4-week monitoring 
period during January 2014; and the second was a 2-day monitoring period in May 2016. 
The purpose of the second period was to confirm that the process of conjugation was a 
consistent phenomenon, and to collect rumen fluid with improved methods for preserving 
RNA. 
An improved method for urine sample collection and preservation is also described, which 
allowed the conjugated form of DHP to be studied. 
 
Plate 8.1: The hamlet of Jati Sari in the foreground, with leucaena planted in rows in the background. 
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8.2.1 Animal selection and feeding 
In the 2014 sampling period, six farmers were selected, from whom 18 Bali bulls (Bos 
javanicus) were monitored. These included 6 existing bulls (average weight 201 ± 11 kg 
(±s.d.)) which had been fattened on a 100% leucaena diet for >5 months, and 12 bulls 
(average starting weight 154 ± 37 kg (±s.d.)) which had newly arrived and commenced 
high-leucaena diets for their first time. 
In the 2016 sampling, 10 existing Bali bulls (average starting weight 200 ± 18 kg (±s.d.)) 
from a single farmer were selected which had been maintained on 100% leucaena diets 
for 4–6 months. 
Animals were fed fresh cut leucaena 4–5 times per day. Leucaena was sourced from trees 
grown on each individual farmer’s land, that were up to 20 years old. Side branches of up 
to 2 m in length were cut twice per day, and distributed throughout 4–5 feedings. It was 
common for farmers to collect enough feed to offer bulls a midnight feed to maximise 
intake and therefore shorten the fattening period. Leucaena was fed ad lib, and the time 
fresh feed was available in front of animals was maximised to encourage increased intake. 
These monitoring studies were sanctioned under animal ethics #SAFS/023/15/ACIAR 
(Appendix 4) and #SAFS/038/12/ACIAR (Appendix 5). 
8.2.2 Liveweight measurements 
Liveweight measurements for bulls in the first period were already being recorded monthly 
after overnight fasting from food and water as part of a supplementary longitudinal 
productivity assessment (Panjaitan et al. 2014). Bulls were weighed on arrival and for the 
duration of their fattening in this hamlet. 
8.2.3 Urine sample collection 
Urine samples were collected into a plastic receptacle, using a small brush to stimulate the 
penis sheath to encourage urination. Fresh urine samples were then cleaned through 
grade 1, 11 µm filter paper. A 9.5 mL subsample was preserved in solution with 0.5 mL 
32% hydrochloric acid (HCl), in polypropylene tubes (Dalzell et al. 2012). A second 
subsample was retained for analysis without acid-hydrolysis. To prevent bacterial 
degradation of DHP, 10 mL of clean urine was passed through a syringe driven filtration 
system consisting of a GF/C filter and a 0.22 µm Millex Millipore filter, into polypropylene 
tubes. Samples were then immediately placed on ice and stored at <−20ºC. 
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In the 2014 period, samples were collected three times per day (at approximately 08:00, 
13:00, and 17:00), three days per week (Monday, Wednesday, and Friday), for four 
consecutive weeks during the month of January 2014. 
In the 2016 period, sampling occurred three times at 09:00 and 13:00 on day one, and at 
09:00 on day two. 
In total, 226 individual urine samples were collected from period 1, and 30 from period 2. 
8.2.4 Colorimetric identification and proportion of conjugated DHP 
Estimation of the concentration, type of isomer, and proportion of conjugated DHP was 
conducted colorimetrically based on the iron(III) chloride method of Graham (2010); this 
was conducted for both the acidified and unacidified urine samples. The immediate colour 
reaction of unacidified urine was recorded and photographed. The acidic solution of 
iron(III) chloride facilitated the gradual hydrolysis of the unacidified sample. A 
corresponding increase in colour intensity of this sample was indicative of hydrolysis of 
conjugated DHP, which was not able to immediately complex with the iron(III) in solution. 
The colour reaction of the unacidified sample was monitored through to hydrolysis 
reaching the same intensity as the acidified urine samples. 
The colour intensity of each observation was recorded and assigned a rank from 0–5 
adapted from Graham et al. (2014). The colour hue of the iron(III) chloride reaction was 
compared with standards for the following isomers of DHP: 2,3-dihydroxypyridine (2,3-
DHP); 2,4-dihydroxypyridine (2,4-DHP); 2,5-dihydroxypyridine (2,5-DHP); 2,6-
dihydroxypyridine (2,6-DHP); and 3,4-dihydroxypyridine (3,4-DHP), and the following 
isomers of mono-hydroxypyridine (HP): 2-hydroxypyridine (2-HP); 3-hydroxypyridine (3-
HP); and 4-hydroxypyridine (4-HP) (Plate 8.2). 
 
Plate 8.2: Colour development of isomers of hydroxypyridine and dihydroxypyridine compounds with iron(III) 
chloride solution. 
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8.2.5 Optimisation of hydrolysis and HPLC confirmation of 2,3-DHP conjugate 
The existing method for hydrolysis of DHP to release bound glucuronides reported by 
Dalzell et al. (2012), and adapted from Hegarty et al. (1964b), consisted of 1:1 purified 
urine with 32% HCl. However, this has been shown to be ineffective at achieving complete 
hydrolysis of strongly bound conjugated DHP, as evidenced by the presence of a related 
2,3-DHP peak eluting prior to free 2,3-DHP in chromatograms of urine samples reported in 
Chapters 4, 5, 6 & 7. The following procedure was conducted to advance the hydrolysis of 
the conjugate and confirm the peak as conjugated 2,3-DHP. 
A representative selection of 10 samples identified by colorimetric assay as having high 
levels of conjugated 2,3-DHP was chosen. All samples were cleaned with Millex Millipore® 
0.45-µm cellulose acetate ﬁlters (Sartorius AG, Goettingen, Germany), followed by reverse 
phase solid phase extraction (RP-SPE) on Maxi-Clean™ 300 mg C18 cartridges (Alltech 
Associates Inc., Deerﬁeld, IL, USA) to remove particulate and non-polar contaminants. 
Unacidified urine samples (10 mL) were separated into 2 mL subsamples, and subjected 
to the following hydrolysis treatments: 
1. Minimal acidification (HCl-pH3): A 2 mL subsample was diluted 1:4 with distilled 
H2O and the pH adjusted to ≤ 3 with 0.1 M HCl using a Radiometer analytical® 
automatic titrator. 
2. Standard HCl hydrolysis (HCl-WB): A 2 mL subsample was diluted 1:1 with 32% 
HCl in a sealed polypropylene tube and heated in a water bath at 90ºC for 60 min. 
3. Advanced HCl hydrolysis (HCl-HB): A 2 mL subsample was diluted 1:1 with 32% 
HCl and transferred into a glass vial. The air space was purged with argon prior to 
sealing with a Teflon sealed cap and placed in a heating block at 105ºC for 60 min. 
4. Advanced trifluroacetic acid hydrolysis (TFA-HB): A 2 mL subsample was diluted 
1:1 with 4 M trifluroacetic acid (TFA) (Quemener et al. 1997) and transferred into a 
sealed glass vial. The air space was purged with argon prior to sealing with a Teflon 
sealed cap and placed in a heating block at 110ºC for 35 min. 
DHP was quantified with HPLC according to the method of Dalzell et al. (2012), with a 
corrected mobile phase of 25 mM ammonium dihydrogen phosphate, adjusted to pH 2.5, 
and a Luna 5u C18(2) 150 x 4.6 mm 5 micron Phenomenex column. 
Spectral analysis was conducted with an ultraviolet (UV) photodiode array (PDA) detector 
set to the wavelength range of λ = 190–400 nm. The adsorption spectra of identified peaks 
based on retention time (RT) were then compared with those of standards of HP and DHP 
isomers as additional confirmation (Figure 8.1). The integration of peaks for each isomer 
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was calculated on Shimadzu Lab Solutions SP1 software, version 5.57, at their 
corresponding wavelength maxima (λmax): λ = 235 nm for 4-HP; λ = 270 nm for 2,4-DHP, 
2,5-DHP, 2,6-DHP and 3,4-DHP; λ = 275 nm for 3-HP; λ = 295 nm for 2-HP, 2,3-DHP, and 
2,3-DHP conjugate peaks. 
The area under the 2,3-DHP and 2,3-DHP conjugate peaks was compared for each 
sample preparation method to confirm that the conjugated 2,3-DHP peak converted to free 
2,3-DHP with increasing hydrolysis. 
In order to assess the level of conjugation of DHP, the 226 urine samples from period 1 
(2014) collections were analysed using HPLC with minimal acidification (HCl-pH3). 
8.2.6 Confirmation of the 2,3-DHP conjugate with HDMS 
In addition to HPLC, unacidified filtered urine samples were analysed using high definition 
mass spectrometry (HDMS) in order to confirm the form of the 2,3-DHP conjugate based 
on molecular weight of the peaks using time of flight (TOF) MS, and tandem mass 
spectrometry (MS/MS) on suspected conjugates. Representative samples from 2014 and 
2016 samplings (n = 11 and n = 10, respectively), where an increase in colour was 
recorded using the colorimetric test after acid hydrolysis, were selected. 
As the existing chromatography method was not suitable for introduction to LCMS, the 
polar hydroxy-pyridinyl compounds were separated by anion exchange resin prior to direct 
injection to MS, without a column. The anion exchange resin procedure was in substitute 
for the C18 RP-SPE column and based on the technique presented in Hegarty et al. 
(1979). The exchange resin was prepared by slurry washing 20 g of AG-1 100–200 mesh 
in chloride form with 30 mL of 50% methanol. The resin was packed into 3 mL tubes to 1 
cm below the top with 10 mL of deionised water (DI) using a luer adapter. The resin was 
then converted to hydroxide form with 15 mL of 1 M sodium hydroxide (NaOH) slowly 
passed through, followed with 20 mL of DI, ensuring eluate was pH neutral. 
Subsamples of urine (4 mL) were adjusted to pH 9 using 4 M NH4OH dropwise, ensuring 
that the carboxyl moiety of the conjugate, and the hydroxyl moiety of the free DHP, were 
fully ionised. After standing for 2 hours, samples were filtered using a 0.45 µm Millex 
Millipore membrane filter. The resin-packed tubes were cleaned with 2 mL of DI, and 2 mL 
of air to purge free water from the column. The filtered urine sample (pH ≥9), was slowly (1 
drop per second) passed through the column, followed by 2 mL of DI and 2 mL of air, and 
collected in a 15 mL centrifuge tube. 
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The bound DHP was slowly (1 drop per second) eluted using 10 mL of 5 M formic acid in 
50% methanol, followed by 2 mL of air and eluate collected in a 50 mL centrifuge tube. 
Tubes were stored at <5 °C prior to centrifugal evaporation with a miVac Quattro 
concentrator to remove the formic acid and methanol. The 15 mL tubes were spun at 50ºC 
for 3 hours using H2O method; 50 mL tubes were spun at 40ºC for 4 hours using the –OH 
method, to reduce the volume to <4 mL. Millipore water was used to reconstitute samples 
to the original volume of 4 mL. 
For each sample, two additional 2 mL subsamples were prepared using the minimal 
acidification (HCl-pH3) and the standard HCl hydrolysis (HCl-WB) procedures previously 
described. 
5µL of the eluate from the anion exchange resin was injected into a Waters Acquity UPLC 
system without an LC column, using an isocratic mobile phase of 50:50 water/acetonitrile 
with 0.1% formic acid, at a flow rate of 0.3 mL/min. The flow from the system was 
connected to a Waters Synapt G2-S High Definition Mass Spectrometer. A mass spectrum 
was collected in the range 50–400 Da every 0.5 sec, for a 1 minute period. Data were 
collected in both positive and negative mode. 
Tandem mass spectrometry (MS/MS) with collision-induced dissociation (CID) using a 
collision energy ramp of 10–30 V was performed for peaks of interest. The major fragment 
peaks were then matched to the masses corresponding to the breakdown projects of the 
conjugates. Data were analysed using MassLynx software. All samples analysed by MS 
were also analysed with HPLC as described above. 
8.2.7 Rumen fluid collection 
Rumen fluid samples were collected twice during sampling in 2014 (commencement and 
conclusion of monitoring) and once during the 2016 sampling from each of the bulls. The 
method of collection as described in Graham et al. (2013) was updated with the use of a 
catheter-tip 50 mL syringe in place of a vacuum pump to more efficiently collect samples 
and minimise animal stress. A minimum of 100 mL of rumen fluid was extracted and 
strained through 4 layers of muslin cloth into a collection container. Duplicate 8 mL sub-
samples were withdrawn from the centre of the collected fluid, and added to 11.5 mL of 
100% ethanol for 2014 collections; and 8 mL of RNALaterTM Stabilisation Solution 
(Thermofisher Scientific) for 2016 collections, in 50mL falcon tubes. Tubes were inverted 
for 10 seconds and stored immediately on ice. After 48 hours at ~2ºC, samples were 
centrifuged at 6000 × g for 15 minutes and the supernatant discarded. The pellet was re-
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suspended in 20 mL of 70% ethanol and exported to Australia at ambient temperature for 
PCR isolation. 
DNA analysis for the presence of S. jonesii was conducted following the method described 
in Chapter 5, and rRNA based reverse transcriptase quantitative PCR (qPCR) was 
conducted using the method briefly described below. 
8.2.8 Extraction of DNA and RNA and detection of S. jonesii 
After DNA extraction with a Sodium dodecyl sulphate (SDS) lysis buffer, RNA was 
extracted using the RNeasy® Mini Kit (cat. No. 74104, QIAGEN) protocol with the following 
modifications: 500 µL RLT buffer was added to the aqueous phase, mixed well, and 500 
µL ethanol was added to precipitate RNA. 
The 3 primer pairs described in Chapter 5, plus an additional primer: Sj449R (5’-CGT CAC 
TCG CTT CTT CCC GC-3’), were used to target S. jonesii. PCR products were sequenced 
with BigDye® Terminator v3.1 Cycle Sequencing Kit and analysed on an ABI3130xl 
automatic sequencer (Applied Biosystems, Foster City, CA, USA). Sequences were 
aligned and analysed using AlignX software (Vector NTI software, Invitrogen) against 16S 
sequences from S. jonesii 78.1 as the reference. 
The gDNA from rumen digesta samples was diluted approximately to 50–100 ng/μL and 
used in a 25 μL PCR. Nested PCR (Chapter 5) increased the sensitivity of S. jonesii 
detection, with positive products confirmed by cloning and sequencing. Multiple alignment 
of all sequences was done using Vector NTI’s Advance 11 software (Invitrogen, Life 
Technologies, USA) AlignX module using Clustal W with S. jonesii ATCC 49833 (78-1) 
type strain 16S rDNA as the reference. 
8.2.9 Statistical analyses 
Data were analysed using Microsoft Excel computer software (©2016, Microsoft, 
Redmond, WA, USA) and Minitab® statistical software 16 (©2010, Minitab Inc., State 
College, PA, USA). One-way ANOVA tests were used to analyse total D/HP and 
proportion of conjugated 2,3-DHP with respect to the number of weeks since leucaena-
feeding commenced, time of sampling and individual animal. Means were compared using 
Fisher’s least significant difference (LSD) test (P < 0.05). Descriptive statistics were used 
to summarise mean values with standard errors listed. A probability level of P < 0.05 was 
considered statistically significant, while a P-value between 0.05–0.10 was considered a 
moderate trend.  
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Figure 8.1: UV absorption spectra of: (a) 2-hydroxypyridine (2-HP); (b) 3-hydroxypyridine (3-HP); (c) 4-
hydroxypyridine (4-HP); (d) 2,3-dihydroxypyridine (2,3-DHP); (e) 2,4-dihydroxypyridine (2,4-DHP); (f) 2,5-
dihydroxypyridine (2,5-DHP); (g) 2,6-dihydroxypyridine (2,6-DHP); (h) 3,4-dihydroxypyridine (3,4-DHP), (i) 
3,5-dihydroxypyridine (3,5-DHP); and (j) glucuronic acid.  
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8.3 Results 
8.3.1 Bull LWG and feed chemical composition 
The mean fattening period was 151±15 days, with a range of 28–247 days. The average 
LWG for bulls fattened during 2014 samplings was 0.51±0.02 kg/d with the greatest 
individual LWG of 0.71 kg/d, over a 152-day period. 
The crude protein content of the leucaena feed offered was consistent with previous 
values (Chapter 7) obtained for fresh-cut leucaena leaf material. Bulls were able to 
selectively strip and eat fresh leaf material from the branches offered via prehension with 
their tongue and teeth. Small stem material was also consumed up to a diameter of ~10 
mm. The feed quality of leaf plus small stem was similar to leaf only material (Table 8.1). 
The fibre content and mineral composition were also consistent with results obtained in 
Chapter 7. 
Table 8.1: Chemical composition (g/kg DM) of fresh leucaena leaf and leucaena leaf and stem offered to 
Bos javanicus bulls. 
CP: crude protein; NDF: neutral detergent fibre; ADF: acid detergent fibre 
Parameter Leucaena leaf Leucaena leaf and stem 
CP (g/kg DM) 239 ± 5 203 ± 39 
NDF (g/kg DM) 420 ± 9 397 ± 43 
ADF (total) (g/kg DM) 343 ± 6 308 ± 36 
Fe (mg/kg) 109 ± 20 78 ± 8 
Zn (mg/kg) 12 ± 1 13 ± 2 
 
8.3.2 HPLC DHP results of the longitudinal survey 
The results of the 2014 HPLC analysis of samples collected during the 4 weeks of period 1 
(n = 226), with minimal acidification (HCl-pH3), indicated that the conjugate forms of DHP 
were preserved with almost all (97 ± 1%) mimosine-derived pyridinyl metabolites (HP 
and/or DHP isomers—D/HP) excreted in conjugate form (Figure 8.2). Of note was the 
finding that animals sampled during their first week consuming 100% leucaena diets were 
conjugating DHP at this level with no detected lag period for the up-regulation of 
conjugation to occur. 
The 2,3-DHP isomer (in the primary conjugated form) represented the majority of D/HP 
metabolites (97 ± 1%) (Figure 8.2), with all possible isomers screened (Table 8.2). The 
isomers of 2-HP, 2,4-HP, 2,5-DHP, 2,6-DHP, and 3,5-DHP were never detected in HPLC, 
while 3-HP, 4-HP and 3,4-DHP were detected only sporadically and at low concentrations. 
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Figure 8.2 Relative percentages of metabolite excretion in urine of Bos javanicus bulls sampled during a 1-
month period in 2014 by number of weeks since leucaena-feeding first commenced (values are means of all 
samples collected in that week from corresponding animals). 
3,4-DHP, violet; 2,3-DHP, blue; primary 2,3-DHP conjugate (RT = 5.3 m), dark grey; secondary 2,3-DHP conjugate (RT 
= 3.7 m), light grey; 3-HP, red; and 4-HP, orange. 
There was no significant difference in the proportion of conjugated 2,3-DHP excreted 
regardless of the number of weeks animals had been consuming leucaena (P = 0.98) 1-
way ANOVA or the time of day samples were collected (P = 0.20) 1-way ANOVA, however 
there was a difference among animals (P = 0.00) 1-way ANOVA (Table 8.3); animals 6–10 
& 12 were new to 100% leucaena diets. Instances where the proportion of conjugated 2,3-
DHP was 0% corresponded to samples where the only metabolite was 4-HP, present at 
low (~100 mg/L) levels, with one instance of 3,4-DHP. This occurred in 8 samples for 
animals that had been consuming leucaena for 2–26 weeks. 
The mean amount of total pyridinyl metabolites (HP+DHP) excreted was variable between 
weeks since leucaena-feeding commenced (P = 0.01) 1-way ANOVA (Figure 8.3) and time 
of day the samples were collected (P = 0.00) (Figure 8.4); samples collected at 08:00 had 
the lowest mean total D/HP concentrations (733±108 mg/head) whereas samples 
collected at 13:00 had the highest mean total D/HP concentrations (1418±168 mg/head). 
Of all collections, a total of 29 samples had <100 mg/L D/HP present, which if assessed in 
isolation as “spot” samples would wrongly provide a false negative result. 
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Table 8.2: Chemical structure of all mono- and di-hydroxypyridine compounds with their UV absorption 
maxima and HPLC retention time. 
Compound name/s Common 
abbreviations 
Structure Molecular 
formula 
Molecular 
weight 
(g/mol) 
UV 
λmax 
(nm) 
HPLC 
retention 
time (m) 
2-hydroxypyridine; 
2-(1H)-pyridone 
2-HP; 
2-Po 
 
C5H5NO 95.10 195, 
221, 
293 
7.21 
3-hydroxypyridine 3-HP 
 
C5H5NO 95.10 200, 
277, 
219 
2.27 
4-hydroxypyridine; 
4-(1H)-pyridone 
4-HP; 
4-Po 
 
C5H5NO 95.10 229, 
201 
2.41 
2,3-dihydroxypyridine; 
3-hydroxy-2(1H)-pyridone 
2,3-DHP; 
3,2-HPo 
 
C5H5NO2 111.1 197, 
296, 
234 
6.51 
2,4-dihydroxypyridine; 
4-hydroxy-2(1H)-pyridone 
2,4-DHP; 
4,2-HPo 
 
C5H5NO2 111.1 200, 
272 
4.89 
2,5-dihydroxypyridine; 
5-hydroxy-2(1H)-pyridone; 
3,6-dihydroxypyridine; 
3-hydroxy-6(1H)-pyridone 
2,5-DHP; 
2,5-HPo; 
3,6-DHP; 
3,6-HPo 
 
C5H5NO2 111.1 210, 
224, 
318 
3.68 
2,6-dihydroxypyridine; 
6-hydroxy-2(1H)-pyridone 
2,6-DHP; 
6,2-HPo 
 
C5H5NO2 111.1 305, 
220 
5.27 
3,4-dihydroxypyridine; 
3-hydroxy-4(1H)-pyridone 
3,4-DHP; 
3,4-HPo 
 
C5H5NO2 111.1 205, 
268, 
242 
2.46 
3,5-dihydroxypyridine 3,5-DHP 
 
C5H5NO2 111.1 201, 
289 
2.65 
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Table 8.3: Mean proportion of conjugated 2,3-DHP of total D/HP metabolites by animal. 
Means with different subscripts are significantly different at P < 0.05 
  Proportion of (primary) conjugated 2,3-DHP (%) 
Animal no Mean±s.e. Range n 
1 100±0a 100–100 18 
2 100abcdef 100–100 1 
3 98±1ad 91–100 15 
4 98±1ad 91–100 16 
5 92±6ad 0–100 16 
6 86±8def 0–100 12 
7 87±4abcdef 75–100 7 
8 95±2ad 81–100 13 
9 86±1abcdef 80–89 12 
10 87±4abcdef 59–100 9 
11 75±8cf 0–100 21 
12 95±2ad 89–100 11 
13 91±8ad 0–100 13 
14 73±10bcef 0–100 12 
15 99±1ad 91–100 12 
16 99±1ad 92–100 12 
17 92±1abcdef 90–93 5 
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Figure 8.3: Mean (+s.e.) total HP+DHP excretions of Bos javanicus bulls sampled during a 1-month period 
in 2014 by number of weeks since leucaena-feeding first commenced (values are means of all samples 
collected in that week from corresponding animals). 
 
 
Figure 8.4: Mean excretion of metabolites at the 3 sampling times collected from Bos javanicus bulls during 
a 1 month period in 2014. Bar indicates 1 x LSD0.05 where the mean total D/HP excreted was significant (P < 
0.05). 
3,4-DHP, violet; 2,3-DHP, blue; primary 2,3-DHP conjugate (RT = 5.3 m), dark grey; secondary 2,3-DHP conjugate (RT 
= 3.7 m), light grey; 3-HP, red; and 4-HP, orange. 
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8.3.3 Quantification of D/HP conjugates 
While virtually no free 2,3-DHP (RT = 6.5 m) was detected in samples prepared with 
minimal acidification (HCl-pH3) (Figure 8.5 & Figure 8.6; green trace), a conjugated 2,3-
DHP peak was detected at a RT of 5.3 m, more than 1 m prior to the 2,3-DHP peak. This 
primary 2,3-DHP conjugate had a similar (98% similarity) UV absorption spectra as 2,3-
DHP (Figure 8.7), and was identical to the 2,3-DHP conjugate identified in previous 
chapters. The increased polarity of conjugated DHP resulted in a reduced RT, eluting 
sooner from the RP-C18 HPLC column. 
This peak was confirmed as conjugated 2,3-DHP by sequential hydrolysis of the sample, 
as the standard HCl hydrolysis procedures (HCl-WB) (Figure 8.5; red trace) resulted in a 
shift in area of the primary 2,3-DHP conjugate to free 2,3-DHP. Despite following the 
method of the published best practices an average of 77 ± 5% and 61 ± 2% of 2,3-DHP, 
collected in 2014 and 2016, respectively, remained in conjugated form. Quantification of 
free 2,3-DHP following this procedure, integrating the area of the curve at the RT of the 
2,3-DHP standard, greatly underestimated the amount of 2,3-DHP in the urine. 
Near complete hydrolysis of conjugated DHP was achieved following the advanced HCl 
(HCl-HB) (Figure 8.5; blue trace) methods. The same trend was observed in samples 
collected in 2016 (Figure 8.6). The advanced trifluroacetic acid (TFA-HB) method achieved 
similar hydrolysis as HCl-HB (Figure 8.8). 
In screening for all mimosine-derived pyridinyl urine metabolites, the mono-
hydroxypyridines 3-HP and 4-HP were detected, with 3-HP being greater in abundance 
(Figure 8.5). These were commonly conjugated, as acid hydrolysis increased their 
concentration at the RT of the corresponding standard (Figure 8.8). 
A secondary 2,3-DHP conjugate was also identified with a greatly reduced retention time 
(3.7 m) (Figure 8.5). UV spectral analysis of this peak (Figure 8.7) confirmed a 95% 
similarity to the free 2,3-DHP standard, and 98% similarity to the primary 2,3-DHP 
conjugate (RT = 5.3 m). This peak also reduced after acid hydrolysis. While not 
conclusive, it is speculated that this may be a sulphate conjugate of DHP (Pang et al. 
1994).
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Figure 8.5: Overlaid chromatograms at λ = 295 nm of a single urine collection from a representative animal (99) from 2014 sampling with the following methods: 
HCl-pH3, green; HCl-WB, red; and HCl-HB, blue.  
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Figure 8.6: Overlaid chromatograms at λ = 295 nm of a single urine collection from a representative animal (1609) from 2016 sampling with the following methods: 
HCl-pH3, green; HCl-WB, red; and HCl-HB, blue. 
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Figure 8.7: Overlaid UV absorption spectra for: 2,3-DHP standard, black; primary 2,3-DHP conjugate at RT 
= 5.3 m, red; and secondary 2,3-DHP conjugate at RT = 3.7 m, blue. 
 
 
Figure 8.8: Mean (+s.e.) values of metabolites present in 2016 samplings based on the following methods: 
HCl-pH3; HCl-WB; HCl-HB; TFA-HB. 
2,3-DHP, blue; primary 2,3-DHP conjugate, dark grey; secondary 2,3-DHP conjugate, light grey; 3-HP, red; and 4-HP, 
orange; present in 2016 samplings based on the following methods: HCl-pH3; HCl-WB; HCl-HB; TFA-HB. 
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8.3.4 Identification of D/HP conjugates 
The use of HDMS was employed to identify the form of conjugate for both DHP and HP. 
Time of flight (TOF) identification was conducted in both electrospray negative and 
positive, to account for the different ionisation modes of the free and conjugated forms of 
D/HP. The common conjugate is that with glucuronic acid (Hegarty et al. 1979), combining 
in a condensation reaction to produce a DHP-3-O-glucuronide (DHP-O-G) conjugate 
(Figure 8.9) at a mass of ~287.23 g/mol, and a HP-3-O-glucuronide (HP-O-G) conjugate at 
a mass of 271.23 g/mol. 
 
Figure 8.9: 2,3-DHP-3-O-glucuronide conjugate, adapted from Galanello (2007). 
The analysis of extracted anionic compounds identified both a corresponding DHP 
conjugate species at the mass −1 charge (m−H−) of 286.13 g/mol and a HP conjugate of 
m−H− of 270.09 g/mol in electrospray negative (ESI−) (Figure 8.10a). These conjugates 
were also detected in electrospray positive (ESI+), with the mass +1 charge (m+H+) of 
288.09 and 272.09 g/mol, respectively (Figure 8.10b), although at a reduced intensity. The 
free forms of DHP and HP were also detected in electrospray positive, with a m+H+ of 
112.05 and 96.05 g/mol, respectively. The initial anion resin eluate (“cations”) was 
negative for any D/HP compounds, free or conjugated. 
Tandem MS/MS was performed on the conjugated species of DHP and HP to confirm the 
glucuronide conjugate. Detected in ESI− MS/MS for the HP-O-G conjugate (270.13 g/mol) 
(Figure 8.11a) was the original HP-O-G conjugate, as well as free HP (94.05 g/mol) and 
the corresponding fragmented glucuronic acid [minus the molecular weight of H2O, due to 
the condensation reaction undertaken in the initial conjugation (G.A. – H2O)] (175.07 
g/mol). A proportion of the conjugated form remained intact due to the ramped voltage 
applied to induce disassociation, and the large number of unidentified peaks was due to 
the lack of chromatography prior to injection. 
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Tandem MS/MS of the DHP-O-G conjugate in ESI− (Figure 8.11b) similarly resulted in the 
detection of DHP-O-G (286.13 g/mol), free DHP (110.06 g/mol) and G.A. – H2O (175.08 
g/mol). 
Although the use of HDMS was not quantitative, all samples from 2014 and 2016 
collections were positive for both free and conjugated DHP and HP via TOF and MS/MS 
analysis. The quantification of these compounds performed using HPLC (Figure 8.12) 
confirmed that the majority of D/HP was maintained in conjugated form in the “anion” 
solution.
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Figure 8.10: Molecular identification based on time of flight (TOF) MS from sample 383C from the 2014 collection in: (a) electrospray negative; and (b) electrospray 
positive. 
HP: hydroxypyridine/pyridone; DHP: dihydroxypyridine/hydroxypyridone; HP-O-G: HP-O-glucuronide; DHP-O-G: DHP-O-glucuronide  
(a) 
(b) 
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Figure 8.11: Molecular identification of tandem MS/MS results of sample 383C from the 2014 collection in electrospray negative with CID at: (a) m/z 270 for the HP-
O-G conjugate; and (b) m/z 286 for the DHP-O-G conjugate. 
HP: hydroxypyridine/pyridone; DHP: dihydroxypyridine/hydroxypyridone; HP-O-G: HP-O-glucuronide; DHP-O-G: DHP-O-glucuronide; G.A. − H2O: glucuronic acid – molecular weight 
of water 
(a) 
(b) 
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Figure 8.12: Mean values of the metabolites present from: (a) 2014; and (b) 2016 samplings in 
representative samples chosen for HDMS prepared with the following methods: initial eluate from anion 
exchange resin, cations; eluted anions from anion exchange resin, anions; minimal acidification, HCl-pH3; 
partially hydrolysed DHP, HCl-WB. 
2,3-DHP, blue; primary 2,3-DHPconjugate, dark grey; secondary 2,3-DHP conjugate, light grey; and 4-HP, orange. 
8.3.5 Colorimetric results 
In the past, iron(III) chloride colorimetric tests have been used extensively to confirm the 
approximate amount of DHP in urine (Graham et al. 2014). The results of this study have 
identified that the validity of the test depends completely on the effectiveness of the 
hydrolysis method. For this reason, colorimetric tests were utilised in the selection of 
conjugated samples for further analysis using HDMS. An initial lack of blue colour (Plate 
8.3a), followed by dark blue/black colour development after acid hydrolysis (Plate 8.3b) 
indicated high levels of conjugated 2,3-DHP. The assigned rank of the colorimetric tests 
was moderately correlated with the corresponding HPLC results, with an exponential curve 
(y = 37.20e0.73x; R2 = 0.85) (Figure 8.13). The estimation of the percentage of DHP 
conjugated was also related. Thus, interpretation of on-site colorimetric tests has the 
capacity to provide an approximate assessment of the range of D/HP isomers present and 
the level of conjugation in urine. 
A shortcoming in the method of hydrolysis was that it was only 23–40% effective, thus 
underestimating the total amount of DHP present. However, the detection range for the 
colorimetric method for 2,3-DHP was limited to a maximum of ~2000 mg/L, above which 
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any additional D/HP was masked by the resultant intense dark blue/black colour. The initial 
pink/red colour in the sample tested in Plate 8.3a corresponded to 197 mg/L 3-HP, 
however the method requires further work to advance the test to scale. Further, several 
isomers of D/HP produced a similar colour, and when multiple isomers were present the 
colour mixture was not able to be easily interpreted with the naked eye. Despite these 
limitations, the test was effective in estimating the level of conjugation, and provided a 
more accurate assessment of the toxicity status of the animal. 
 
Figure 8.13: Calibration curve of 2,3-DHP estimation based on colorimetric rank against HPLC results after 
normal acid hydrolysis procedures HCl-WB. 
 
Plate 8.3: Initial colorimetric test result of: (a) filtered unacidified urine; and (b) the same sample after acid-
hydrolysis (HCl-WB). The concentration of 2,3-DHP-O-G in (a) was 1300 mg/L; of which 65% remained 
conjugated after standard acid hydrolysis procedures (HCl-WB) (b). This sample contained 197 mg/L 3-HP 
after complete hydrolysis (HCl-HB). 
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8.3.6 PCR detection of S. jonesii 
Rumen fluid from 17 animals, preserved in 70% ethanol, sampled in 2014 was tested with 
all samples positive for S. jonesii at their final collection based on qPCR RNA. However, 
only 82% of samples (n = 14) were positive for detection of S. jonesii at the initial 
collection. Two of the three animals that were negative at their first collection were new to 
high leucaena diets and were sampled during their first week on leucaena. The detection 
levels of S. jonesii for gDNA-based nested PCR was much lower with only 1 bull positive 
at the first sampling (3% of all collections). 
When samples were collected in 2016 (n = 10) and preserved in RNAlater®, 100% of 
samples analysed based on qPCR RNA were positive for S. jonesii; none of these animals 
were positive when analysed with gDNA-based nested PCR. 
The RNA analysis method had a 1000-fold increase in sensitivity of detection compared 
with DNA analysis. The finding that samples which tested negative for S. jonesii based on 
DNA analysis were positive based on RNA analysis confirmed that the populations of S. 
jonesii were at the limits of detection for nested DNA PCR (Chapter 5). Despite its 
increased sensitivity, RNA based PCR is not suitable for quantification of S. jonesii as it is 
based on an unknown number of sequence copies that may not represent individual 
bacteria.  
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8.4 Discussion 
The results of this study point to conjugation as the major protective mechanism against 
leucaena toxicity for Bali bulls and validate the findings of previous “spot” samplings 
throughout Indonesia and Australia, where high urinary 2,3-DHP concentrations were 
recorded, largely conjugated, and in animals that were asymptomatic. These findings 
confirm that 100% leucaena diets were productive at fattening bulls without adverse toxic 
effects. 
8.4.1 Conjugation as a detoxification technique 
This study provides evidence that conjugation with glucuronic acid is the major pathway in 
the detoxification of DHP in ruminants consuming high levels of leucaena. From the outset, 
it was apparent that most DHP was not being degraded by bacteria as mean urinary DHP 
concentrations of bulls monitored were persistently high. This occurred throughout the 4-
week period, regardless of the length of time they had been consuming leucaena. Despite 
this, neither animal health nor productivity were negatively impacted; on the contrary, the 
LWGs of animals on high-leucaena diets were consistently high. Further, the results of the 
in-depth analysis of the excretory patterns of DHP revealed that almost all DHP is voided 
in the conjugated form. Therefore, complete conjugation of otherwise toxic levels of DHP 
had a profound detoxifying effect for the bulls. 
The detoxifying effect of conjugation is related to the mode of toxicity of DHP which is due 
to the chelatory nature of the compound. The arrangement of the two ortho (O,O) moieties 
in DHP readily bind to divalent transition metals. This is biologically toxic in mammals as 
many of those metals, such as Zn, Mg, and Cu, are essential to regular cellular function 
(Berdoukas et al. 1993; Hoffbrand and Wonke 1997; Porter 1997; Kwiatkowski 2008). The 
effect of conjugation is to enzymatically attach an acidic compound to a hydroxyl group to 
inhibit chelation, effectively eliminating the biological activity of the toxin (Singh et al. 1992; 
Galanello 2007; Crisponi and Remelli 2008). Conjugation also increases the water 
solubility of the compound, increasing the speed of urinary clearance of toxin (Pang et al. 
1994; Galanello 2007; Sooriyaarachchi and Gailer 2010; Dhakal et al. 2013). 
Conjugation of DHP in ruminants has long been known to have occurred, as hydrolysis of 
the conjugate was a necessary step in the method for measuring free DHP levels (Hegarty 
et al. 1964a), although it was not historically considered a protective mechanism. The 
initial focus of DHP-toxicity was on its inhibition on thyroid hormones, even though it was 
reported that the conjugated form of DHP had little negative effect on the enzymes 
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involved in thyroid hormone synthesis (Christie et al. 1979). Interestingly, there was no 
regard for the possible role of conjugation in reducing toxicity. Much like the early work on 
mineral supplementation, after the discovery of S. jonesii, research into the protective 
properties of conjugation was largely ignored. 
The original notion that bacterial degradation was the principal pathway of detoxification 
(Jones and Megarrity 1983), was also probably based on misinterpretation of why 
asymptomatic leucaena-fed goats in Hawaii were excreting “virtually no DHP” (Jones 
1994). A crucial detail at the time was largely overlooked: the goats were in fact excreting 
2,3-DHP and this was reported as a blue colour reaction to iron(III) chloride solution 
(Jones and Megarrity 1983). The original publication from this study (Jones 1981) however 
made no mention of this reaction, but it was later noted by Jones et al. (2009) as one of 
the first instances of 2,3-DHP detection. There have since been several 
misrepresentations of the occurrence of 2,3-DHP (Jones and Megarrity 1983; Ford et al. 
1984; Jones et al. 1985a; Jones et al. 2009), all of which overlooked the significance of 
conjugation of DHP at the time of analysis. 
8.4.2 High levels of 2,3-DHP 
This study confirms the now persistent finding that 2,3-DHP is the end-point metabolite of 
mimosine degradation in ruminants. The breakdown of 3,4-DHP in the presence of S. 
jonesii has been widely studied and it has been reported in numerous studies to be 
converted to the isomer 2,3-DHP as an intermediate before complete degradation, despite 
infrequent detection in vitro (Jones et al. 1985a; Allison et al. 1987; Allison et al. 1990; 
Allison et al. 1992; Paul et al. 1999). This led researchers to assume that it was 
uncommon and transient, which is in conflict with the majority of recent findings where 
incomplete degradation of 3,4-DHP in vivo, resulted in high concentrations of 2,3-DHP 
(Ghosh et al. 2007; Dalzell et al. 2012; Phaikaew et al. 2012; Contreras-Hernández et al. 
2013; Graham et al. 2013; Ruz-Ruiz et al. 2013; Halliday et al. 2014b; Halliday et al. 
2014c) (Chapter 5). RNA PCR screening indicated that S. jonesii was present in many of 
these studies, although frequently at low populations. As such, it is unlikely that the 
accumulation of 2,3-DHP is the sole result of S. jonesii activity (McSweeney and Shelton 
2009). Despite the continuous high levels of 2,3-DHP excreted in the leucaena-fed bulls in 
this study, this did not impact animal LWG production. This can largely be attributed to 
both the conjugation of DHP and the reduced toxicity of the 2,3-DHP isomer. The 
persistent identification of 2,3-DHP also confirms the herd spot samplings of previous work 
were correct interpretations of DHP status of the animals. 
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8.4.3 The conjugate of 2,3-DHP identified 
The vast majority of 2,3-DHP excreted in bulls (which accounted for the vast majority of 
DHP excreted) was in conjugated form. The toxicity of DHP is due to the long-term 
disruption of homeostasis of essential metals (including Cu2+, Mn2+, Zn2+, Fe2+) impacting 
metalloenzyme function (Puchała et al. 1995; B. Di Marco et al. 1999; Liu and Hider 2002; 
Flora and Pachauri 2010). This concept has been widely researched in human 
pharmacological research where 3,4-DHP is exploited for iron overload therapy (Santos 
2008; Santos et al. 2012; Lachowicz et al. 2015). However, the compound is rapidly 
eliminated from the body after between 47–132 minutes due to conjugation (Galanello 
2007; Flora and Pachauri 2010; Sooriyaarachchi and Gailer 2010). The conjugate form of 
DHP in the present study was identified as a glucuronide (bound with glucuronic acid). 
This is a common non-specific detoxification mechanism for dealing with a variety of 
xenobiotics, especially hydroxyl compounds (Gupta and Akbar 1993; Sahlu et al. 1995; 
Galanello 2007; Crisponi and Remelli 2008). It is this hepatic biotransformation of the 
ligand by glucuronidation that renders the DHP inert, with previous studies in humans also 
identifying up to 90% excreted as the 3-O-glucuronide conjugate (Singh et al. 1992; Flora 
and Pachauri 2010). 
The conjugate form of DHP was identified in the HPLC chromatogram, with a shift from 
conjugated to free form with increasing acid hydrolysis. Of note is the finding that the 
methodology for all previous samplings has been incomplete in acid-hydrolysing urinary 
DHP, with ~70% remaining conjugated. Re-analysis of previous chromatograms from 
buffalo, goats and cattle from Australia and Indonesia confirmed the presence of large 
amounts of the 2,3-DHP-O-glucuronide via UV spectral analysis (data presented in 
previous chapters). While this finding infers that all previous work underestimated the 
amount of DHP excreted by over half, it also implies that any conjugated DHP was likely to 
be non-toxic. Unfortunately, due to the acid-preservation of these samples, it was not 
possible to determine the percentage of DHP conjugated at the time of collection. 
Due to the strong detection of glucuronic acid conjugates, the primary conjugate of DHP is 
confirmed as the glucuronide form. The secondary conjugate is presumed to be that of a 
sulphate conjugate, which is also common (Pang et al. 1994; Shelnutt et al. 2002; Dhakal 
et al. 2013). The greatly reduced HPLC RT of the secondary conjugate is indicative of a 
much more polar compound, such as the sulphate form. The secondary DHP conjugate 
was present sporadically, and was not present in samples subjected to HDMS analysis. 
Thus, the presence of a sulphate form of conjugate is inconclusive and work is ongoing. 
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8.4.4 Findings regarding S. jonesii 
The results of this study once again confirm that S. jonesii is simultaneously ubiquitous to 
ruminants with the high positive RNA PCR results, yet present in the rumen in low 
numbers with infrequent detection with DNA PCR indicative of low populations, at the limit 
of detection (Padmanabha et al. 2014). The assertion that S. jonesii is part of the normal 
flora of ruminants stems from the fact that it shows specificity for arginine and histidine as 
metabolisable substrates (Allison et al. 1992), with growth in vitro enhanced with the 
addition of these amino acids, as well as phenylalanine (McSweeney and Shelton 2009). 
This occurs at the expense of 3,4-DHP or 2,3-DHP utilisation. The unusual use of arginine 
and histidine as energy substrates is unique to S. jonesii [a strict anaerobic 
Chemoorganotroph (Allison et al. 1987; Allison et al. 1992; McSweeney et al. 2002)] and 
most likely explains why it is always detected in ruminants with the absence of leucaena in 
diet (Padmanabha et al. 2014). This affords it a unique, albeit limited, physiological niche 
in the rumen (McSweeney et al. 1993a), although the lack of specificity for DHP as 
preferred substrate may explain why, despite large amounts of DHP in the rumen, 
populations remain low in leucaena-fed bulls. In fact, other authors have indicated that in 
vitro degradation of the isomers of DHP by S. jonesii can be lost in the absence of a 
substrate (Domínguez-Bello et al. 1997), but also inhibited by an excess of the alternate 
isomer (Rincón et al. 1998; McSweeney and Shelton 2009). In addition, there is known 
isomer-specificity within the isolated strains of S. jonesii (Allison et al. 1992; Jones 1994; 
McSweeney and Shelton 2009), not accounting for the SNPs that have been identified in 
this thesis. 
Without explicitly testing for it in this study, the accumulation of 2,3-DHP is likely due to 
several factors, including: critically low populations of S. jonesii (Hammond et al. 1989; 
Domínguez-Bello et al. 1997; McSweeney et al. 2002); strains of S. jonesii not able to 
degrade 2,3-DHP (Jones 1994); and competitive inhibition of DHP degradation due to the 
presence of more favourable amino acid substrates (McSweeney and Shelton 2009). 
The findings that high levels of 2,3-DHP were present despite low populations of S. jonesii 
may suggest that a consortium of many morphological types of bacterial species and/or 
strains are involved in the conversion of 3,4-DHP to 2,3-DHP (Domínguez-Bello and 
Stewart 1990; Domínguez-Bello and Stewart 1991; Tan et al. 1994; Domínguez-Bello et 
al. 1997; Chhabra et al. 1998; McSweeney et al. 2002; McSweeney and Shelton 2009; 
Aung et al. 2011; Derakhshani et al. 2016). While little is known of the metabolic fate of 
2,3-DHP, nor why isomerisation of 3,4-DHP occurs (Allison et al. 1994), it is suggested 
 Chapter 8 Conjugation in eastern Indonesia 
 135 
that the degradation of 2,3-DHP likely follows similar pathways to the catabolism of related 
DHP compounds by aerobic microbes (Allison et al. 1994). There are many aerobic 
microorganisms known to degrade pyridine-compounds (Watson et al. 1974a), and thus 
there should be no surprise that biological pathways have evolved to degrade naturally 
occurring DHP compounds (Watson et al. 1974b), as they also commonly exist as 
intermediates in pyridine degradation. 
The finding of the mono-hydroxypyridines 3,-HP and 4-HP in urine has not been recorded 
previously, and may provide insight as to the pathways by which 3,4-DHP is isomerised to 
2,3-DHP. Whilst the toxicities of these monohydroxypyridines is not certain, they also were 
found to be highly conjugated when excreted.  
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8.5 Conclusion 
This study has highlighted the high value of leucaena as a forage for fattening, and 
confirmed the new paradigm of toxicity amelioration in ruminants via a process of hepatic 
conjugation. The attachment of a glucuronic acid conjugate to DHP effectively neutralises 
the biological toxicity of the otherwise strong ligand, preventing essential element 
deficiencies. This occurred with all bulls and with almost all DHP. Bulls newly introduced to 
high levels of leucaena also demonstrated this same proficiency for conjugation as those 
on long-term 100% leucaena diets. 
Despite the apparent ubiquitous presence of S. jonesii in bulls tested, the implied low 
populations cannot be sufficient to degrade all DHP in vivo and indeed this was the case in 
this study, confirming consistently similar findings through this thesis. The longitudinal 
profile of DHP excretion obtained in this study also confirms that the high levels of 2,3-
DHP in mean herd spot urine tests are not transient and are valid assessments of the 
usual metabolism of mimosine, whereby 2,3-DHP is the majority endpoint, albeit in a 
conjugated form. 
It is recommended that there should be a redefinition of how DHP-toxicity is assessed, 
with the level of conjugation a vital parameter in the determination. Further work should 
include improved spot-urine testing using iron(III) chloride to estimate the level of 
conjugation of DHP. The role of mono-HP compounds as possible intermediates in the 
isomerisation of 3,4-DHP to 2,3-DHP should also be investigated, as well as the indication 
of a possible sulphate conjugate of DHP. 
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Chapter 9 Conclusions and future directions 
9.1 Conclusions 
Despite the many nutritional values of leucaena, the issue of toxicity, first identified in 
Australia in the 1970s, has been an ongoing barrier to wide-scale adoption for ruminant 
feeding in the tropical world. The discovery of the hydroxypyridone (DHP) degrading 
bacterium Synergistes jonesii in the mid 1980s, and subsequent commercialisation of a 
bacterial inoculum, was thought to overcome this issue. However, since 2003, concerns 
have been raised over the efficacy and persistence of the inoculum in Australia, and of the 
occurrence of the bacterium in other tropical countries. The research presented in this 
thesis has led to significant advances in microbiological identification and quantification of 
S. jonesii, and in DHP chromatographic measurement. The main objective of this thesis 
was to study protective mechanisms against toxicity, including the efficacy of microbial 
degradation of DHP by S. jonesii, and to identify other mechanisms such as metabolic 
detoxification. The results of this thesis have greatly advanced our understanding of 
leucaena toxicity, many of which are in dissensus with original views. This has led to a 
new paradigm for toxicity management and the following conclusions. 
9.1.1 Findings regarding DHP 
Historically, 3-hydroxy-4(1H)-pyridone (3,4-DHP) was considered the primary metabolite of 
mimosine post-ingestion in ruminants and was described as a potent goitrogen, inhibiting 
the iodination of tyrosine-based hormones due to its analogous nature with pyridoxal 
which antagonises peroxidase-based enzyme pathways. The secondary isomer 3-
hydroxy-2(1H)-pyridone (2,3-DHP) — often incorrectly referred to as 2,3-dihydroxypyridine 
— was originally detected infrequently in urine and rarely in in vitro degradation studies, 
and as such, it was thought to exist as merely a transitory intermediate isomer. 
However, a less studied aspect of DHP was the chelatory nature of these compounds as 
ligands, binding with essential metals and leading to deficiencies. Indeed, the clinical signs 
of DHP-toxicity in ruminants can more accurately be ascribed to severe essential element 
deficiencies. Whilst research in the field of DHP toxicity in ruminants largely considered the 
goitrogenic effects, a largely unacknowledged body of work, published during the same 
time period investigating pharmacological uses of DHP, strongly supports the toxic 
chelatory nature of DHP, leading to the conclusion that DHP acts primarily as a potent 
ligand, chelating with divalent metal cations in vivo. This is due to the arrangement of DHP 
as the keto-enol tautomer at physiological pH, with the hydroxy-carbonyl functional moiety 
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on the pyridine ring forming strong bidentate coordinate-covalent bonds with a central 
metal ion, which is subsequently voided in the urine. 
A consistent finding throughout all studies in this thesis was that high levels of DHP are 
excreted when ruminants consume high leucaena diets and that almost all DHP excreted 
is of the isomer 2,3-DHP. As such, 2,3-DHP can now be considered the common end-
point metabolite of mimosine degradation in ruminants on high leucaena diets. Despite 
high levels of 2,3-DHP excreted, there was no evidence of deleterious impacts on animal 
health or production observed throughout all studies. A contributing factor to this is that, 
contrary to initial views that both isomers were equally toxic, when considering the 
chelatory capacity, 2,3-DHP is in fact an order of magnitude less toxic than 3,4-DHP. This 
is due to the re-arrangement of the electronegative carbonyl moiety significantly closer to 
the electropositive ring nitrogen, greatly reducing the affinity to bind to cationic metals. 
This conversion of 3,4-DHP to 2,3-DHP may in fact be a synergistic coping response with 
the evolutionary advantage of isomerisation considered two-fold: for the ruminant, it 
reduces the toxic chelatory capacity; whereas for the microbial populations, it results in a 
weaker structure to break down. 
The conversion pathway of 3,4-DHP to 2,3-DHP is as yet unknown. S. jonesii is known to 
be capable of this, and was commonly detected in ruminants in all studies of this thesis, 
however it was often at or below the levels of detection, indicating low populations which 
are unlikely to be solely capable of this isomerisation when 100% diets of leucaena are 
consumed. 
Whilst not conclusive, this thesis has contributed to the advancement of this pathway, with 
the previously undescribed hydroxypyridines 3-HP and 4-HP commonly detected. This 
may suggest microbial isomerisation, at least in part, occurs via stepwise reductive 
reactions prior to re-hydroxylation. This is a common pathway in many pyridine-degrading 
bacteria which destabilises the compound, more easily enabling hydrolytic ring fission. 
9.1.2 Findings regarding S. jonesii 
The results of this thesis support the new notion that S. jonesii is ubiquitous in all 
ruminants and is not dependent on previous exposure to leucaena. Whilst this indicated 
that inoculation was not required to introduce S. jonesii into ruminants newly consuming 
leucaena, there were several provisos: (a) there were many molecular variants of S. 
jonesii (often associated with differing geographical locations), due to the presence of 
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point mutations in the genetic sequence, likely affecting functional DHP-degrading 
capacity; and (b) S. jonesii was always present at low population density. 
In the absence of inoculation as a management strategy, there was evidence that 
indigenous populations of S. jonesii were likely contributing to partial, yet incomplete, 
degradation of DHP and likely also contributing to the conversion of 3,4-DHP to the less 
toxic isomer 2,3-DHP. It is not known to what extent other microbial populations may also 
be contributing to this conversion. Also, whilst high levels of DHP are commonly measured 
in urine, it is not clear what proportion of ingested DHP (mimosine) this represented. As 
such, although the capacity to fully degrade DHP appears limited, the role of S. jonesii in 
total animal protection cannot be excluded, and further work, such as DHP recovery 
studies with the new methodologies should aim to apportion a relative significance on the 
ruminal degradation and isomerisation of DHP in addition to metabolic conjugation. It is 
however concluded that, whether animals received inoculum or not, S. jonesii alone is not 
capable of affording complete protection to ruminants on high leucaena diets. 
9.1.3 Findings regarding metabolic detoxification via conjugation 
The findings of this thesis strongly support the pathway of conjugation as a crucial method 
in the neutralisation of DHP toxicity for ruminants consuming leucaena. The phenomenon 
of asymptomatic and highly productive ruminants consuming sole leucaena diets, despite 
excreting high levels of undegraded 2,3-DHP, was commonly observed in all experiments. 
This can be attributed primarily to the fact that almost all DHP (and associated HP) was 
excreted in conjugated form, with the primary conjugate identified as glucuronic acid. The 
resulting DHP-3-O-glucuronide complex has a severely reduced ligand strength, and an 
increased water-solubility enabling it to be more rapidly excreted from the body (Galanello 
2007; Flora and Pachauri 2010; Sooriyaarachchi and Gailer 2010). Ruminants were 
shown to quickly adapt to high leucaena diets as the process of glucuronidation is a non-
specific metabolic mechanism for neutralising a variety of toxins. 
9.1.4 A new paradigm 
The results of this thesis have contributed new insights into the detoxification mechanisms 
ruminants employ to deal with the leucaena toxin DHP, of which a critical pathway is that 
of hepatic conjugation. Conjugation was shown to be highly efficient and effective in all 
ruminant species. This approach is not novel, however its importance is only now being 
fully appreciated. 
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This thesis showed that 100%-leucaena diets were successful in providing a low-cost, low-
labour feed source for the productive fattening of bulls for smallholder farmers in 
Indonesia. These findings have great importance to livestock production in the tropical 
world, as ruminants are inherently and autonomously capable of detoxifying mimosine 
(after a brief adaptation period) and its metabolites, without negatively affecting their 
heath, performance, or production. This represents the removal of a world-wide barrier to 
adoption of leucaena-feeding for farmers. 
This has led to a new paradigm in animal management and new research opportunities, 
however is in dissensus with many reports from earlier leucaena toxicity research. Where 
possible, the discordant results of this thesis are ascribed to likely reasons and remaining 
knowledge gaps acknowledged. These include: 
The lack of incidence of enlarged thyroids and/or decreased thyroid hormones 
The goitrognic effect of DHP and associated symptoms were widely reported in early 
research, however, were not observed in the studies of this thesis; other authors published 
similar findings (Hamilton et al. 1971; Falvey 1976). It is hypothesised that the conversion 
of 3,4-DHP to 2,3-DHP and subsequent conjugation prevented toxicity from manifesting. 
Whilst goitre was commonly reported on in early research, anecdotal instances of goitre 
from graziers and smallholder farmers are rare and when present, compounding factors 
such as pre-existing essential metal deficiencies and/or an increased susceptibility of 
individual animals may contribute to the severity of presentation. The age of the animal, 
breed, and seasonal conditions (Jones et al. 1976) can also have an effect on 
susceptibility. The common practice of supplementing animals with mineral blocks/licks 
would also alleviate any possible metal deficiencies DHP toxicity may cause, and 
contribute to the prevention of clinical symptoms. 
The lack of significant levels of 3,4-DHP in urine 
Whist studies conducted during the 1980s reported 3,4-DHP as the common isomer 
excreted in ruminants consuming leucaena, in most cases there were low to negligible 
levels of 3,4-DHP measured in the studies of this thesis, with the vast majority excreted as 
2,3-DHP. Possible causes for this isomerisation to 2,3-DHP include the numerous bacteria 
that have been shown to specialise in degradation of either isomer (Hammond et al. 1989; 
Domínguez-Bello and Stewart 1990; Domínguez-Bello and Stewart 1991; Tan et al. 1994; 
Domínguez-Bello et al. 1997; Chhabra et al. 1998; Aung et al. 2011; Derakhshani et al. 
2016), including different strains of S. jonesii (Allison et al. 1992). Indeed there were many 
variants of S. jonesii detected in the studies of this thesis, which are likely to affect the 
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capacity to degrade DHP isomers. While the different, and possibly changing, strains of S. 
jonesii may be responsible for the change in the dominant isomer excreted, there has 
historically been a general misunderstanding and misrepresentation of the isomer 2,3-DHP 
(Jones 1981; Ford et al. 1984; Jones et al. 1985a; Jones 1994; Jones et al. 2009). Indeed, 
the seminal study of Jones and Megarrity (1983) initially overlooked the finding of 2,3-DHP 
in urine. The lack of detection of 2,3-DHP in in vitro degradation studies would have also 
contributed to the reduced emphasis on the isomer. In addition, in early studies, detection 
of DHP was conducted by colorimetric assessment with iron(III) chloride solution, which 
can be confounded by incomplete hydrolysis of conjugated DHP, and the presence of 
other polyphenolic compounds if not removed (Megarrity 1978; Lowry et al. 1985). 
Considering HPLC analysis, the more polar 3,4-DHP elutes early in the chromatogram and 
can more easily be confounded by the presence of other polar urinary metabolites 
absorbing at that wavelength. While 2,3-DHP elutes much later and is far more easily 
identifiable, if not completely hydrolysed, it will have a reduced retention time compared to 
a 2,3-DHP standard which could easily have been overlooked. 
The reduced efficacy of inoculation with S. jonesii 
The results of this thesis did not show a rapid and complete degradation of DHP after 
inoculation, in contrast with many earlier studies. In addition, when S. jonesii was present, 
animals on high leucaena diets continued to excrete undegraded DHP. As such, it is 
possible some degradation was occurring by indigenous S. jonesii strains which prevented 
an observable effect of the inoculated S. jonesii. Dosing with the fermenter cultured 
inoculum was shown to influence the rate of degradation of different isomers however. 
The low populations of S. jonesii in the rumen suggest it alone is not capable nor 
responsible for complete DHP degradation, especially when animals are consuming high 
levels of leucaena. An explanation for the more dramatic differences in DHP excretion 
after ruminal inoculation in Australia may be attributed to the lower levels of leucaena in 
diet, typical of Australian grazing systems, combined with the inoculation of variants of S. 
jonesii with greater functional degradation capacity. 
There are many anecdotal reports from graziers, of steers improving in condition and 
recovering from toxicity symptoms such as hair loss and excessive salivation after 
inoculation in Australian grazing systems. These signs of initial mimosine toxicity 
commonly abate within the first 4 weeks, regardless of inoculation and are also commonly 
reported by Indonesian farmers. The coincidence of the recovery from mimosine toxicity 
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and the inoculation of animals in Australian grazing systems could be mistaken for the 
effects of inoculation. 
The prevalence of conjugation 
A major finding of this thesis was the role of conjugation in detoxification of DHP, however 
this finding was not novel and was given consideration as a detoxification mechanism in 
early research into leucaena toxicity (Christie et al. 1979; Hegarty et al. 1979). Indeed the 
original method for determining DHP in urine acknowledged the conjugate and the need to 
hydrolyse samples for accurate colorimetric assessment (Hegarty et al. 1964a). 
After microbial degradation of DHP was postulated in 1981 (Jones 1981) and the 
subsequent discovery of S. jonesii in 1984 (Jones and Lowry 1984), research into DHP 
toxicity in ruminants converged with a strong focus on microbial degradation, with little 
consideration for the role of conjugation. As largely all measurement of urinary DHP from 
1984 onwards was conducted on acid-hydrolysed samples, utilising a method that has 
been shown to be incomplete, the extend of conjugation would not have been detected.  
9.1.5 Practical animal recommendations 
The practical outcome of this research is the identification that high levels of leucaena are 
safe to consume in Indonesian smallholder bull fattening systems and that conjugation of 
undegraded DHP plays an important role in this. In order to manage the initial mimosine 
toxicity commonly experienced, a graduated introduction to leucaena is recommended for 
these systems. 
The results also suggest that inoculation in Australian grazing systems may not be as 
effective as originally postulated, and indeed may no longer even be required, due to the 
presence of indigenous DHP-degrading bacteria and the effect of conjugation neutralising 
the toxicity of undegraded DHP. Whilst not explicitly tested, all indications are that 
conjugation occurs in Australian cattle at similar rates as in Indonesian ruminants. 
The conclusions of this thesis herald a revision of current recommendations to Australian 
graziers whereby inoculation may no longer be necessary. Further investigation into the 
remaining knowledge gaps, identified as future research needs, is important before such a 
dramatic change in practice is advised. 
It is however, strongly recommended that herd urine testing be conducted in order to 
elucidate the protection strategies being employed, whereby strategic inoculation may still 
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play a role in certain circumstances. Maintaining available mineral supplements and ready 
access to water, especially in Indonesian systems, is also recommended. 
9.2 Future research needs 
Despite the findings of this thesis, there remain topics of further research in order to fully 
appreciate this new paradigm, and to inform decisions to change current practices. Initially, 
testing of Australian animals consuming leucaena should be conducted to confirm the 
efficacy of conjugation domestically. This would involve improving chromatographic 
methodologies: combining liquid chromatography with UV absorption, with a volatile 
mobile phase suitable for mass spectroposcy. The use of LCMS would allow the 
secondary conjugate to be identified, hypothesised to be a sulphate conjugate. This would 
allow the most accurate assessment of DHP toxicity in ruminants. 
Before management techniques can be updated, the overall significance of conjugation 
and degradation is required. Research to achieve this would involve metabolic recovery 
trials with a N isotope labelled mimosine infusion, allowing the fate of mimosine to be 
mapped throughout the circulatory system and excreta. This would also assist in 
understanding the isomerisation pathways of 3,4-DHP to 2,3-DHP. 
As mimosine was not present in urine samples analysed, it was not the focus of this thesis. 
However, signs of alopecia and excessive salivation, ascribed to the antimitotic and 
chelatory effect of mimosine, were commonly observed in bulls upon their initial 
introduction to leucaena, especially when fed at 100% of diet. This is supported by strong 
anecdotal accounts from many farmers. As the effects are short-term in nature, mimosine 
is not considered an issue in animals fattened for human consumption, however, further 
research should consider the implications of mimosine on the reproductive performance of 
stud bulls or gestating cows when leucaena is first introduced. 
Additional knowledge gaps that require further research include: the isomerisation 
pathway/s of 3,4-DHP to 2,3-DHP, which would involve the assessment of intermediates 
such as HP in the rumen and in circulation; and, the potential effect of DHP in circulation 
prior to conjugation, which would involve comparing the levels of free and conjugated DHP 
in the portal and hepatic veins. 
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